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ABSTRACT 
 
BACKGROUND 
 
Participation in regular physical activity has numerous health benefits, but there 
is also a risk of musculoskeletal soft tissue injuries that may occur as a result of 
participation in physical exercise. The number of training and competition days 
lost due to anterior cruciate ligament (ACL) ruptures has been reported as the 
highest of all musculoskeletal soft tissue injuries, implying that ACL ruptures are 
among the most severe musculoskeletal soft tissue injuries that can occur 
during exercise. The exact aetiology and mechanisms that cause these ACL 
ruptures are still under investigation. A large number of research studies have 
been conducted to establish the potential extrinsic and intrinsic risk factors, as 
well as mechanisms for ACL ruptures. Specific intrinsic risk factors for ACL 
ruptures that have been reported include anatomical, hormonal, and 
neuromuscular factors. Recently, the possibility of genetic influence on the risk 
of ACL ruptures has been suggested, but to date, this area has received little 
attention. 
 
In a single study a specific genetic sequence variation, namely the functional 
COL1A1 Sp1 binding site polymorphism, has been associated with acute soft 
tissue injuries (cruciate ligament ruptures and shoulder dislocations). In this 
study, the rare TT genotype of this polymorphism was under-represented within 
the acute ligament injury groups. Since soft tissue injuries, including ACL 
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ruptures are multifactorial disorders, it is unlikely that only a single genetic 
variation is associated with an altered risk for ACL ruptures.  
 
AIM OF THE THESIS 
 
The primary aim of this thesis was to identify candidate genes that may be 
associated with ACL ruptures, and then use a genetic association approach 
following a case-control study design to identify specific sequence variants 
(single nucleotide polymorphisms, SNPs) within these candidate genes which 
may predispose individuals to ACL ruptures. Candidate genes (COL1A1, 
COL5A1 and COL12A1) were selected based on the biological function of their 
encoded proteins (type I, type V and type XII collagen respectively) within the 
basic structural and functional unit of ligaments, namely the collagen microfibril. 
The objectives of the specific gene association studies which addressed the 
primary aim of this thesis were as follows: 
 
• To determine if the rare TT genotype of the functional Sp1 binding site 
polymorphism within intron 1 of the COL1A1 gene was associated 
specifically with ACL ruptures in an independent second South African 
Caucasian population with gender-matched controls. (Study 1) 
• To determine if two sequence variants (BstUI and DpnII restriction 
fragment length polymorphisms, RFLPs) within the 3’-UTR of the COL5A1 
gene, which has previously been investigated in Achilles tendon injuries, 
were associated with an increased risk of ACL ruptures. Due to the 
reported increased risk of ACL ruptures in females, a secondary objective 
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of this study was to investigate if there were any gender-specific 
associations between the two COL5A1 sequence variants and risk of ACL 
ruptures. (Study 2) 
• To determine if two previously described non-synonymous genetic 
sequence variants, the AluI and BsrI RFLPs within exons 65 and exon 29 
respectively, within the COL12A1 gene, were associated with an 
increased risk of ACL ruptures.  A secondary objective of this study was to 
investigate if there were any gender-specific associations between the two 
COL12A1 sequence variants and risk of ACL ruptures. (Study 3) 
 
The secondary aim of this thesis was to investigate the similarities and 
differences between the genetic risk factors for ACL ruptures and other soft 
tissue injuries. The genetic variants investigated in Study 2 and 3 of this thesis 
have previously been investigated as risk factors for other musculoskeletal soft 
tissue injuries (Achilles tendinopathy and/or Achilles tendon ruptures). However, 
the possible association of the functional Sp1 binding site polymorphism with 
Achilles tendon injuries has not been investigated. Therefore, the objectives of 
the studies which addressed  the secondary aim of this thesis are as follows:   
 
• To determine if the rare TT genotype of the functional Sp1 binding site 
polymorphism within intron 1 of the COL1A1 gene was associated with 
other common acute (spontaneous Achilles tendon ruptures) and chronic 
(Achilles tendinopathy) injuries. (Study 4) 
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• To report the combined effect of the rare COL1A1 TT genotype and the 
risk for acute soft tissue ruptures from the previously published study, and 
the results presented in this thesis (Study 1 and Study 4). (Study 5) 
• To determine if there are any gender-specific COL5A1 BstUI RFLP 
genotype effects in chronic Achilles tendinopathy when the two previously 
published studies were re-analysed. Another objective of this study was to 
investigate if the distribution of the COL5A1 BstUI RFLP within the 
combined asymptomatic control participants from this thesis (Study 2), as 
well as the two previously published studies were age-dependant. (Study 
6) 
 
METHODS 
 
One hundred and twenty nine Caucasian participants with surgically diagnosed 
ACL ruptures, and 310 apparently healthy, unrelated, physically active gender-
matched Caucasian control (CON) participants were recruited for the studies 
that address the primary aim of this thesis (Study 1 – Study 3). Due to slight 
differences in design, only 130 of these CON participants, which had no history 
of ligament and/or tendon injury, were included in Study 1, while 217 CON 
participants, with detailed sports participation information, were included in 
Studies 2 and 3.  
 
In addition, 85 participants diagnosed with chronic Achilles tendinopathy and 41 
participants diagnosed with Achilles tendon ruptures, as well as an additional 
126 apparently healthy, unrelated, Caucasian CON participants without any 
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history of symptomatic Achilles tendon injuries, which had previously been 
recruited for other published studies, were included in Study 4.  
 
The participants included in each of the first four studies were genotyped 
foreither; (1) the functional COL1A1 Sp1 binding site polymorphism, (2) the 
COL5A1 BstUI and DpnII RFLPs, and/or (3) the COL12A1 AluI and BsrI RFLPs.  
 
The combined analyses of Study 5 and the comparative analysis of Study 6, 
which were done to answer the second aim of this thesis, included pooled data 
from previous studies of the thesis, as well as previous published papers. 
  
      
RESULTS AND DISCUSSION 
 
Primary aim: Genetic variants associated with risk for ACL ruptures 
 
The rare TT genotype of the COL1A1 Sp1 binding site polymorphism was 
significantly under-represented (OR=12.3; 95% CI 0.7 - 220.4; P=0.031) in 
participants with ACL ruptures, when compared to controls with no history of 
ligament or tendon injuries, in a second South African Caucasian population 
(Study 1). There was no evidence of a gender-specific genotype effect in this 
study. Furthermore, the COL5A1 BstUI RFLP (Study 2) and the COL12A1 AluI 
RFLP (Study 3) were significantly associated with ACL ruptures in female, but 
not male participants. The CC genotype of the COL5A1 BstUI RFLP (OR=6.6, 
95% CI 1.5 – 29.7; P=0.006) and the AA genotype of the COL12A1 AluI RFLP 
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(OR=2.4, 95% CI 1.0 – 5.5; P=0.048) were significantly under- and over-
represented, respectively, in the female ACL group, when compared to the 
female CON group. No significant genotype distributions between the CON and 
ACL groups were observed for the COL5A1 DpnII and COL12A1 BsrI RFLPs.  
 
When compared to the CON group included in Study 1, the participants in the 
ACL group had a significantly higher family history of ligament injury (13.5% vs 
39.6%, P<0.001). Similar findings were observed when the female ACL group 
was compared to the female CON group included in Studies 2 and 3 (21.5% vs. 
50.0%, P=0.002). No significant difference was found when the male ACL group 
was compared to the male CON group included in Studies 2 and 3. 
 
When all the ACL and CON participants within Study 2 were combined and 
analysed, the genotype distribution of the COL5A1 BstUI RFLP was significantly 
different between participants with a family history of ligament injury, and 
participants without a family history of ligament injury (P=0.022). This finding 
remained significant when only female participants were analysed (P=0.005), 
but not when male participants were analysed (P=0.369).  A similar finding was 
also observed in Study 3, where there was a trend (P=0.082) for the AA 
genotype of the COL12A1 AluI RFLP to be over-represented in female 
participants with a family history of ligament injury, when compared to female 
participants without a family history of ligament injury. 
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Secondary aim: Genetic variants associated with other soft tissue injuries 
and traits 
 
Although not statistically significant, the main finding from Study 4 was that the 
rare TT genotype of the COL1A1 Sp1 binding site polymorphism was absent in 
participants with another acute soft tissue injury (spontaneous Achilles tendon 
ruptures). The TT genotype was however present in participants with chronic 
Achilles tendinopathy. When reported data for the  COL1A1 Sp1 binding site 
polymorphism from this thesis, and previously published data, were combined 
and analysed (Study 5), the TT genotype was shown to be associated with an 
11.1 times reduced risk of acute musculoskeletal soft tissue ruptures (cruciate 
ligament ruptures, shoulder dislocations, and Achilles tendon ruptures). 
Furthermore, when only the risk of cruciate ligaments were analysed, the TT 
genotype was associated with a 15.1 times reduced risk of cruciate ligament 
rupture.   
 
There was no evidence that the previously reported association of the COL5A1 
BstUI RFLP with Achilles tendinopathy is gender-specific. There was however a 
significant age dependant increase in the CC genotype distribution (P=0.047) 
among the pooled male asymptomatic CON participants of Study 2 of this 
thesis, and previously published papers. A similar trend among the female 
participants was not observed.  
  
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
 
xxxi 
 
CONCLUSION: 
 
The novel findings of this thesis provide initial evidence that genetic elements 
within the genes which encode for structural components of the collagen 
microfibril are significant risk factors for ACL ruptures, in particular among 
females. Based on the research presented in this thesis, further research 
studies designed to identify genetic intrinsic risk factors for ACL ruptures are 
warranted. Once the findings of this thesis have been confirmed in other 
populations, and a stronger estimate of risk predicted, these genetic sequence 
variants should be included in multifactorial models developed to reduce the 
incidence of ACL ruptures. 
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CHAPTER 1 
 
INTRODUCTION AND SCOPE OF THE THESIS 
 
 
The regular participation in physical activity is an important component in the 
development and maintenance of a healthy lifestyle [1]. In spite of the numerous 
health benefits, there is however, an increased risk of injuries, particularly 
musculoskeletal soft tissue injuries, during participation in physical activity [2]. 
Among these injuries, anterior cruciate ligament (ACL) ruptures have been 
described as the most severe injury [3]. Although the incidence of ACL ruptures 
is relatively low in the general population, the devastating consequences that 
may result from such an injury highlight the importance to identify the risk 
factors that are associated with this injury by conducting scientific research 
studies. 
 
The exact aetiology and mechanisms that cause this acute injury are largely 
unknown, however various intrinsic and extrinsic risk factors for ACL ruptures 
have been identified [4-6]. Research to date has primarily focused on identifying 
anatomical, hormonal and neuromuscular intrinsic risk factors for ACL ruptures 
[6].  In comparison there are only limited data suggesting genetic elements are 
also intrinsic risk factors for ACL ruptures [7-9]. Studies investigating a familial 
predisposition to ACL ruptures initially provided evidence that hereditary factors 
may play an important role in the development of these injuries [7;10]. More 
recently, a single study has found a specific genetic element, namely the 
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functional COL1A1 Sp1 binding site polymorphism, to be associated with risk of 
acute ligament injuries, including cruciate ligament ruptures and shoulder 
dislocation [9].  
 
The identification of additional intrinsic risk factors, specifically genetic risk 
factors, will further improve the understanding of the aetiology and mechanisms 
of ACL ruptures. As originally proposed by van Mechelen and colleagues [11] 
(Figure 1.1), understanding the aetiology and mechanisms of sport injuries is 
required to introduce appropriate evidence-based preventative measures which 
may result in a reduction in the incidence of injuries, such as ACL ruptures.  
 
The primary objective of this thesis was therefore to identify specific genetic 
elements which may predispose an individual to ACL ruptures. Genetic 
association studies (case-control design) were used to test whether sequence 
variants (single nucleotide polymorphisms) within candidate genes modify the 
risk of ACL ruptures.  Candidate genes were selected, based on their structural 
and biological function within the ligament. For the purpose of this thesis, only 
genes which encode for the basic structural and functional unit of ligaments, 
namely the collagen microfibril, were identified as candidate genes.  
 
Certain genetic variants investigated in this thesis have previously been 
investigated as possible risk factors for Achilles tendon injuries, another 
common soft tissue injury that includes Achilles tendinopathy and/or 
spontaneous Achilles tendon ruptures. A second objective of this thesis was 
therefore to further investigate the similarities and differences between the 
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genetic risk factors for ACL ruptures, chronic Achilles tendinopathy and/or 
spontaneous Achilles tendon ruptures.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: A modified four step model of sport injury prevention research as originally 
described by van Mechelen and colleagues [11]. The identification of intrinsic and 
extrinsic risk factors (black box) is essential in establishing the aetiology and 
mechanism of sport injuries (grey box). 
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In preparation for the exploration and further discussion of the experimental 
chapters of this thesis, Chapter 2 will provide a brief review of the gross 
anatomy of the ACL (Section 2.1), mechanisms of ACL ruptures (Section 2.2), 
the epidemiology of ACL ruptures (Section 2.3), the risk factors for ACL 
ruptures (Section 2.4), and the molecular structure of the ACL and selection of 
candidate genes for ACL ruptures (Section 2.5). Various comprehensive review 
articles covering similar topics have been published [4;6;12;13]. Therefore, this 
review will primarily focus on contemporary concepts, understanding and the 
evidence for identified extrinsic and intrinsic risk factors for ACL ruptures. 
Subsequent experimental chapters will use a candidate gene approach to 
achieve the primary (Chapters 3, 4 and 5) and the secondary (Chapters 6, 7 
and 8) aims of this thesis.  
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CHAPTER 2 
 
INTRINSIC RISK FOR ANTERIOR CRUCIATE LIGAMENT RUPTURES: A 
REVIEW 
 
 
2.1 GROSS ANATOMY OF THE ACL 
 
The anterior cruciate ligament (ACL) is an intra-articular ligament which 
connects the femur to the tibia (Figure 2.1). Together with the posterior cruciate 
ligament (PCL), the lateral collateral ligament (LCL) and the medial collateral 
ligament (MCL), the ACL guides the knee joint through its normal range of 
motion while a tensile load is applied [14]. This band-like structure of dense 
connective tissue runs from its femoral attachment on the posterior part of the 
inner surface of the lateral femoral condyle, medially, and distally to a fossa 
located anterior and lateral to the tibial spine [15].  
 
Although not anatomically distinct, the ACL is commonly sub-divided into two 
functionally distinct bundles, the posterolateral bundle (PLB) and the 
anteromedial bundle (AMB) [15]. The AMB is slightly longer (34mm vs. 22.5mm) 
than the larger PLB and spirals around the rest of the ligament during flexion 
[16]. Both the PLB and the AMB consist of closely packed parallel bundles of 
collagens and other extracellular matrix (ECM) proteins [14]. The molecular 
structure, in particular the collagen component of the ECM is a key focus of this 
thesis, and will be further reviewed in more detail in section 2.5.1. 
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The specific function of the ACL is to resist anterior tibial translation and 
rotational loads over the range of motion of the knee [15]. The two functionally 
distinct bundles, the AMB and PLB, work synergistically with each other to 
optimise this restraining function of the ACL. These bundles experience 
different patterns of strain during passive knee flexion; the AMB lengthens and 
tightens during flexion, while the PLB shortens and becomes slack [17;18].  
 
The collagen fibres, of the ACL are longitudinally arranged and display a crimp 
(“waviness”), which straightens when sufficient strain is applied to the ligament 
[19]. Once all the collagen fibres have been straightened, a sharp increase in 
stiffness is observed. The application of further strain at this point may result in 
ACL rupture [14]. Although there have been isolated reports of AMB and PBM 
ruptures, there is doubt whether a partial ruptures can actually occur [20]. The 
majority of studies classify significant injury to the ACL only as ruptures [4-6]. 
For the purpose of consistency in this thesis, all ACL injuries will be referred to 
as ACL ruptures. 
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Figure 2.1: A schematic anterior view of the right knee. The patella and patella tendon 
are lifted to expose the inner structure of the knee joint. The locations of the primary 
ligaments (The anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), the 
medial collateral ligament (MCL), and the lateral collateral ligament (LCL)) as well as 
other primary components of the knee joint and surrounding structures are indicated on 
the schematic diagram. 1 Although technically (by definition) a ligament, the structure 
which joins the patella bone to the tibia bone is commonly referred to as the patella 
tendon. Image adapted from Tandeter and Shvartzman [21].   
LCL
PCL
ACL
MCL
Femur (thighbone)
Tibia (shin bone)
Fibula 
Patella (kneecap)
Patella tendon1
Medial femoral condyle
Lateral femoral condyle
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2.2 THE MECHANISM OF ACL RUPTURES 
 
2.2.1 The classification of mechanisms of injury 
 
Although direct or indirect external forces to the knee can result in an ACL 
rupture, intrinsic or non-contact forces are also thought to play a critical role in 
the causation of ACL ruptures. Intrinsic forces occur as a result of the athlete’s 
own movements [13], and not due to any external contact to the athlete. It may 
thus be hypothesised that intrinsic risk factors may have a greater contributing 
role in non-contact ACL ruptures, and it is therefore important to report the 
frequency of non-contact ACL ruptures separately from contact injuries. 
 
There is however a lack of agreement regarding the classification and definition 
of ACL ruptures [13]. Although the majority of research has classified ACL 
ruptures as contact (direct contact to the knee) or non-contact (no direct contact 
to the knee); the lack of a common classification scheme has traditionally 
limited a researcher’s ability to define non-contact injuries in a standardised 
manner. A standardised definition and classification scheme based on external 
force application was therefore recently proposed at the American Orthopaedic 
Society of Sports Medicine consensus conference on non-contact ACL ruptures 
(Atlanta, Georgia, “Hunt Valley II”) [13]. This classification scheme divides ACL 
ruptures according to the degree of external force applied to the knee (Figure 
2.2). Direct contact to the knee is classified as a direct contact mechanism of 
injury, whereas direct contact to the athlete, but not directly to the injured knee 
is classified as an indirect contact mechanism of injury [13]. A non-contact injury 
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is the result of the athlete’s own movements and does not involve contact with 
another athlete or object [13]. For the purpose of this thesis, ACL ruptures will 
be classified using this scheme. 
 
 Direct contact  
 External force was directly applied to the injured knee as was probably the 
proximate cause of injury. 
Example: Injured knee was forcefully struck by another player. 
 
 Indirect contact  
 External force was applied to the athlete but not directly to the injured knee. 
The force was involved in the injury process but was probably not the 
proximate cause. 
Example: Injured athlete was struck and knocked off balance by an 
opponent in an area distal to the knee. Athlete’s resultant movement 
led to the injury without direct contact to the knee. 
 
 Non-contact  
 Forces applied to the knee at the time of injury resulted from the athlete’s own 
movements and did not involve contact with another athlete or object. 
Example: Athlete landed from a jump and attempted to cut to one side. 
 
 
 
Figure 2.2: Proposed classification scheme of the American Orthopaedic Society for 
sports medicine for ACL injuries by type of contact. This Figure was modified from 
Marshall et al. [13]. 
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2.2.2 The mechanisms of non-contact ACL ruptures 
 
ACL ruptures are unique when compared to other acute musculoskeletal soft 
tissue injuries, in that they are most commonly caused by non-contact 
mechanisms. The frequency of these non-contact injuries depends on the type 
of sports. Contact sports typically have a lower frequency of non-contact ACL 
ruptures, whereas sports which involve landing and pivoting have a much 
higher frequency of non-contact injuries [22]. The frequency of non-contact 
injuries thus varies from 21% during motor sports to 78% during netball [22]. 
The total frequency of all sports related ACL ruptures in a recent nationwide 
population based study in New Zealand, which were caused by a non-contact 
mechanism of injury, as previously defined [13], was 58.2% [22]. The population 
based study by Gianotti et al. [22] reported the mechanism of injury in 7375 
cases of ACL ruptures. No other study has reported the mechanisms of injury in 
such a large cohort. Furthermore, Gianotti et al. [22] also used the proposed 
classification scheme (refer to Figure 2.2) which will be used in this thesis.   
 
The mechanism of injury may also be explained by precise biomechanical 
descriptions at the time of injury, also referred to as the inciting event [23] (refer 
to Figure 2.6). Although various studies have attempted to describe the events 
which leads to non-contact ACL ruptures, the widely used terminology of injury 
mechanism has made interpretation of data difficult [23;24]. In spite of these 
difficulties it is generally accepted that non-contact ACL injuries typically occur 
with the knee in an extended position as the athlete lands from a jump, 
sidesteps or changes direction abruptly [23;24]. An expert panel of researchers 
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reviewing videos of ACL ruptures concluded that the ACL is likely to be ruptured 
if the following occurred: (1) the knee was less than 30º flexed, (2) the knee was 
in valgus, (3) the foot was in external rotation relative to the knee, and (4) the 
centre of gravity was behind the knee on landing a jump or stopping a run [25]. 
This biomechanical description is in agreement with the injury mechanism 
defined by Ireland [26] as the “position of no return”, as described in Figure 2.3. 
In this position, failure of the muscles which normally protect the ACL, 
contribute to the rupture [24].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: A schematic diagram showing the “position of no return”. This term refers 
to a gross biomechanical description during landing. In this high risk landing position, 
the ACL is placed at increased risk, when compared to the safety position. This figure 
was modified from Ireland [26]. 
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2.3 BRIEF OVERVIEW OF THE EPIDEMIOLOGY OF ACL RUPTURES 
 
2.3.1 The incidence of ACL ruptures 
 
2.3.1.1 The incidence in the general population 
 
The incidence of injuries, such as ACL ruptures, are most commonly reported 
as an incidence rate, which is the number of new injuries per unit of time (years, 
hours or exposures) [13]. Determining the incidence of ACL ruptures in the 
general population is extremely difficult and is only possible in countries with 
comprehensive national injury registries. Within New Zealand (NZ), all citizens 
are covered by the government funded accident compensatory commission 
(ACC), and the ACC is thus uniquely positioned to provide detailed and 
accurate national epidemiological data. In a recent study, data from the ACC 
were used to provide a detailed descriptive epidemiology of knee ligament 
injuries, including injury to the ACL [22]. Seven thousand three hundred and 
seventy five claims for ACL surgery were accepted by the ACC over a 5 year 
period (2000 – 2005). The population-based incidence of ACL ruptures per 
100,000 person-years was 37. The majority (65%) of ACL ruptures which 
required surgery occurred at a place of recreation or sport. These data by 
Gianotti et al. [22] is currently the largest measure of the general population 
incidence of ACL ruptures. 
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Research from Norway, which has recently introduced a national knee ligament 
registry, also provides useful and accurate incidence data [27]. Two thousand 
seven hundred and ninety three ACL ruptures were registered during the first 2 
years of operation, and this equates to an incidence of 34 ACL ruptures per 
100,000 citizens, and 85 per 100,000 citizens in the main at-risk age group, 
which is 16-39 years [27]. These data are remarkably similar to the data 
reported by the NZ ACC which, based on a population estimate of 4.1 million, 
reported 36 ACL ruptures per 100,000 citizens per year [22].  
 
Although many studies have suggested that females are at greater risk of ACL 
ruptures (as will be discussed in subsequent sections of this review), it is 
however interesting to note that in both population based studies, the number of 
ACL ruptures in the general population was greater in males when compared to 
females. This may be explained by greater sports participation by males. 
 
2.3.1.2 Variation in the incidence of ACL ruptures by age and gender 
 
The mean age at which ACL ruptures occur are roughly 27 years [27;28], which 
is much younger than other common musculoskeletal soft tissue injuries [28]. In 
addition, various studies have shown that the incidence of ACL ruptures is 
greater during late adolescence and early adulthood [29;30]. The data from 
comprehensive population based New Zealand national injury registries (Figure 
2.4) recently confirmed an increased rate of ACL surgery in late adolescent and 
early adulthood [22]. More specifically, it was shown that the highest number of 
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injuries occur between the ages of 16 and 18. This trend was observed in both 
males and females.  
 
It has become widely accepted that the incidence of ACL ruptures in the general 
population is higher in males when compared to females [13;22;30]. This is 
most certainly due to a higher exposure in males to high risk athletic tasks such 
as landing, pivoting and cutting [31]. However, when comparing the incidence of 
ACL ruptures during specific sports where males and females are similarly 
represented, females consistently have a higher risk of ACL ruptures [29;31]. 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 2.4: The incidence (number per 100,000 person-years) of ACL ruptures 
requiring surgery by age category amongst males and females. The data presented are 
from the New Zealand national injury registry [22]. The figure is adapted from Gianotti 
et al. [22].  
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2.3.1.3 Variation in the incidence of ACL ruptures by sport and gender 
 
The gender-specific incidence of ACL ruptures in different sports have been 
published and extensively reviewed [13;32;33]. Although there is no consensus 
as to the magnitude, females have been shown to have an increased risk during 
most sporting activities.  
 
It is important to briefly summarise some of the more recent studies 
investigating gender differences in incidence of ACL ruptures during specific 
sporting activities, however it is beyond the scope of this literature review to 
comprehensively review all available data. In a recent meta-analysis [32], 
studies reporting the incidence of ACL ruptures were combined and analysed to 
estimate the incidence of ACL ruptures as a function of gender and sport. The 
female:male ratios of ACL ruptures for various sports were found to be as 
follows: wrestling, 4.05; basketball, 3.5; indoor soccer, 2.77; soccer, 2.67; 
rugby, 1.94; lacrosse, 1.18; and alpine skiing, 1.00.  
 
The most conclusive evidence for gender differences in the incidence of ACL 
ruptures in soccer and basketball are from data obtained through the North 
American National Collegiate Athletic Association (NCAA) injury surveillance 
system database. In this report, data were reviewed for all men's and women's 
basketball and soccer anterior cruciate ligament injuries between 1990 and 
2002 [34]. Data from a total of 586 (394 Female, 192 Male) ACL injuries 
amongst soccer players and 682 (514 Female and 168 Male) ACL injuries 
amongst basketball players were analysed [34]. When comparing incidence of 
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ACL injury per 1000 athlete-exposures (an exposure was defined as a practice 
or match) by gender, the female to male ratio of ACL injuries was 2.8 (95% CI; 
2.3 - 3.3) for soccer and 3.6 (95% CI 3.0 – 4.2) for basketball (Figure 2.5) [34]. 
Another noteworthy finding from this study was that in soccer, the frequency of 
non-contact injuries was significantly higher in females (58.3%) when compared 
to males (49.6%) [34]. A similar difference was however not found in basketball 
when comparing males (70.1%) and females (75.7%) [34].    
 
 
 
 
 
 
 
 
 
 
Figure 2.5: A summary of the data from Agel et al. [34], showing the incidence 
(number per 100,000 person-years) of ACL injuries occurring during men’s and 
women’s college basketball and soccer.  
 
Although numerous other studies have been performed, the majority only report 
a small number of ACL ruptures. Further large scale studies, such as the study 
presented by Agel et al. [34], are required to determine the incidence of ACL 
ruptures as a function of gender for different sporting activities.   
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2.3.2 The consequence of ACL ruptures 
 
ACL ruptures are one of the most severe injuries sustained during sports 
participation [3;31;35]. The time out of play due to ACL ruptures has been 
reported to be as high as 255 days [35]. For many athletes this also means a 
potential loss of sport participation for an entire season, loss of scholarship 
funding, lowered academic performance, long term disability, and a  significantly 
greater risk of osteoarthritis of the knee may occur as a result of ACL ruptures 
[36;37].  
 
Furthermore, the cost associated with the surgical repair of ACL (ACL 
reconstruction), and subsequent prolonged rehabilitation  is extremely high. De 
Loes and colleagues [31] have shown that cost of an ACL rupture is the highest 
cost of medical care of any knee injury when this is calculated by cost per hour 
of participation. Conservative estimates of the cost of surgery and rehabilitation 
are between US$ 17,000 and US$ 25,000 per ACL rupture [31].  
 
As previously mentioned, a rupture of the ACL significantly increases the risk of 
developing osteoarthritis of the knee joint [36;37]. In a analysis of 50 retired 
Australian rules footballers, Deacon at al. [38] showed that the risk of 
radiographically diagnosed osteoarthritis is 105 times greater in footballers who 
had sustained intra-articular ligamentous and/or meniscal injury when this was 
compared to a group who only injured their collateral ligaments or no ligament. 
In summary, due to the severity, cost and potential long term disability, ACL 
rupture is one of the most significant injuries sustained during sports. 
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2.4   FACTORS ASSOCIATED WITH INCREASED RISK OF ACL RUPTURE 
 
Multiple factors have been shown to be associated with an increased risk for 
ACL ruptures. ACL ruptures are therefore, like most sports related injuries, 
considered multifactorial disorders. As a basis for understanding the 
multifactorial nature of sports injuries, such as ACL ruptures, Meeuwisse [39] 
developed a model to account for all factors involved in the causation of the 
injury (Figure 2.6). Risk factors for these multifactorial disorders are broadly 
divided into either intrinsic (within the body) or extrinsic (from outside the body). 
In the proposed model [39] the intrinsic risk factors predispose the individual or 
athlete to an increased risk of injury. Once predisposed, the susceptibility to 
injury is determined by the extrinsic risk factors. It is important to note that these 
intrinsic and extrinsic risk factors do not cause an injury. Rather, a specific 
inciting event has to occur and place the ACL under sufficient strain for it to 
rupture [39;40].  
 
Although the exact aetiology and mechanism of ACL ruptures are poorly 
understood, various intrinsic and extrinsic risk factors have been indentified. As 
discussed in the introduction to this thesis (Chapter 1), the identification and 
characterisation of these risk factors are important in order to understand the 
aetiology and mechanism of these injuries (refer to Figure 1.1).  
 
The primary objective of this thesis was to identify genetic sequence variants 
which may predispose an individual to ACL ruptures. To date there is only 
limited data that suggest that genetic elements are intrinsic risk factors for ACL 
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ruptures. In this section of the review, the genetic elements which have been 
associated with an increased risk of ACL ruptures, as well as the other risk 
factors for ACL ruptures will be discussed. In Sections 2.4.2 and Section 2.4.2 
respectively the extrinsic and intrinsic risk factors for ACL ruptures will be 
reviewed.  
 
  
 
 
 
 
 
 
 
 
 
 
Figure 2.6: A schematic diagram, adapted from the original model proposed by 
Meeuwisse [39], illustrating the complex relationship between intrinsic risk factors, 
extrinsic risk factors and a specific inciting event in the causation of ACL ruptures. 
Several intrinsic risk factors, broadly classified as anatomical, hormonal, 
neuromuscular or genetic elements, have been identified. It is highly likely that these 
factors are not independent risk factors and that a relationship between them exists. 
With regards to genetic elements, while some sequence variants might alter the 
properties of ligaments, other genetic elements may be associated with phenotypes 
already identified as intrinsic risk factors. 
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Although numerous articles have reviewed the available data on the extrinsic 
and intrinsic risk factors for ACL ruptures [4;12;41], this review will critically 
appraise the level of evidence for each study reviewed according to the 
classification adopted by the American edition of the Journal of Bone and Joint 
Surgery [42;43]. In the hierarchy of evidence, high quality prospective studies 
are level I studies, retrospective studies and lesser quality prospective studies 
are level II, case-control studies are level III, case series are level IV, and expert 
opinions are level V [42].   
 
In addition, a level of certainty that the risk factor is associated with ACL 
ruptures, based upon the level of evidence for each individual study, will also be 
incorporated in this review. Based on previously definitions for the levels of 
certainty (High, moderate or low) by the US Preventative Services Task Force 
[44], the following descriptions were used for the purpose of this review. 
 
i) High Certainty; The available evidence includes consistent results from 
level I studies. These studies provide a good estimate of risk and are 
unlikely to be strongly affected by future studies. 
ii) Moderate Certainty; The available evidence includes sufficient evidence 
to determine that there is risk associated with the injury, but confidence in 
the estimate is constrained by factors such as the sample size and quality 
of studies, as well as inconsistency of findings across individual studies. 
As more information becomes available, the magnitude of risk could 
change or even alter the conclusion.  
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iii) Low Certainty; The available evidence is insufficient to assess risk. 
Evidence is insufficient because of the limited number or size of studies, 
and inconsistency of findings across individual studies. More information 
may allow an estimation of risk. 
 
 
2.4.1 Extrinsic risk factors for ACL ruptures 
 
Any external factor affecting the risk of ACL ruptures may be regarded as an 
extrinsic risk factor. Although previous reviews have only discussed the 
contribution of environmental risk factors, other extrinsic factors such as sports 
participation and type of sporting activity are often taken for granted.  
 
In a large population based prospective cohort study with a 9 year follow up, 
Parkarri et al. [45], found that participation in organised sports resulted in a 
significantly increased risk of ACL ruptures. Furthermore, the frequency of 
participation was related to the degree of risk. Participation in organised sports 
> 3 times/week resulted in an 8.5 (95% CI 4.3 – 16.4) and a 4.0 (95% CI 2.7 – 
6.1) times increased risk in females and males respectively. This study provides 
evidence that participation in organised sports is undoubtedly associated with 
ACL ruptures. As ACL ruptures are not able to occur without an inciting event 
(refer to Figure 2.6), which typically occurs during sports participation, sports 
participation will not be further discussed as a risk factor. 
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Environmental risk factors associated with ACL ruptures include, (1) 
meteorological conditions, (2) the type of surface, (3) footwear, and (4) 
protective bracing. Only a few studies have investigated the association of 
these environmental factors to risk of ACL ruptures, and therefore only a brief 
discussion for each factor will be included. 
 
2.4.1.1 Environmental factors as extrinsic risk factors for ACL ruptures 
 
2.4.1.1.1 Weather conditions 
 
The environmental (weather) conditions have been investigated as a possible 
extrinsic risk factor for ACL ruptures in the Australian Football League (AFL). In 
this prospective cohort study, Orchard et al [46] reported an increased risk of 
ACL ruptures during periods of low rainfall and high water evaporation. In this 
study it was proposed that the likely mechanism involves an increased shoe-
surface traction which occurs on dry hard fields, when compared to soft moist 
fields as a likely causative factor [46;47]. Similar findings were also observed in 
the National Football League (NFL), where more than 95% of all ACL ruptures 
occurred on a dry field [48].  
 
Due to the evidence presented (Table 2.1), the certainty that meteorological 
conditions increase the risk of ACL ruptures are moderate and need to be 
further investigated. The number of studies investigating this risk factor is low 
and data are insufficient to accurately assess risk, especially among different 
sports. 
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2.4.1.1.2 Type of playing surface 
 
As previously discussed (Section 2.4.1.1.1), increased shoe-surface traction 
has been implicated as a risk factor for ACL ruptures [47]. A prospective cohort 
study of 8 high schools NFL teams reported a 50% reduction in the rate of ACL 
ruptures with the use of artificial turf [49]. Similar results were also obtained in a 
retrospective analysis where a relationship between the type of floor in 
Norwegian team handball and risk of ACL ruptures was reported in females, but 
not in males. This study reported that females were at an increased risk of injury 
when playing on artificial floors, when compared to natural wooden floors [47]. 
In support of the hypothesis that increased shoe-surface traction increases the 
risk of ACL ruptures, friction tests demonstrated an increased coefficient of 
friction on the artificial compared to the natural wooden floor surface [47].  
 
In summary (Table 2.1), based in the evidence presented (Table 2.2), the 
certainty that the type of surface is a risk factor for ACL ruptures is moderate in 
females, and low in males.  
 
2.4.1.1.3 Type of footwear 
 
As discussed, an increased shoe-surface friction is related to an increased risk 
of ACL ruptures. In support of this, there is evidence from a prospective cohort 
study that football cleat design may alter the risk of ACL ruptures [50]. Longer 
irregular cleats, which resulted in significantly higher torsional resistance when 
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compared to other cleat designs, were associated with a significantly higher risk 
of ACL ruptures. Although only one study investigated footwear as a risk factor 
for ACL ruptures, it appears that footwear with a greater shoe-surface friction 
increases the risk of ACL ruptures. However, the risk can not be accurately 
predicted from this single study and therefore the level of certainty is moderate 
(Table 2.1). 
 
2.4.1.1.4 Protective bracing 
 
To date, there is only one study where the effect of prophylactic knee bracing 
on the risk of ACL ruptures was investigated. The results from this randomised 
controlled study in 1396 cadets, playing tackle football at the US military 
academy, showed that the rate of ACL ruptures was 3.0 times higher in the 
unbraced compared to the braced group [51]. It is however important to note 
that only 16 ACL ruptures occurred (4 in the braced group, and 12 in the 
unbraced group) and this small sample size is a limitation in this study. In 
another large epidemiological study it was shown that the use of prophylactic 
knee braces did not reduce the risk of MCL injury [52;53]. In summary (Table 
2.1), the role of prophylactic knee bracing on the risk of ACL ruptures still 
remain equivocal [6], and therefore the level of certainty is low.  
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Table 2.1: Summary of research studies investigating environmental risk factors 
for ACL ruptures, including the level of evidence of each individual study and the 
level of certainty that the risk factor is associated with risk of ACL ruptures.  
 
 
a The level of evidence according to evidence-based medicine criteria [42].  
b The level of certainty, as described in section 2.4.     
 
 
 
Risk Factor 
Study Details and 
References 
Number 
of ACL 
ruptures 
Level of 
evidence       
(I-V)a 
Level of 
Certaintyb 
Weather 
conditions 
Positive Association 
Prospective cohort study –   
Australian Football 
league [46] 
Retrospective study – 
   National Football league 
[48] 
No association - none 
59 
 
40 
I 
 
II 
Moderate 
Type of playing 
surface 
Positive Association 
Prospective cohort study –      
National Football league 
[49] 
Retrospective study – 
Norwegian team 
handball [54] – Only 
females 
No Association 
Retrospective study – 
Norwegian team 
handball [54] – Only 
males 
 
 
7 
 
44 
 
 
9 
 
 
 
I 
 
II 
 
 
II 
Moderate 
(in 
females) 
Low  
(in males) 
 
Type of footwear Positive Association 
Prospective cohort study –      
National Football league 
[50] 
 
42 
 
I 
Moderate 
Protective bracing Positive Association 
Prospective cohort study –  
    Cadets, National 
Football league [51] 
 
16 
 
I 
Low 
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2.4.2 Intrinsic risk factors for ACL ruptures 
 
There are different classification systems for the various intrinsic risk factors 
that have been associated with ACL ruptures. The system that is commonly 
used by physicians, physical therapists, athletic trainers, biomechanists, 
epidemiologists, and other scientists [6], sub-divides the intrinsic risk factors into 
four categories: (1) anatomical, (2) hormonal, (3) neuromuscular and (4) familial 
predisposition. Since the development of the above classification system, a 
specific genetic risk factor that is associated with cruciate ligament ruptures has 
been identified [9]. Therefore, for the purpose of this review, the intrinsic risk 
factors will be discussed under the following sub-divisions: (1) anatomical, (2) 
hormonal, (3) neuromuscular and (4) genetic intrinsic risk factors, which 
includes a familial predisposition. 
 
As previously discussed, there is evidence from large scale prospective cohort 
studies that there is a greater risk of ACL ruptures in female athletes during 
specific sporting activities. These data indicate that there is strong evidence that 
female gender is an intrinsic risk factor for ACL ruptures [32;34;45;55]. 
However, it is likely that the increased risk of ACL ruptures in females is a result 
of various anatomical, hormonal and neuromuscular risk factors. Gender will 
therefore not be included as separate intrinsic risk factor for ACL ruptures in this 
review. Rather, when applicable, gender differences will be addressed within 
this review of the four categories of intrinsic risk factors.  
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2.4.2.1 Anatomical intrinsic risk factors for ACL ruptures  
 
2.4.2.1.1 The quadriceps (Q) angle  
 
Lower extremity alignment, specifically the quadriceps (Q) angle, has been 
related to an increased risk of ACL ruptures, possibly by altering lowed limb 
alignment and therefore the kinematics of the knee [56;57]. The Q angle is 
clinically defined as the angle in the frontal plane formed by intersecting lines 
from the centre of the patella to the anterior superior iliac spine and the centre 
of the patella to the tibial tubercle (Figure 2.7A) [58]. The Q angle is thought to 
reflect the pelvic angle, as well as hip rotation, tibial rotation, patella position, 
and foot position. This composite measure is larger in females when compared 
to males, and has therefore often been mentioned (anecdotally) as a possible 
reason for the increased risk of ACL ruptures in females [59;60]. It has been 
proposed that an increased Q angle may contribute to dynamic knee valgus, 
and thereby increase the risk of ACL ruptures [58].  
 
In one study, where the relationship between lower extremity alignment and the 
risk of knee injury was reported, it was found that the Q angle of individuals who 
had injured their knee was greater than the Q angle of uninjured individuals (14º 
vs. 10º) [61]. However in two other studies where the Q angle was measured 
and compared between ACL injured and ACL non-injured individuals, no 
significant differences were observed [62;63]. In these two independent studies, 
where lower extremity alignment variables were measured in ACL injured and 
non-injured individuals, Q angle was not associated with injury risk [62;63].     
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In summary (Table 2.2), although an increased Q angle is commonly reported 
as a possible risk factor for ACL ruptures, there is a lack of clinical research to 
confirm that this is an independent risk factor for ACL ruptures. Therefore, the 
certainty that a large Q angle increases the risk for ACL ruptures is currently 
low. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: (A) The static Q angle is determined by measuring the acute angle 
produced by the two intersecting lines. The first line is drawn from the centre of the 
patella to the anterior superior iliac spine. The second line is drawn from the centre of 
the patella to the centre of the tibial tubercle. (B) The Notch width index (NWI) is the 
ratio of the width of the anterior outlet of the femoral intercondylar notch (NW) to the 
total condylar width (CW) at the level of the popiteal groove. Figure modified from 
Huston [64].  
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2.4.2.1.2 Notch width  
 
Both a smaller femoral intercondylar notch width and a smaller femoral notch 
width index, (ratio of the width of the anterior outlet of the intercondylar femoral 
notch to the total condylar width at the level of the popiteal groove) (Figure 
2.7B), have been shown to be associated with an increased risk of ACL 
ruptures [55;65-67]. A summary of the published literature has shown that the 
notch width of bilateral ACL injured knees are smaller than that of unilateral 
ACL injured knees [6], similarly, the notch width of unilateral ACL injured knees 
were smaller than the notch width of normal controls [6].  
 
Various large cohort prospective studies have found association between (1) 
smaller notch width and (2) smaller notch width index, and increased risk of 
ACL ruptures [55;65-67]. In one prospective study of 902 high school athletes, 
Souryal and Freeman [65] showed that athletes with a small intercondylar notch 
width were at increased risk of ACL rupture. La Prade and Burnett [66] found 
similar results when 213 collegiate athletes were prospectively analysed. In 
addition, Shelbourne et al. [67] found a higher incidence of contra-lateral ACL 
rupture in individuals with narrower notches in a prospective study of 714 
patients who underwent patella graft ACL reconstruction.  In a recent published 
prospective study, Uhorchak et al.[55] investigated numerous risk factors, 
including notch width and notch width index in 859 cadets. In this study, both 
decreased notch width and notch width index were significantly associated with 
increased risk of ACL ruptures. Various retrospective case-control studies also 
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confirm the findings that notch width and notch width index is associated with 
increased risk of ACL ruptures [68;69]. 
 
In summary (Table 2.2), although some studies reported no association 
between notch width or notch width index and risk for ACL ruptures [70;71], 
several well controlled prospective studies and retrospective case-control 
studies have found a significant relationship. These studies provide a good 
estimate of risk and are unlikely to be affected by future studies. Therefore, the 
certainty that a decreased notch width and notch width index is associated with 
an increased risk of ACL ruptures is high. 
 
2.4.2.1.3 Tibial slope 
 
The tibial slope is defined as the angle between the line perpendicular to the 
tibial axis and the posterior inclination of the tibial plateau [72]. Tibial slope is 
commonly reported as an anatomical risk factor for ACL ruptures [73]. Dejour et 
al. [74] investigated the tibial slope in 281 knees and established a significant 
association between an increased tibial slope and anterior tibial translation. 
Increased anterior tibial translation, as a result of increased tibial slope, may 
increase the strain on the ACL. In addition, a recent study concluded that 
decreasing the tibial slope may be protective in the ACL-deficient knee [75].  
 
In one recent case-control study (33 matched pairs of patients divided into two 
groups: a group with ACL ruptures and a control group which consisted of 
patients with patello-femoral pain) an increased tibial slope was documented in 
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the patients with ACL ruptures [72]. It was therefore suggested that an 
increased tibial slope is a risk factor for ACL ruptures. In contrast, findings from 
a similar case-control study failed to confirm an association between increased 
tibial slope and ACL ruptures [76]. 
 
In summary (Table 2.2), there are data from only one level III study that support 
the hypothesis that an increased tibial slope is a risk factor for ACL ruptures 
[43;72]. Therefore, due to the limited number of research studies and the lack of 
consensus among the published studies, the level of certainty that tibial slope is 
associated with risk of ACL ruptures is low.   
 
2.4.2.1.4 Foot pronation 
 
It has been suggested that increased sub-talar joint pronation (measured by 
greater navicular drop values) ma  be associated with an increased risk of ACL 
ruptures [77]. An increased pronation is correlated with a greater rotation 
moment at the knee joint [78]. In a number of studies significant differences in 
navicular drop values between ACL injured and ACL non-injured individuals 
were reported [62;79-81]. In the most recent published study, Hertel et al. [62] 
found that participants with a navicular drop greater than 8mm were 20 times 
more likely to rupture their ACL than subjects with a navicular drop of less than 
6.3mm. However, in a similar case-control study, no significant differences in 
the navicular drop values between ACL injured and control subjects were 
observed [82]. 
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In summary (Table 2.2), the majority of studies have shown that increased foot 
pronation (as measured by the navicular drop) is a significant predictor of ACL 
ruptures. However, there are few high quality prospective cohort studies: 
therefore the confidence in the estimate is constrained. The level of certainty 
that increased foot pronation, and more specifically navicular drop values, are 
associated with risk of ACL ruptures is therefore moderate. 
  
2.4.2.1.5 Pelvic tilt 
  
It has been hypothesised that an increased anterior pelvic tilt may be a predictor 
of ACL rupture due to its effects on lower extremity postural alignment [58]. 
Excessive anterior pelvic tilt of the pelvis may lead to an internal rotation and 
medial collapse of the lower extremities, specifically internal femoral rotation, 
genu valgus, genu recurvatum, and subtallar pronation [63;83]. A case-control 
study by Hertel et al. [62] found a significantly greater anterior pelvic tilt in male 
and female participants with a previous history of an ACL rupture compared to 
uninjured participants. In addition, a similar association was found when only 
females were analysed [63]. Therefore, data from two case-control studies have 
identified a univariate association between increased anterior pelvic tilt and ACL 
injury. However, it is not clear if the degree of anterior pelvic tilt itself or the 
lower extremity misalignments as a result of an increased anterior pelvic tilt are 
associated with increased risk of ACL ruptures. This highlights the fact that 
case-control studies do not provide evidence for a cause-effect relationship 
between two variables. 
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In summary (Table 2.2), there is some evidence that increased anterior pelvic 
tilt may be associated with an increased risk of ACL ruptures, but there is a lack 
of confidence in the estimate. Therefore the certainty that increased anterior 
pelvic tilt is associated with risk of ACL ruptures is at best, moderate. 
 
2.4.2.1.6 ACL geometry  
 
As previously reviewed, there is high certainty that a narrower notch width is a 
risk factor for ACL ruptures. However, there is no consensus in the literature 
over the possible mechanism by which narrower notches increase the risk of 
ACL ruptures [58]. One hypothesis is that a narrower intercondylar notch simply 
reflects a smaller ACL. It is generally stated that ACL size would be a risk factor 
for ACL ruptures because a smaller ACL has less material strength than a 
larger ACL and will rupture sooner under similar loading conditions. In support 
of a narrower notch reflecting a smaller, and therefore weaker ACL, Shelbourne 
et al. [67] showed that after reconstruction with a standardised 10mm autograft, 
the incidence of graft rupture is not dependant on notch width, whereas rupture 
of the contralateral ACL, as mentioned above, is associated with a reduced 
notch width. 
 
In the prospective study of 859 cadets [55], eminence width and eminence 
width index, which are simple indirect measurements of the ACL diameter, were 
found to be significantly smaller in both the male and female participants with 
ACL ruptures, compared to uninjured controls. These measurements are based 
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on the assumption that the ACL diameter is the same as the tibial eminence 
width. 
 
In summary (Table 2.2), it is generally stated that a smaller ACL size is at 
increased risk of rupture. However, there is little evidence from well conducted 
studies in support of this, particularly as no direct measurements of ACL size 
have been related to increased risk of ACL ruptures. Data from a single 
prospective study [55] has however found an association between an indirect 
measure of ACL geometry and risk of ACL ruptures. Therefore the certainty that 
a smaller ACL size is a risk factor for ACL ruptures is, at best, moderate.   
 
2.4.2.1.7 Increased body mass index  
 
An increased Body Mass Index (BMI) is often reported as a risk factor for lower 
extremity injuries in general, and ACL ruptures in particular [6]. It has been 
shown that an increased BMI results in a more extended knee position on 
landing, and increased knee extension during landing increases the risk of ACL 
ruptures [84]. In a recent prospective study [55], the US military academy found 
that BMI was a significant predictor of risk of ACL ruptures in female, but not 
male recruits. Female cadets with a BMI of greater than one standard deviation 
above the mean were at a 3.5 times greater risk of developing ACL ruptures. 
However, in another population based cohort study of 45 500 people, there was 
no significant association between being overweight (BMI > 25kg/m2) and an 
increased risk of ACL ruptures in males (Hazard ratio = 1.1; 95% CI: 0.8 – 1.7) 
or females (Hazard ratio = 1.5; 95% CI: 0.8 - 3.1) [45]. However, the data from 
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this study were difficult to interpret due to the heterogeneity of the large 
population based cohort. Finally, in other studies that were primarily designed to 
investigate the relationship between BMI and training related injury risk, no 
relationship between BMI and an increased risk of training related injuries was 
observed [85].  
 
In summary (Table 2.2), data from only one prospective study has found a 
relationship between increased BMI and risk of ACL ruptures in females [55]. 
Other prospective studies have however failed to show a similar association. 
Therefore, the certainty that increased BMI is a significant risk factor for ACL 
ruptures is low.  
 
2.4.2.1.8 Generalised joint laxity 
 
Generalised joint laxity (GJL), as measured by the Beighton score reflects an 
overall measure of whole body joint laxity [86]. The score ranges from 0 – 9 and 
is determined by assigning one point each for: (1) hyperextension of the 
metacarpophalangeal joint of each finger beyond 90º, (2) the ability to touch the 
volar surface of each forearm with the respective thumb, (3) hyperextension of 
each elbow, (4) hyperextension of each knee joint, and (5) the ability to place 
the palm of both hands on the floor by forward flexion with straight extended 
knees. 
 
In general, females have a greater GJL when compared to males [87]. Although 
it has been suggested that increased GJL is a risk factor for lower extremity 
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injury [88], and ACL injury [89], there is limited research supporting an 
association between increased GJL and an increased risk of ACL ruptures [58]. 
In the military cadet prospective cohort study, that was previously mentioned, 
the association between GJL and the risk of ACL ruptures was investigated 
[55]. The results of this study showed that increased GJL was a significant 
predictor of ACL ruptures in both males and females. More specifically, cadets 
with a Beighton score of ≥ 5 regions were at 2.8 times greater risk of ACL 
ruptures. In a further case-control study, a significantly greater proportion of 
individuals with ACL ruptures had a GJL score of > 6 regions, when compared 
to an uninjured control group [63].  
 
In certain studies, the association between individual components of the 
composite Beighton score and ACL ruptures were investigated. In one of these 
studies, increased knee hyperextension (genu recurvatum) greater than 10º, 
was significantly associated with risk of ACL ruptures [63]. Increased hamstring 
flexibility, another component of the Beighton score, has also been associated 
with an increased risk of ACL ruptures in a retrospective case-control study [90]. 
 
In summary (Table 2.2), the association between increased GJL and ACL injury 
has been reported in some retrospective and one prospective cohort study. The 
certainty that increased GJL is a risk factor for ACL ruptures is therefore 
moderate. 
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2.4.2.1.9 Anterior knee laxity 
 
Increased anterior knee laxity, which refers to the increased anterior tibial 
translation, has often been cited as a risk factor for ACL ruptures [58]. It has 
been shown that females have a greater anterior knee laxity at comparable 
progressive forces when compared to their male counterparts [91]. However, to 
current knowledge, increased anterior knee laxity as a potential risk factor for 
ACL ruptures had only been investigated in two studies. Woodford-Rodgers et 
al. [80] investigated anterior knee laxity, as measured by an anthrometer, in 14 
ACL injured males and 8 ACL injured females. In this retrospective case-control 
study, discriminate analysis and multiple regression showed that increased 
anterior knee laxity is an important factor in predicting ACL injury status in ACL 
ruptured and ACL intact individuals. In a prospective study, in which only 16 
males and 8 females were investigated, increased anterior knee laxity, as 
measured on a KT-2000 arthrometer, was shown to increase the risk of ACL 
ruptures in females, but not in males [55]. In this study, the relative risk of 
sustaining an ACL rupture was increased by 2.7 times in female subjects who 
had increased knee laxity. 
 
In summary (Table 2.2), there are data from two studies, a prospective and a 
retrospective case-control study, that support the hypothesis that increased 
anterior knee laxity is a risk factor for ACL ruptures. The results of these two 
studies suggest a moderate certainty that anterior knee laxity is associated with 
increased risk of ACL ruptures in females, but not males. 
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Table 2.2: Summary of research studies investigating anatomical intrinsic risk 
factors for ACL ruptures, including the level of evidence of each individual study 
and the level of certainty that the risk factor is associated with risk of ACL 
ruptures.  
Risk Factor 
Study Details, population 
studied, and References 
Number 
of ACL 
ruptures 
Level of 
evidence 
(I-V)a 
Level of 
Certaintyb 
Q Angle Positive Association: 
Association with knee injuries 
[61] 
No association:  
Case-control studies      
University students [62] 
Female athletes [63] 
 
 
N/A 
 
 
 
20 
20 
 
V 
 
 
 
III 
III 
Low 
Notch Width Positive Association: 
Prospective cohort studies –      
High school athletes [65] 
Intercollegiate athletes [66]  
   Military Cadets [55] 
Case-control study –  
ACL patients [69]   
Female handball [68] 
No Association 
Case-control study –  
Male national basketball 
 
 
 
 
14 
7 
24 
 
108 
20 
 
 
14 
 
 
I 
I 
I 
 
III 
III 
 
 
III 
High 
Tibial Slope Positive Association 
Case-control study 
Unspecified [72]  
No Association 
Case-control study –  
Unspecified [76] 
 
 
 
 
 
 
 
33 
 
 
49 
 
 
III 
 
 
III 
Low 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
LITERATURE REVIEW 
39 
 
Foot 
Pronation 
Positive Association 
Retrospective case-control 
High School & College 
athletes  [80]  
 
Case-control study 
University students [62]  
ACL patients [79]  
ACL patients [79]  
 
No Association 
Case-control study 
 Unspecified [82] 
 
 
 
 
22 
 
 
 
20 
18 
50 
 
 
 
14 
 
 
II 
 
 
 
III 
III 
III 
 
 
 
III 
Moderate 
Pelvic Tilt Positive Association 
Case-control study 
University students [62]  
ACL patients [63]  
No Association - none 
 
 
 
20 
20 
 
 
III 
III 
Moderate 
ACL 
geometry 
Positive Association 
Prospective cohort study –       
Military Cadets [55] 
Case-series 
Graft reconstruc ion patients 
[67]  
 
No Association - none 
 
 
 
 
24 
 
714 
 
 
I 
 
IV 
Moderate 
BMI Positive Association 
Prospective cohort study –       
Military Cadets [55] 
       - Only females 
No Association 
Prospective cohort studies –       
Military Cadets [55] 
       - Only males 
Finnish population [45] 
 
 
 
 
 
 
8 
 
 
 
16 
 
265 
 
 
I 
 
 
 
I 
 
I 
Low 
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a The level of evidence according to evidence-based medicine criteria [42]. 
b The level of certainty, as described in section 2.4.     
 
 
2.4.2.2 Hormonal factors as intrinsic risk factors for ACL ruptures 
   
2.4.2.2.1 Phase of the menstrual cycle 
 
There is evidence that oestrogen and progesterone receptors are found on the 
surface of cells within the ACL. More specifically, both oestrogen and 
progesterone receptors can be localised to the synoviocytes in the synovial 
 
Generalised 
Joint Laxity 
Positive Association 
Prospective cohort study –       
Military Cadets [55] 
Case-control study- 
ACL patients [92] 
ACL patients [63] 
Athletes [90] 
No Association – none 
 
 
 
 
24 
 
 
169 
20 
89 
 
 
I 
 
 
I 
III 
III 
Moderate 
Anterior 
Knee Laxity 
Positive Association 
Prospective cohort study –  
    Military cadets [55] 
        - Females only 
Retrospective case-control 
High School & College 
athletes  [80]  
No association 
Military cadets [55] 
        - Females only 
 
 
 
 
 
8 
 
 
22 
 
 
16 
 
 
I 
 
 
II 
 
 
I 
Moderate 
(in females) 
Low (in 
males) 
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lining, fibroblasts in the ACL stroma and cells in the blood vessel walls of the 
ACL [93]. These findings suggest that these hormones may have a role in the 
biological processes of the ACL. In previous studies it has been shown that 
oestrogen reduces the rate of fibroblast proliferation and type I procollagen 
synthesis [94;95]. This inhibition is attenuated by progesterone, which is though 
to have the opposite effect on fibroblast proliferation and type I procollagen 
synthesis [94;95]. It therefore suggests that fluctuations in oestrogen and 
progesterone concentrations during the menstrual cycle may influence the 
material properties of the ACL, and that there may be an increased risk of ACL 
rupture during certain phases of the menstrual cycle. Numerous studies have 
attempted to investigate the relationship between the phase of the menstrual 
cycle and the risk of ACL ruptures [96-104]. 
 
The results of these studies are not consistent, but a consensus suggests that 
the risk of ACL ruptures does not remain constant during the menstrual cycle 
[105]. The two major problems with research in this field are (1) that it is difficult 
to accurately predict the phase of the cycle at the time of the injury, and (2) that 
authors have not used consistent classifications of the menstrual cycle. The 
perimenstrual [99;100;103], follicular [97], ovulatory [98;101;102] and pre-
ovulatory [104] phases have been identified as possible high risk phases of the 
menstrual cycle. However, the results of the majority of studies suggest that the 
risk of ACL rupture is greater during the pre-ovulatory phase (first half of the 
menstrual cycle), compared to the post-ovulatory phase (second half of the 
menstrual cycle) [105]. In a systematic review, which combined all the published 
literature, Hewett et al. [105] established that both the follicular and ovulatory 
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phases, which together make up the first half of the menstrual cycle, was 
associated with an increased incidence of ACL ruptures when compared to 
expected values. 
 
It is however important to note that only three studies have measured hormone 
levels in order to confirm the menstrual cycle phase at the time of injury. Wojtys 
et al. [102] measured the hormone levels of 69 females within 24 hours of 
sustaining an ACL injury. They found that women had significantly greater risk 
of ACL rupture during the ovulatory phase (mid-cycle) of the menstrual cycle. In 
a similar study, saliva samples were obtained from 38 females with ACL 
ruptures [103]. In this study, the frequency of ACL ruptures was greater in the 
days immediately after the onset of menses. Finally, in one further study, the 
serum concentrations of hormones were measured immediately after an ACL 
injury in 46 females [104]. The results of this study showed that females in the 
first half of the menstrual cycle had a significantly higher risk of ACL rupture. 
  
In summary (Table 2.3), although there appears to be consensus that the 
majority of ACL ruptures occur during the pre-ovulatory phase of the menstrual 
cycle in females, further studies with greater sample sizes as well as a 
standardised classification system of the phases of the menstrual cycle are still 
required to confirm this. Due to this lack of consistency amongst the studies, the 
level of certainty that the first half of the menstrual cycle is a significant risk 
factor for ACL rupture is therefore moderate.    
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Table 2.3: Summary of research studies investigating hormonal intrinsic risk 
factors for ACL ruptures, including the level of evidence of each individual study 
and the level of certainty that the risk factor is associated with risk of ACL 
ruptures.  
 
 
a The level of evidence according to evidence-based medicine criteria [42]. 
b The level of certainty, as described in section 2.4.     
 
2.4.2.3 Neuromuscular intrinsic risk factors for ACL ruptures 
 
A number of neuromuscular factors, including kinematic and kinetic differences 
during landing from a jump, cutting or pivoting, have been suggested as intrinsic 
risk factors for ACL ruptures [106]. These factors include the following: reduced 
hip and knee flexion angles, increased knee valgus, internal rotation of the 
Risk Factor 
Study Details and 
References 
Number 
of ACL 
ruptures 
Level of 
evidence 
(I-V)a 
Level of 
Certaintyb 
Phase of the 
menstrual 
cycle  
(females only) 
Positive Associations 
 
Case-control studies: 
Alpine skiers [104] 
 
Systematic review 
     Level IV evidence studies 
 
Case-series studies 
ACL patients [101] 
Elite handball [99] 
Collegiate athletes [96] 
Collegiate athletes [97] 
Athletes [103] 
ACL patients [102] 
Elite handball [100] 
Athletes [98] 
 
 
 
 
46 
 
 
404 
 
 
28 
17 
28 
83 
68 
69 
64 
28 
 
 
 
 
III 
 
 
V 
 
 
IV 
IV 
IV 
IV 
IV 
IV 
IV 
IV 
Moderate 
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femur on the tibia, high quadriceps muscle activity relative to hamstring muscle 
activity and inadequate trans-knee muscle stiffness. Furthermore, gender 
differences in these factors have also been extensively researched [106]. 
However, there are limited studies where these factors have been studied as 
possible independent risk factors for ACL rupture. Therefore, for the purpose of 
this evidence-based review, only factors that have been evaluated as 
independent risk factors will be discussed.  
 
2.4.2.3.1 Dynamic knee valgus 
 
It is well established that landing from a jump is one of the primary non-contact 
mechanisms of ACL rupture [107]. During landing, the lower extremities absorb 
the forces through joint flexion. It had been widely reported that females land 
with greater knee valgus when compared to males [108;109]. In addition, it has 
been shown that valgus loading places increased strain on the ACL [26]. In one 
prospective cohort study, lower limb biomechanical data were collected from 
205 female athletes during the execution of sports movements and then 
followed prospectively to determine if any measurable differences exists 
between ACL injured and non-injured individuals [110]. The results of this study 
show that females who developed non-contact ACL ruptures had a significantly 
increased lower extremity knee valgus and knee abduction loading during 
landing, before sustaining their injuries, when compared to the non-injured 
individuals. It is however important to note that only nine participants ruptured 
their ACL during the course of this prospective study. This is the only study, to 
current knowledge, where increased dynamic knee valgus as a possible risk 
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factor for ACL ruptures was investigated.  Although the study by Hewett et al. 
[110] was a prospective study, further research incorporating a greater number 
of individuals with ACL ruptures is required. Therefore, the level of certainty that 
increased dynamic knee valgus is a risk factor for ACL ruptures is low (Table 
2.4). 
 
 
Table 2.4: Summary of research studies investigating neuromuscular intrinsic 
risk factors for ACL ruptures, including the level of evidence of each individual 
study and the level of certainty that the risk factor is associated with risk of ACL 
ruptures.  
 
 
a The level of evidence according to evidence-based medicine criteria [42]. 
b The level of certainty, as described in section 2.4.     
 
 
2.4.2.4 Genetic factors as intrinsic risk factors for ACL ruptures 
 
One of the most recent additions to the list of possible risk factors for ACL 
ruptures is the possible genetic component. To date, there are data from only 
three studies which suggest that genetic factors are associated with ACL 
ruptures. Two of the studies have investigated a familial predisposition to ACL 
Risk Factor 
Study Details and 
References 
Number 
of ACL 
ruptures 
Level of 
evidence 
(I-V)a 
Level of 
Certaintyb 
Dynamic knee 
valgus 
Positive Associations 
Prospective cohort study:- 
High risk sports [110] 
 
      
 
 
9 
 
 
II 
Low  
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ruptures and only a single study has shown that a specific genetic element is 
associated with an increased risk of ACL ruptures. 
 
2.4.2.4.1 Familial predisposition 
 
The first evidence of a genetic predisposition to ACL ruptures was presented in 
a study that was designed to investigate anatomical risk factors for ACL 
ruptures [10]. In this study, data obtained from personal information of the 
participants showed a highly significant difference in the frequency of ACL 
ruptures in immediate family members in patients with bilateral ACL ruptures 
compared with control subjects. Eleven of the 31 (35%) patients with bilateral 
ACL ruptures had a family history of ACL ruptures, in comparison to only 1 out 
of 23 (4%) of the control subjects.   
 
In a more recent case-control study, the familial predisposition towards 
rupturing an ACL was investigated in 171 patients with ACL rupture and 171 
matched controls [7]. Patients with an ACL rupture were twice as likely (OR = 
2.00; 95% CI, 1.19 – 3.33) to have a relative (first, second or third degree) with 
an ACL rupture compared to participants without any history of ACL rupture. 
The risk was slightly increased (OR = 2.24; 95% CI, 1.24 – 4.00) when only first 
degree relatives were included in the study. The strength of this investigation 
was that data from a large number of participants were available for this study, 
which made matching of gender, age and primary sport possible. Of the 732 
eligible subjects (348 cases and 384 controls), 171 matched pairs were 
achieved and used in the analysis. The percentage of cases with first, second 
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or third degree family history of ACL rupture was 31%, compared to only 19.3% 
amongst the control. Similarly, 23.4% of cases and 11.7% of control participants 
had a first degree family history of ACL rupture.  
 
Although it appears that familial predisposition is a significant risk factor ACL 
rupture, the available evidence is insufficient to accurately predict risk. The level 
of certainty for this risk factor is therefore moderate (Table 2.5).  
 
2.4.2.4.2 COL1A1 Sp1 binding site polymorphism 
 
In a recently published study, the first genetic sequence variant to be 
associated with ACL ruptures was identified [9]. In this study, the TT genotype 
of the COL1A1 (the gene encoding for the α1 chain of type I collagen) Sp1 
binding site polymorphism was shown to be significantly under-represented in 
participants with cruciate ligament ruptures. Only 1 out of 233 participants with 
ACL rupture, compared to 6 out of 358 subjects control participants had a TT 
genotype at the Sp1 binding site within COL1A1.  
 
However, due to the lack of data investigating this specific polymorphism and 
low frequency of the rare TT genotype, the level of certainty that the COL1A1 
Sp1 binding site polymorphism is a risk factor for ACL ruptures is low (Table 
2.5). 
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Table 2.5: Summary of research studies investigating genetic risk factors for 
ACL ruptures, including the level of evidence of each individual study and the 
level of certainty that the risk factor is associated with risk of ACL ruptures.  
 
 
a The level of evidence according to evidence-based medicine criteria [42]. 
b The level of certainty, as described in section 2.4.     
c All bilateral ACL ruptures 
d Al cruciate ligament injuries, ACL and PCL. 
 
 
 
2.4.3 Summary: Extrinsic and Intrinsic risk factors for ACL ruptures. 
 
Both extrinsic (environmental) and intrinsic (anatomical, hormonal, 
neuromuscular and genetic) risk factors have been extensively reviewed 
according to evidence based guidelines. A summary of the specific risk factors, 
as well as the level of certainty (refer to Section 2.5) that each risk factor is 
associated with ACL ruptures is included (Table 2.6).  
 
 
Risk Factor 
Study Details and 
References 
Number 
of ACL 
ruptures 
Level of 
evidence 
(I-V)a 
Level of 
Certaintyb 
Familial 
predisposition 
Positive Associations 
Case-control studies: 
ACL patients [10] 
ACL patients [104] 
 
 
 
31c 
171 
 
 
III 
III 
 
Moderate 
COL1A1 Sp1 
binding site 
polymorphism 
Positive Associations 
Case-control studies: 
Khoschnau [9] 
 
 
 
233d 
 
 
III 
Low 
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Table 2.6: Summary of the risk factors reviewed in this thesis. All risk factors are 
listed according to their level of certainty.    
 Level of Certaintya 
Risk factors Low Moderate High 
Environmental • Protective bracing 
• Type of playing 
surface (in males) 
 
• Weather conditions 
• Type of playing 
surface (in 
females) 
• Footwear 
 
 
Anatomical • Q angle 
• Tibial slope 
• BMI 
• Anterior knee laxity (in 
males) 
 
• Foot pronation 
• Pelvic tilt 
• ACL geometry 
• GJL 
• Anterior knee laxity 
(in females) 
 
• Notch Width 
 
Hormonal  • Phase of the 
menstrual cycle (in 
females) 
 
 
Neuromuscular • Dynamic knee valgus 
 
  
Genetic • COL1A1 Sp1 binding 
site polymorphism 
• Familial 
predisposition 
 
a The level of certainty, as described in Section 2.4 
 
 
As is evident from this summary (Table 2.6), the investigation of genetic risk 
factors of ACL ruptures is still in its infancy. Therefore, this thesis will use a 
candidate gene approach to identify further specific sequence variants which 
may alter the risk of ACL ruptures. A candidate gene approach requires basic 
knowledge of the molecular structure of the ACL. The following section will 
therefore review the molecular structure of the ACL, and the identification of 
candidate genes for ACL ruptures. 
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2.5 MOLECULAR STRUCTURE OF THE ACL AND IDENTIFICATION OF 
CANDIDATE GENES FOR ACL RUPTURES.  
 
2.5.1 Molecular structure of the ACL 
 
The major cell types within ligaments are the ligamentoblasts and 
ligamentocytes. These cells constitutes less than 5% of the total volume of the 
ligament [111]. Other minor cell types within ligament include osteocytes, 
synovial cells and vascular cells [111]. The remaining 95% of the tissue consists 
of the ECM, which consists of various collagen types, glycoproteins, 
proteoglycans and glycosaminoglycans [15;111]. A large proportion (55 - 70%) 
of the ligament consists of water [111].  
 
Although there are important functional differences, ligaments and tendons 
have a very similar hierarchical structure and composition [111]. The collagen 
microfibril, the basic unit of the ligament, consists predominantly of the type I 
collagen molecules (also known as tropocollagen).  Type I collagen constitutes 
70% - 80% of the dry mass of ligaments and is responsible for the tensile 
strength of the ligament [14].  This protein is a member of the major fibrillar 
collagen sub-family and is a heterotrimeric triplehelix consisting of two α1(I) 
chains and one α2(I) chain.  Other collagen types, such as types III, IV, V, VI, 
XII and XIV, are also structural components of the microfibrils and the 
surrounding ECM [112;113] (Figure 2.6). As illustrated in Figure 2.8 the 
collagen microfibrils assemble into subfibrils, which in turn form the fibrils. The 
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collagen based fibrils gather into fascicles, which are the largest subunits of 
ligaments [111].   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: The hierarchical structure of ligaments. Figure adapted from Hoffman and 
and Gross [111].  
 
 
It has been proposed that the quantitatively minor type III and type V fibrillar 
collagens, have significant functional roles within the collagen microfibril 
[114;115]. As illustrated in Figure 2.9, both type V and type III collagen are 
intercalated into the microfibril together with type I collagen. Type V and type III 
collagen have been shown to make up as much as 12% and 8% of the type I 
collagen content, respectively [114]. Although the specific role of type V and 
type III collagen has not been clearly defined, both collagens have been 
implicated in the formation of the fibril (fibrillogenesis) [114;116].  Type III 
collagen, a homotrimer consting of three α1(III) chains, is also a member of the 
major fibrillar collagen sub-family, while type V collagen is a member of the 
minor fibrillar collagen sub-family.  The major isoform of type V collagen is a 
Ligament
Fasicle
Fibril
Subfibril
Microfibril
Tropocollagen
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heterotrimer consisting of two α1(V) and one α2(V) chains.  Some of the minor 
isoforms of type V collagen contain an α3(V) chain. The major and minor fibrillar 
collagens are synthesised and secreted as procollagen molecules which 
contain globular amino- and carboxy-terminal domains. These domains are 
usually cleaved from the secreted procollagen molecules as a prerequiset for 
fibrillogenesis (Figure 2.10).  The amino-terminal domain of type V collagen is 
however not removed.    
 
The retained amino-terminal domain of type V collagen extends perpendicularly 
to the surface of the fibril, where it is believed to regulate microfibril diameter 
(Figure 2.9) [117]. In agreement with this proposed function, an age-dependant 
increase in the content of type V collagen of the rabbit patellar tendon has been 
shown to be associated with a decrease in fibril diameter [118]. The relative 
proportion of type V collagen also increases during ligament healing, this 
increase has been implicated in the poor mechanical properties of the healed 
ligament [114;119]. Furthermore, it has been proposed that reducing the 
synthesis of type V collagen through antisense gene therapy may be a viable 
option to improve the strength and mechanical properties of weak ligaments 
[119]. 
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Figure 2.9: A schematic diagram of the basic structural unit of ligaments, the collagen 
microfibril. The microfibril consists predominately of type I collagen, a major fibrillar 
collagen.  The microfibril also contains trace amounts of type III and type V collagen 
which belong to the sub-families of major and minor fibrillar collagens respectively.   
Types XII and XIV collagen are associated with the surface of the fibril and belong to 
the sub-family of fibril-associated collagens with interrupted triple helices (FACITs).  
Other collagen types, proteoglycans and glycoproteins which are associated with or 
structural components of the fibril are not shown. Genes that encode for type V 
collagen, type I collagen, type II collagen and type XII collagen, are italicised.      
Type V collagen 
(Minor fibrillar collagen)
COL5A1, COL5A2, COL5A3
Type III collagen 
(Minor fibrillar collagen)
COL3A1
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Figure 2.10: The synthesis of the major and minor fibrillar collagens. Procollagen 
polypeptides (α chains) are synthesised from the genes which for encode the 
respective chains of the specific collagen. A procollagen triple helix molecule is formed 
from the procollagen polypeptides within the cells (ligamentocytes), and then secreted 
into the extracellular space. Once in the extracellular space, the amino- and carboxy-
terminal domains are cleaved and the newly formed collagen triple helix molecule is 
incorporated into the microfibril. 
 
 
It has been proposed that type III collagen may regulate the diameter of type I 
collagen fibrils by coating the surface of the fibrils and thereby allowing tip 
growth and not lateral growth of the fibrils [120]. Similarly to type V collagen, 
type III collagen is also increased in content during healing, specifically during 
the early phase [115]. It is suspected that the increased type III content during 
healing results in smaller fibrils [116].  
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In addition to type III and type V collagen, other collagen types have also been 
implicated in fibrillogenesis. A sub-family of collagens, refered to as Fibril 
Associated Collagens with Interupted Triple helices (FACITs), which include 
type XII and type XIV collagen, associate with the surface of collagen 
microfibrils and are thus able to form interfibrillar connections and mediate fibril 
interaction with other extracellular and cell surface molecules within ligaments 
and tendons (refer to Figure 2.9) [121-125]. These fibril interactions may further 
influence the fibril and matrix density, which suggests that these quantitatively 
minor FACIT collagens may also be involved in fibrillogenesis [122;126;127]. In 
addition, the expression of these collagens is regulated by mechanical stretch 
[126;128]. 
 
As a common feature of FACITs, type XII collagen consists of two collagenous 
domains (COL1 and COL2), interrupted and flanked by three non-collagenous 
domains (NC1-NC3) [129]. Differential splicing within the NC3 domain, the 
largest of the NC domains, results in long (XIIA) and short (XIIB) isoforms [130]. 
One of the short isoforms, the XIIB-1 isoform is predominantly expressed in 
ligaments and tendons [130;131].  Furthermore, similarly to type V collagen, 
type XII collagen has also been shown to be increased during healing [132]. It 
can thereofre be proposed that these two collagens are at least partly involved 
in similar biological processes.  
 
Other quantitatively minor components of the collagen fibril include type IV and 
type VI collagen [15;113]. Type IV collagen is a common component of the 
basement membranes, whereas type VI collagen serves as a gliding 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 2 
56 
 
component between fibril sub-units [15;113]. These genes that encode for these 
collagens were not considered as candidates in this thesis and the detailed 
functions of these proteins will therefore not be reviewed. 
 
Although this section of the review focuses on collagens within the microfibril, it 
is important to mention that ligaments also contain non-collageneous proteins 
and other macromolecules. The ligamentous ground substance, which 
surrounds the collagen molecules and cells, consists of various proteoglycans 
(such as decorin, lumican and versican) and glycoproteins (such as elastin, 
tenacin C, fibrillin and Cartliage Oligomeric Matrix Protein (COMP)) [133]. The 
proteoglycans consists of a protein core which is covalently bound to 
glycosaminoglycans, a polysaccharide chain which has a consiberable water 
binding capacity, and therefore provide support and stability to the collagenous 
tissue [133]. Glycoproteins are macromolecules that consist of a large protein 
fraction and a small glycidic component, and are involved in many biological 
processes within the ligament [133]. Some of the functions of these protein 
molecules include providing elasticity, connecting cells to the ECM and binding 
collagens. Although many  of the genes that encode for these non-collagenous 
molecules could also be considered as ideal candidate genes, such as for 
example tenacin-C, none were investigated in this thesis and therefore these 
molecules were not reviewed. 
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2.5.2 Genetic risk factors for soft tissue injuries 
 
As discussed in Section 2.4.2.4, genetics elements, which include a familial 
predisposition and a specific genetic variation (the functional Sp1 binding site 
polymorphism), have been identified as possible risk factors to ACL ruptures. 
Recently, similar observations have also been made in other soft tissue injuries. 
Harvie et al. [134] demonstrated that the siblings of patients who had ruptured 
their rotator cuff were 4.7 times more likely to rupture their rotator cuff, when 
compared to controls. Similarly, Aroen et al. [135] also found that patients with 
Achilles tendon ruptures are at increased risk of a contralateral Achilles tendon 
rupture. These findings imply that genetic factors play a role in the development 
of acute soft tissue injuries in general. 
 
Some investigators have also reported an association of the ABO blood group, 
a biochemical marker for genetic elements, with Achilles and other tendon 
injuries [136;137]. The O blood group has been shown to be associated with an 
increased risk of Achilles and other tendon ruptures [136;137]. A decreased A/O 
ratio was also reported to be associated with an increase risk of Achilles tendon 
ruptures and Achilles peritendinitis [138]. Other studies have however failed to 
show similar associations [139-142]. Since the ABO blood group is determined 
by a single gene (ABO) on the long arm of chromosome 9 (9q34), Mokone et al. 
investigated the association between two genes, namely COL5A1 [143] and 
TNC [144], which neighbour the ABO gene. The COL5A1 and TNC genes 
encode the previously discussed (Section2.5.1) α1 chain of type V collagen and 
glycoprotein tenacin-C, respectively [143;144].  
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Mokone et al. found that the BstUI restriction fragment length polymorphism 
(RFLP) within the 3’-untranslated (UTR) region of the COL5A1 gene was 
associated with Achilles tendinopathy in a South African Caucasian population 
[143;145]. The CC genotype of this RFLP was significantly over-represented in 
the asymptomatic control participants of the study [143;145]. Although only few 
participants (n=44) with Achilles tendon ruptures were investigated, this BstUI 
RFLP does not seem to be associated with acute tendon ruptures [143]. In a 
recent repeat of this study in an independent Australian Caucasian population, 
the CC genotype of the BstUI RFLP was also over-represented in the 
asymptomatic control participants when compared to those with Achilles 
tendinopathy [145].  
 
In addition to the COL5A1 gene, the TNC gene was also found to be associated 
with Achilles tendon injuries [144]. In this study the variants containing 12 and 
14 GT repeats were over-represented in participants with Achilles tendinopathy 
and Achilles tendon rupture, while variants containing 13 and 17 repeats were 
under-represented [144]. Similar results were observed for the chronic Achilles 
tendinopathy and the Achilles tendon rupture groups. 
 
Other genes which encode for the proteins involved in biological processes in 
the tendon are also likely to be associated with Achilles tendon injuries. The 
matrix metalloproteinases (MMPs) serve a functionally significant role within 
tendons, and one of the proteins within this family, MMP3, may catalytically 
degrade various collagen types and other ECM components [146]. For this 
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reason, Raleigh et al. [147], investigated the possible association of the MMP3 
gene and Achilles tendon injuries. In this study, participants who were 
homozygous for any of the identified risk alleles were at least twice as likely to 
develop Achilles tendinopathy [147]. Furthermore, when the genotypes of the 
one sequence variant within the MMP-3 gene and the BstUI RFLP within the 
COL5A1 gene were combined and analysed, the risk of Achilles tendinopathy 
was increased [147]. 
 
Other genes which have also been investigated as candidate genes for Achilles 
tendon injuries include COL12A1 and COL14A1 [148]. These two genes 
encode for the type XII and type XIV FACIT collagens, respectively. As 
previously discussed (Section 2.5.1), these two FACIT collagens are involved in 
similar biological processes as type V collagen and tenacin-C, and were 
therefore chosen as candidate genes. Sequence variants within either the 
COL12A1 and COL14A1 genes were however not associated with Achilles 
tendinopathy. Although not significant, the absence of both the rare CC and GG 
genotypes of the COL12A1 BsrI and AluI restriction fragment length 
polymorphisms, respectively, in the Achilles tendon rupture subjects warrants 
further research [148].   
 
From the genetic-association studies discussed above, it has become evident 
that there is a genetic contribution to soft tissue injuries. To date, only one 
genetic sequence variant has however been investigated as risk factor for ACL 
ruptures.  
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2.5.3 Candidate genes for ACL ruptures 
 
There are however more than 25 000 protein coding genes within the human 
genome, and many different strategies may be used to identify genetic 
elements that could be associated with or cause disease and injury. Genetic 
association studies remain the most widely used method to identify genetic risk 
factors that may predispose individuals to an increased risk of multifactorial 
conditions such as an injury [149]. The underlying genes may be identified 
either through whole genome screens, or by following a candidate gene 
approach. A large amount of genetic information may be obtained from genome 
wide screens however, these studies are expensive, require very large sample 
sizes, and often not hypothesis driven. The candidate gene approach requires 
the identification of candidate genes based on their biological function. Case-
control studies, following a candidate gene approach, are more suited to initial 
exploratory genetic studies, and are less expensive than whole genome 
screens and was therefore the method used in this thesis. Potential candidate 
genes for ACL ruptures include any gene encoding proteins that are either 
directly or indirectly involved in the structure, degradation, remodelling and/or 
metabolism of ligaments.  
 
To date, a single genetic variant, namely the COL1A1 Sp1 binding site 
polymorphism, has been associated with risk of ACL ruptures (Section 2.4.2.4) 
[55]. However, it is unlikely that a single gene or a single sequence variant 
within that gene exclusively predisposes individuals to ACL ruptures. ACL 
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ruptures, similar to Achilles tendon injuries, are multifactorial conditions, and 
therefore more likely to be polygenic in nature.  
 
Polymorphisms within the COL1A1 and COL5A1 genes have been associated 
with acute ligament injuries [9], and/or Achilles tendinopathy [143;145]. 
Therefore, it is reasonable that genes which encode for structural collagenous 
components of the ligament microfibril should be chosen for initial 
investigations.  Although there are a large number of genes which encode for 
structural components of the ligament (Table 2.7), the previously investigated 
COL1A1 [9], COL5A1 [143;145] and COL12A1 [148] genes were selected as 
initial possible candidate genes that could be associated with an increased risk 
of ACL ruptures and will now be reviewed.  
 
2.5.3.1 The COL1A1 gene 
 
Type I collagen, which constitutes up to 80% of the dry mass of the ligament 
[14], is a heterotrimer consisting of 2 α1(I) chains and 1 α2(I) chain. The α1(I) 
and α2(I) chains are encoded for by the COL1A1 (17q21.33) and COL1A2 
(7q22.1) genes respectively.  
 
The COL1A1 gene, and specifically the functional Sp1 binding site 
polymorphism, has been associated with various complex disorders of 
connective tissue, including, myocardial infarction [151], lumbar disc disease 
[152] stress urinary incontinence [153], and most notably, osteoporosis 
[154;155]. 
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Table 2.7: The genes encoding for the ligament and tendon extracellular matrix 
(ECM) collagens, proteoglycans and glycoproteins. 
 
Protein Structure/Type Gene(s) and Chromosomal Location(s) 
Collagen   
Type I Fibril-forming COL1A1 (17q); COL1A2 (7q) 
Type III Fibril-forming COL3A1 (2q) 
Type IV Forms meshwork 
COL4A1 & COL4A2 (13q); COL4A3 & COL4A4 (2q); 
COL4A5 & COL4A6 (Xq) 
Type V Fibril-forming COL5A1 (9q); COL5A2 (2q); COL5A3 (19q) 
Type VI Forms beaded filaments COL6A1 & COL6A2 (21q); COL6A3 (20q) 
Type XII FACITa COL12A1 (6q) 
Type XIV FACITa COL14A1 (8q) 
   
Proteoglycan   
Decorin SLRPb DCN (12q) 
Fibromodullin SRLPb FMOD (7q) 
Lumican SLRPb LUM (12q) 
Versican Hyalectan CSPG2 (5q) 
   
Glycoprotein   
Elastin Oligomeric network ELN (7q) 
Fibrillin Linear arrays FBN1 (15q); FBN2 (5q) 
Tenascin-C Oligomeric molecule TNC (9q) 
COMPc Oligomeric molecule COMP (19p) 
Fibronectin Modular protein FN1 (2q) 
Laminind Modular protein  
Thrombospondin Modular protein THBS1 (15q); THBS2 (6q); THBS3 (1q); THBS4 (5q) 
Link protein Globular protein CTR1 (5q) 
Tenomodulin Transmembrane protein TNMD (Xq) 
 
The fibrocartilagenous types II, IX, X and XI collagens, as well as biglycan and 
aggregan are not included in this table.  
aFACIT, Fibril Associated Collagen with Interrupted Triple helix; bSLRP, small leucine-
rich repeat proteoglycan; cCOMP, cartilage oligomeric matrix protein; dMultiple genes 
coding for multiple proteins.  Adapted from Riley [150] and September [163]. 
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A recent study investigating the molecular mechanism of the functional COL1A1 
Sp1 binding site polymorphism, the most widely studied candidate gene for 
osteoporosis, demonstrated that the G to T substitution results in reduced bone 
quality [155]. In this study, it was shown, by in vitro gel shift assays, that the T 
allele had an increased binding affinity for the transcription factor Sp1, which 
was accompanied by an increase in COL1A1 mRNA, and an altered production 
of the α1(I) chain relative to the α2(I) chain [155]. The mechanism whereby this 
altered protein ratio results in reduced bone quality and strength does however 
remain unknown. Although a α1(I)3 homotrimer is known to impair bone 
strength, as is seen in the classical Mendelian disorder osteogenesis imperfecta 
[113], no studies have formally demonstrated the presence of a α1(I)3 
homotrimer in bone derived from patients with a T allele. In addition, the T allele 
was also associated with a reduced inorganic component and an increased 
organic component in bone [155].  
 
In contrast to the effects in bone, the previously discussed Swedish study 
(Section 2.4.2.4.2) showed the TT genotype of the Sp1 binding site 
polymorphism to be significantly under-represented in participants with acute 
soft tissue injuries, including cruciate rupture and shoulder dislocations. These 
data suggests that the G to T substitution increases the tensile strength of 
ligaments. Further investigation is however required to confirm these findings in 
a second population, more specifically within participants with ACL ruptures and 
with gender-matched controls. Studies are also required to determine possible 
molecular mechanisms. 
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2.5.3.2 The COL5A1 gene 
 
The COL5A1 gene encodes for the α1(V) chain of the fibril forming type V 
collagen. Type V collagen has been implicated in the regulation of fibril diameter 
(fibrillogenesis).  Furthermore, type V collagen has also been shown to be the 
second largest collagen component of ligaments [114]. 
 
The COL5A1 gene (as discussed in Section 2.5.2) has been shown to be 
associated with Achilles tendinopathy. More specifically the CC genotype of the 
BstUI RFLP within the 3’-untranslated region (UTR) of COL5A1 gene was 
significantly over-represented in the control group, when compared the Achilles 
tendinopathy groups within two independent populations [143;145]. It is 
however important to note that the biological mechanisms for these 
observations are currently unknown.  
 
2.5.3.3 The COL12A1 gene 
 
Type XII collagen is a homotrimer consisting of 3 α1(XII) chains and is encoded 
for by a single gene, COL12A1, which has been mapped to chromosome 6q12-
q13 [156]. Type XII is involved in a similar biological process than type V 
collagen, both collagens are believed to regulate microfibril diameter 
(fibrillogenesis) [125;127;157].  Furthermore, mechanical forces have been 
shown to regulate the production of type XII collagen. More specifically the 
COL12A1 gene is directly activated by mechanical force [126;128]. 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
LITERATURE REVIEW 
65 
 
As discussed (Section 2.5.2) the COL12A1 AluI and BsrI RFLPs, have been 
investigated as candidate genes for Achilles tendinopathy. Although not 
significant, the absence of both the rare CC and GG genotypes of the COL12A1 
BsrI and AluI RFLPs, respectively, in participants with Achilles tendon ruptures 
(acute soft tissue injuries) warrants further research. 
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2.6 SUMMARY AND CONCLUSIONS OF THE LITERATURE REVIEW 
 
Although there has been a considerable amount of research and development 
in the understanding of the factors which predisposed individuals to ACL 
ruptures. It is widely accepted that the exact aetiology and mechanism of these 
acute injuries are currently unknown. It is however clear that ACL ruptures are a 
multifactorial condition, which have been associated with various intrinsic and 
extrinsic risk factors. Numerous, extrinsic (environmental) and intrinsic 
(anatomical, hormonal, neuromuscular and genetic) risk factors have been 
extensively reviewed in this chapter according to evidence based guidelines. It 
is clear from the levels of certainty presented, that a greater amount of research 
is required for all, but one risk factor, notch width. 
 
Furthermore, the identification of genetic risk factors for ACL ruptures are still in 
its infancy. Only two studies have identified a familial predisposition, and only a 
single study has identified a specific genetic element, the COL1A1 Sp1 binding 
site polymorphism, which is associated with risk of ACL rupture. Due to the 
multifactorial nature of ACL ruptures, it is highly unlikely that this is the only 
genetic element associated with this injury. In support of this argument, various 
polymorphisms have been shown to be associated with Achilles tendon injuries.  
 
In conclusion, novel genetic elements have recently been identified as possible 
intrinsic risk factors for ACL ruptures. The preliminary evidence in support of 
this has been reviewed. Candidate genes that may be associated with 
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increased risk of ACL ruptures have also been identified, and should be 
investigated.   
 
 
 
 
.  
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2.7 AIMS AND OBJECTIVES OF THE THESIS 
 
The primary aim of this thesis was to identify candidate genes that may be 
associated with ACL ruptures, and then use a genetic association approach 
following a case-control study design to identify specific sequence variants 
(single nucleotide polymorphisms, SNPs) within these candidate genes which 
may predispose individuals to ACL ruptures. Candidate genes (COL1A1, 
COL5A1 and COL12A1) were selected based on the biological function of their 
encoded proteins (type I, type V and type XII collagen respectively) within the 
basic structural and functional unit of ligaments, namely the collagen microfibril. 
The objectives of the specific gene association studies which addressed the 
primary aim of this thesis were as follows: 
 
• To determine if the rare TT genotype of the functional Sp1 binding site 
polymorphism within intron 1 of the COL1A1 gene was associated 
specifically with ACL ruptures in an independent second South African 
Caucasian population with gender-matched controls. (Study 1) 
• To determine if two sequence variants (BstUI and DpnII restriction 
fragment length polymorphisms, RFLPs) within the 3’-UTR of the COL5A1 
gene, which has previously been investigated in Achilles tendon injuries, 
were associated with an increased risk of ACL ruptures. Due to the 
reported increased risk of ACL ruptures in females, a secondary objective 
of this study was to investigate if there were any gender-specific 
associations between the two COL5A1 sequence variants and risk of ACL 
ruptures. (Study 2) 
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• To determine if two previously described non-synonymous genetic 
sequence variants, the AluI and BsrI RFLPs within exons 65 and exon 29 
respectively, within the COL12A1 gene, were associated with an 
increased risk of ACL ruptures.  A secondary objective of this study was to 
investigate if there were any gender-specific associations between the two 
COL12A1 sequence variants and risk of ACL ruptures. (Study 3) 
 
The secondary aim of this thesis was to investigate the similarities and 
differences between the genetic risk factors for ACL ruptures and other soft 
tissue injuries. The genetic variants investigated in Study 2 and 3 of this thesis 
have previously been investigated as risk factors for other musculoskeletal soft 
tissue injuries (Achilles tendinopathy and/or Achilles tendon ruptures). However, 
the possible association of the functional Sp1 binding site polymorphism with 
Achilles tendon injuries has not been investigated. Therefore, the objectives of 
the studies which addressed the secondary aim of this thesis are as follows:   
 
• To determine if the rare TT genotype of the functional Sp1 binding site 
polymorphism within intron 1 of the COL1A1 gene was associated with 
other common acute (spontaneous Achilles tendon ruptures) and chronic 
(Achilles tendinopathy) injuries. (Study 4) 
• To report the combined effect of the rare COL1A1 TT genotype and the 
risk for acute soft tissue ruptures from the previously published study, and 
the results presented in this thesis (Study 1 and Study 4). (Study 5) 
• To determine if there are any gender-specific COL5A1 BstUI RFLP 
genotype effects in chronic Achilles tendinopathy when the two previously 
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published studies were re-analysed. Another objective of this study was to 
investigate if the distribution of the COL5A1 BstUI RFLP within the 
combined asymptomatic control participants from this thesis (Study 2), as 
well as the two previously published studies were age-dependant. (Study 
6) 
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CHAPTER 3 
STUDY ONE 
 
GENETIC RISK FACTORS FOR ANTERIOR CRUCIATE LIGAMENT RUPTURES: 
THE COL1A1 SP1 BINDING SITE POLYMORPHISM 
 
The data presented in this chapter was published in the following peer-reviewed 
article: Posthumus, M. September, AV. Keegan, M. O’Cuinneagain, D. van der Merwe, W. 
Schwellnus, MP. Collins, M. Genetic risk factors for anterior cruciate ligament ruptures: The 
COL1A1 gene variant. British Journal of Sport Medicine, 2009, 43:352-356. 
 
 
3.1 INTRODUCTION 
 
As discussed in the literature review (Section 2.5.3.1), the gene encoding for the α1 
chain of type I collagen (α1(I)), COL1A1, was selected as a candidate gene for ACL 
ruptures for the following reasons: (1) type I collagen is the major protein component 
(70-80% of its dry weight) of the ACL, and (2) various other complex connective 
tissue disorders, including acute ligament injuries, have been shown to be 
associated with the Sp1 binding site polymorphism within the COL1A1 gene. 
 
The Sp1 binding site polymorphism is a functional polymorphism within intron 1 of 
COL1A1. It has been shown to alter the expression and translation of the α1(I) chain 
(Figure 1.1) [155]. This polymorphism is the most widely researched genetic variant 
within the COL1A1 gene. 
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Figure 3.1: A schematic diagram showing the G>T substitution (SNP rs1800012) at 
nucleotide 1023 of intron 1 (IVS1) within the COL1A1 gene. The relative sizes and positions 
of the exons (vertical lines) and the introns (horizontal lines) which make up the COL1A1 
gene are shown.  Eighteen bases within intron 1, which contain the the Sp1 binding site 
(nucleotides in bold) are also shown. The binding of the Sp1 transcription factor (grey oval) 
is shown. The substitute of the wild type G nucleotide with T nucleotide increases the affinity 
of the Sp1 transcription factor, which in turn results in an increased expression of the 
COL1A1 gene [155]. 
 
 
As previously discussed (Section 2.4.2.4.2), a single Swedish study has recently 
shown that the functional COL1A1 Sp1 binding site polymorphism is associated with 
acute ligament injuries, including cruciate ligament ruptures and shoulder 
dislocations [9]. In this Swedish study, all cruciate ligament ruptures (not limited to 
ACL) were investigated. Additionally, the control group consisted of only females, 
while the injury group consisted of females and males [9]. Female gender is a 
significant risk factor for ACL ruptures (Section 2.3.1.3). In addition, it has been 
5’ 3’
COL1A1
ATG GGGCGGGATGAGGGGT
INTRON 1
Sp1
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reported that if a gender difference in the risk of a disorder exists, it might be 
expected that the at-risk allele or genotype is over-represented among participants at 
less risk [158]. Therefore, repeating the Swedish study in an independent population 
focusing on a specific clinical phenotype, such as ACL ruptures, with gender-
matched controls, will provide further evidence to support the initial association.   
 
The aim of this first study of this thesis was therefore to determine whether the 
functional Sp1 binding site polymorphism within intron 1 of the COL1A1 gene is 
associated specifically with ACL ruptures in an independent second South African 
Caucasian population with gender-matched controls. 
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3.2 MATERIALS AND METHODS 
 
3.2.1 Participants 
 
One hundred and twenty nine Caucasian participants with surgically confirmed 
anterior cruciate ligament (ACL) ruptures were recruited by convenience sampling 
for this study, and subsequent studies of this thesis, from the Sports Science 
Orthopaedic and Sports Medicine Clinics in Cape Town, South Africa. These same 
participants were also studied in subsequent studies (Study 2 and 3) that are 
presented in this thesis. 
 
Of the 129 participants with ACL ruptures, only 117 participants were genotyped in 
the current study. Eleven (9.4%) of the participants had a history of bilateral ACL 
ruptures. Twenty nine percent (31 of 106; detailed information was unknown in 11 
participants) of all participants with ACL ruptures did not sustain any associated 
(concurrent) injuries. The most common associated injury was injury to the meniscus 
(49% of participants; 52 of 106) and injury to the MCL (20% of participants; 21 of 
106). In addition, 130 apparently healthy, unrelated, physically active gender-
matched Caucasians without any self-reported history of ligament or tendon injury 
were recruited as control (CON) participants from sports clubs and a wellness centre 
(SSISA) within the Southern Suburbs region of Cape Town, South Africa.   
 
Participants which had detailed information available on the mechanism of ACL 
rupture, were subdivided into sub-groups consisting of those where the injury was 
sustained through direct contact (DIR, n=15), indirect contact (IND, n=18) or non-
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contact (NON, n=50), using the American Orthopaedic Society for Sports Medicine 
classification system [13].  In 34 (29%) of the participants who had ruptured their 
ACL, no clear mechanism of injury could be identified and were not included in any 
of the sub-groups.  
 
Although care was taken to ensure that all participants in the CON group were 
physically active, only the ACL group completed sports participation details for this 
particular study. A list of specific sports most often played by the ACL groups (male 
and female) are included in Appendix 1 (Additional material, Table A1.1). In 
summary, the sport most often played by males in the ACL group was rugby 
(65.6%), while the females most often played field hockey (60.0%). Further sports 
participation details are included in Table 4.3 (Study 2). Amongst the female ACL 
group, 57.1% (20 of 35) and 5.7% (2 of 35) participated in non-contact jumping 
sports and contact sports respectively. Amongst the male ACL group, 13.4% (11 of 
82) and 87.8% (72 of 82) participated in non-contact jumping sports and contact 
sports respectively. Detailed lists of the sports within these categories are presented 
in Study 2 (Section 4.2.2).   
 
Prior to participation in this study, all the participants gave informed written consent 
(Appendix 2).  In addition, each participant completed personal details, injury details 
and medical history questionnaire forms (Appendix 3). This study was approved by 
the Research Ethics Committee of the Faculty of Health Sciences within the 
University of Cape Town, South Africa (reference number 164/2006; Appendix 4).   
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 3 
76 
 
3.2.2 DNA extraction  
 
Approximately 4 ml of venous blood was obtained from each participant by 
venipuncture of a forearm vein and collected into an EDTA vacutainer tube.  Blood 
samples were stored at -20°C until total DNA extraction.  
 
DNA was extracted using the procedure described by Lahiri and Nurnberg [159], with 
slight modification. Briefly, the blood samples were transferred to sterile 15 ml 
polypropylene tubes, to which 10 ml of TKM1 buffer (10 mM Tris-HCl pH 7.6, 10 mM 
KCl, 10 mM MgCl2 and 2 mM EDTA) containing 2.5 % Nonidet P-40 was added to 
lyse the red blood cells.  After incubating at room temperature for 10 minutes, the 
white blood cells (WBC) were pelleted by centrifugation at 1200 X g at room 
temperature for 10 minutes and washed at least once with one volume of TKM1 
buffer. The washed WBC pellets were resuspended in 800 µl of TKM2 buffer (10 mM 
Tris-HCl pH 7.6, 10 mM KCl, 10 mM MgCl2, 0.4 M NaCl2 and 2 mM EDTA) 
containing 50 µl of 10 % SDS and incubated for at least  60 minutes at 55 ºC to lyse 
the WBC.  One hundred and fifty µl of 5 M NaClO4 and 500 µl of chloroform was 
added to each sample, which was then mixed thoroughly by vortexing for 15 - 20 
seconds. The samples were transferred to 1.5 ml microfuge tubes and the protein 
precipitated by centrifugation at 15 000 X g (13 000 rpm) for 5 minutes at room 
temperature. Five hundred µl of the top aqueous phases were transferred to new 
microfuge tubes containing 1 ml of absolute ethanol, mixed and the DNA pelleted by 
centrifugation at 13 000 rpm for 2 minutes at room temperature.  The precipitated 
DNA was air dried for at least 30 minutes and resuspended in 200 µl of TE buffer (10 
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mM Tris-HCl, 1 mM EDTA, pH 8.0). Each tube was incubated at 65 °C for 15 
minutes before being stored 4°C until PCR analysis. 
 
3.2.3 COL1A1 genotyping 
 
DNA samples were genotyped for the Sp1 binding site polymorphism (SNP 
rs1800012; IVS1+1023G>T) within intron 1 of the COL1A1 gene using a nested 
polymerase chain reaction (PCR) amplification method as previously described [153] 
(Figure 3.2). The PCR reactions were performed in a final volume of 60 μl containing 
at least 200 ng genomic DNA (primary reaction) or 1 μl of PCR product (secondary 
reaction); 20 pmol of each primer; 2.0 mM MgCl2; 50 mM KCl; 10 mM Tris-HCl (pH 
8.3); 200 μM each dATP , dCTP, dGTP, and dTTP and 0.5 U Taq DNA polymerase 
(New England Biolabs, Ipswich, Massachusetts, USA).  
 
The following primer pairs were used: forward primer for the primary reaction, 5’-
GGA AGA CCC GGG TTA TTG CT-3’; reverse primer for the primary reaction, 5’-
CGC TGA AGC CAA GTG AAA TA-3’; forward primer for the secondary reaction, 5’-
TAA CTT CTG GAC TAT TTG CGG ACT TTT TGG-3’ and the reverse primer for the 
secondary reaction, 5’-GTC CAG CCC TCA TCC TGG CC-3’.  The secondary 
reverse primer was designed to contain two mutated nucleotides (underlined in the 
primer sequence) which introduced a restriction site (TGG/CCA) for the restriction 
endonuclease MscI at the 3’ end of the 260 bp secondary PCR product when 
amplifying the T allele [153].  The conditions for the primary and secondary PCRs 
were as follows: (i) denaturing at 95°C for 15 minutes; (ii) 5 cycles of denaturation at 
95°C for 25 seconds, annealing at 70°C for 45 seconds and extension at 72°C for 30 
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seconds; (iii) 27 cycles of denaturation at 95°C for 25 seconds, annealing at 58°C for 
45 seconds and extension at 72°C for 30 seconds; and (iv) a final extension at 72°C 
for 10 minutes (XP Thermal Cycler Block; Bioer technology Co; Middlesex, UK).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: A schematic diagram showing the G>T substitution (grey box in the genomic 
sequence; SNP rs1800012) at nucleotide 1023 of intron 1 (IVS1) within the COL1A1 gene. 
The relative sizes and positions of the exons (vertical lines) and the introns (horizontal lines) 
within the COL1A1 gene are shown.  A 600 bp genomic sequence within intron 1 is shown to 
indicate the position of  the outer forward (P1) and reverse (P2) primers (solid arrows) 
designed to amplify the primary 598 bp fragment, and the inner forward (P3) and reverse 
(P4) nested primers (dashed arrows) to amplify a 260 bp PCR fragment and introduce a 
MscI restriction recognition site (TGG/CCA) for the T allele. The P4 primer partially spans 
the consensus binding site (boxed) for the Sp1 transcription factor.  
CGGGAAGACC CGGGTTATTG CTGGGTGCGG ACCCCCACCT CTAGATCTGG AAAGTAAAGC 60 
CAGGGATGGG GCAGCCCAAG CCTCTTAAAG AGGTAGTCGG GCCGGTGAGG TCGGCCCCGC 120 
CCCGGCCCCA TTGCTTAGCG TTGCCCGACA CCTAGTGGCC GTCTGGGGAG CCGCTAGCGC 180 
GGTGGGAGTG GTTAGCTAAC TTCTGGACTA TTTGCGGACT TTTTGGTTCT TTGGCTAAAA 240 
GTGACCTGGA GGCATTGGCT GGCTTTGGGG GACTGGGGAT GGCCCCGAGA GCGGGCTTTT 300 
AAGATGTCTA GGTGCTGGAG GTTAGGGTGT CTCCTAATTT TGAGGTACAT TTCAAGTCTT 360 
GGGGGGGCCT CCCTTCCAAT CAGCCGCTCC CATTCTCCTA GCCCCGCCCC CGCCACCCCA 420 
CCTGCCCAGG GAATGGGGGC GGGATGAGGG CTGGACCTCC CTTCTCTCCT CCCTCGCCCT 480 
CCTCCTGTCT CTACCACGCA AGCCACTCCC CACGAGCCTG CCCTCCCGAT GGGGCCCCTC 540 
CTATTCTCCC CCCGCCCTCC CCCTCTCACC CTGTGGTTTT TATTTCACTT GGCTTCAGCG 600
5’ 3’
COL1A1
Genomic sequence 
within intron 1 
P1
P4
P3
P2
G
TMscI
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The secondary PCR products were digested with the restriction endonuclease MscI 
(New England Biolabs, Ipswich, MA, USA) for 3 hours at 37°C following the 
manufacturers instructions. The resultant fragments together with a 100 bp 
molecular weight marker (Promega Corporation, Madison, Wisconsin, USA),  and 
SYBER® Gold nucleic acid gel stain (Invitrogen Molecular ProbesTM, Oregon, USA) 
were separated on 6% non-denaturing polyacrylamide gels.  The gels were 
photographed under UV light using a Uvitec photodocumentation system (Uvitec 
Limited, Cambridge, UK) and the sizes of the DNA fragments determined.  The G 
allele produces a 260 bp fragment while the T allele produces 242 bp and 18 bp 
fragments (Figure 3.3). 
 
3.2.4 Statistical analysis 
 
A one-way analysis of variance (ANOVA) was used to determine any significant 
differences between the characteristics of the CON and ACL groups, as well as the 
DIR, IND and NON sub-groups.  A least squares difference (LSD) post-hoc test was 
used to identify specific differences when the overall F value was found to be 
significant.  A chi-squared (χ2) analysis or Fisher’s exact test was used to analyse 
any differences in the genotype and allele frequencies, as well as family injury 
history between the groups. The sample sizes used for this study and subsequent 
studies within the thesis (Study 2 to Study 5) were based on those reported in 
previous published studies on the genetic basis of Achilles tendon injuries [143-145; 
147] where associations were reported with an odds ratios >2 at a power of 80% and 
significance level of 5%.  When appropriate, adjusted p-values are indicated. 
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Significance was accepted when p<0.05. Hardy-Weinberg equilibrium was 
established using the program Genepop web version 3.4 
(http://genepop.curtin.edu.au/).  
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 3.3: A typical 6% non-denaturing polyacrylamide gel showing the genotypes of the 
COL1A1 Sp1 binding site polymorphism. The secondary PCR product (260 bp) is digested 
with MscI to produce 242 bp and 18 bp fragments for the T allele. The small 18 bp fragment 
ran off the gel and can therefore not be seen in the figure. MscI is not able to digest the 
secondary 260 bp PCR product when the G allele is present. The genotype of each sample 
is indicated at the top of each lane. The left lane contains the 100 bp molecular weight 
marker (MW) and the appropriate fragment sizes are given in base pairs (bp). 
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3.3  RESULTS 
 
3.3.1 Participant characteristics 
 
The participants within the CON and ACL groups, as well as the DIR, IND and NON 
sub-groups, were similarly matched for gender and height (Table 3.1).  The age of 
the control group at recruitment was significantly older than the age of the ACL 
group, as well as the DIR, IND and NON sub-groups, at the time of first ACL rupture 
(p<0.001). The ACL participants were recruited on average 5.1 ± 8.7 years after their 
initial ACL rupture.  Although there were no significant differences in weight between 
the CON and ACL groups after adjusting for age, the IND sub-group was significantly 
heavier at the time of injury when compared to the control group at the time of 
recruitment. The BMI of the ACL participants were significantly higher (p=0.030), 
when compared to the CON group, even after adjusting for age (p=0.018).  The ACL 
participants were on average 1.3 ± 4.4 kg heavier, with a corresponding higher 
average BMI (0.4 ± 1.5 kg/cm2), at recruitment when compared to the time of first 
ACL rupture.  There were significantly less South African born participants in the 
CON group (p<0.012), when compared to the ACL group. Similar results were 
however obtained when only South African born participants were analysed 
(Appendix 1, Additional material, Table A1.2). 
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Table 3.1: General characteristics of the control (CON) and anterior cruciate ligament rupture (ACL) group, as well as the direct 
contact (DIR), indirect contact (IND) and non-contact (NON) ACL rupture sub-groups. 
 CON ACL P-value b DIR IND NON P-value c 
Age (years) a 37.7 ± 10.0 (125) d,e 29.0 ± 11.2 (114) <0.001 26.3 ± 12.3 (15)d 32.8 ± 12.3 (18) 28.0 ± 10.9 (50) e <0.001 
Height (cm) 177.4 ± 9.6 (126) 176.7 ± 9.8 (104) 0.578 175.4 ± 8.2 (14) 180.9 ± 8.9 (17) 177.0 ± 9.5 (49) 0.418 
Weight (kg) a 76.2 ± 13.1 (130) f 79.4 ± 17.3 (104) 0.094 g 81.4 ± 12.5 (14) 87.9 ± 15.9 (17) f 79.9 ± 17.9 (49) 0.008 g 
BMI (kg/cm2) a 24.1 ± 3.3 (126) 25.1 ± 3.7 (100) 0.018 g 26.2 ± 2.7 (14) 25.9 ± 2.8 (16) 25.3 ± 4.4 (47) 0.014 g 
Gender (% males) 74.6 (130) 69.0 (116) 0.325 93.3 (15) 88.9 (18) 66.0 (50) n.d. 
Country of birth  
(% South Africa) 
71.1 (128) 85.1 (107) 0.012 92.9 (14) 83.3 (18) 84.0 (50) n.d. 
 
Gender and country of birth are represented as a frequency (%). The remaining variables are expressed as mean ± standard deviation. The 
number of subjects (n) for each variable is in parentheses.  
a Age, weight and BMI are self-reported values at the time of the first ACL rupture for the ACL group, as well as the DIR, IND and NON sub-
groups, and at recruitment for the CON group. For the ACL group the age, weight and BMI at recruitment were 5.1 ± 8.7 years (n=114), 1.3 ± 
4.4 kg (n=103) and 0.4 ± 1.5 kg/cm2 greater than at the time of the first ACL rupture.   
b  CON vs. ACL; c CON vs. DIR vs. IND vs. NON 
Pairwise, post hoc significant differences: d CON vs. DIR (p<0.001); e CON vs. NON (p<0.001); f CON vs. IND (p=0.010) 
g Adjusted for age 
n.d. = not determined due to small sample sizes 
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Except for one CON participant, none of the CON participants reported a previous 
history of any ligament or tendon injuries (Table 3.2). The single CON participant had 
reported a previous finger ligament injury. Sixty (56.1%) of the ACL participants 
reported a previous history of any other ligament injury, of which 13 (12.3%) and 40 
(37.7%) reported a history of other knee and/or ankle ligament injuries, respectively. 
The other knee ligament injuries included injury to the MCL (n=11), LCL (n=2) and 
the PCL (n=1). Ankle ligament injuries included injury to the lateral (n=39) and (n=5) 
medial ankle ligaments. Only 11 (10.4%) ACL participants reported a history of 
Achilles tendon injuries. 
 
3.3.2 Family history 
 
The family history of any ligament injury, which includes ligament injury to any blood 
relative as reported by the participant at the time of recruitment, was significantly 
higher (OR=4.2; 95% CI = 2.2 – 8.0; P<0.001) in the ACL group (39.6%; n=106) 
compared to the CON group (13.5%; n=126) (Table3.2).  Within the ACL group there 
was a similar incidence in the family history of any ligament injury amongst the DIR 
(n=14, 35.7%), IND (n=18, 38.9%) and NON (n=50, 40.0%) sub-groups (p=0.981).  
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Table 3.2: Personal and family history of soft tissue injuries amongst the control (CON) and anterior cruciate ligament rupture (ACL) 
group, as well as the direct contact (DIR), indirect contact (IND) and non-contact (NON) sub-groups. 
 
All values are represented as frequency (%) of subjects, or the frequency (%) of subjects’ relatives whom have presented with the relevant 
connective tissue pathology. The number of subjects (n) for each variable is in parentheses.  
n.d.= non-determined P-values. a= CON vs. ACL. b= DIR vs. IND vs. NON. c= Includes the lateral and medial ankle ligaments 
d= Includes the posterior cruciate ligament (PCL), the lateral collateral ligament (LCL), and the medial collateral ligament (MCL). 
 CON ACL P-valuea DIR IND NON P-valueb 
Previous ligament injury 0.8 (129) 56.1 (107) n.d. 50.0 (14) 61.1 (18) 57.1 (49) 0.818 
Previous Knee ligamentc 0 (0) 12.3 (106) n.d. 7.1 (14) 22.2 (18) 12.0 (50) 0.414 
Previous Ankle Ligament spraind 0 (0) 37.7 (106) n.d. 35.7 (14) 55.6 (18) 36.0 (50) 0.325 
Previous Achilles tendon injury 0 (0) 10.4 (106) n.d. 0 (14) 5.6 (18) 18.4 (49) 0.112 
Joint Capsule Disease 0 (129) 1.9 (103) n.d. 7.7 (13) 0 (17) 2.1 (48) n.d. 
Family ligament injury 13.5 (126) 39.4 (104) P<0.001 35.7 (14) 38.9 (18) 49.6 (48) 0.966 
Family Achilles tendon injury 1.6 (127) 3.8 (106) n.d. 0 (14) 0 (17) 4 (50) n.d. 
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3.3.3 COL1A1 genotype frequencies 
 
There were no significant differences in the distribution of the genotype (GG vs. GT + 
TT, p=0.890) or allele (p=0.745) frequencies of the COL1A1 Sp1 binding site 
polymorphism between the ACL and CON groups, as well the genotype (GG vs. GT 
+ TT, p=0.548) or allele (p=0.935) frequencies between the CON and NON sub-
groups (Table 3.3). Although the sample size of the DIR and IND sub-groups were 
too small for formal analysis, theses sub-groups appeared to have similar genotype 
distributions to the NON sub-group. It is important to note that although there were 
no differences in the genotype distribution, none of the ACL participants were 
homozygous for the minor T allele.  The rare TT genotype was significantly under-
represented in the ACL group when compared to the CON group (OR=12.3; 95% CI 
0.7 – 220.4; P=0.031) (Figure 3.4).  
 
The COL1A1 genotype distribution of the CON (p=0.219) and ACL (p=0.075) groups 
were in Hardy-Weinberg equilibrium. More females have a TT genotype (4 of 6; 
66.7%) when compared to the GT (18 of 70; 25.7%) and GG (47 of 125; 27.3%) 
genotypes. There were however no COL1A1 genotype effects on any of the other 
physical characteristics of the participants when adjusted for gender (Table 3.4). 
Similar results were obtained when only the SA born subjects were analysed 
(Appendix 1, Additional material, Table A1.3). The genotype distribution between the 
male and female ACL participants was similar (P=0.523; male 54 GG, 66.7%; 27 GT, 
33.3%; female 26 GG, 72.2%; 10 GT, 27.8%).   
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 3  
86 
 
 
 
 
 
Table 3.3: Relative genotype and allele frequencies of the COL1A1 Sp1 binding site 
polymorphism within the control (CON) and anterior cruciate ligament rupture (ACL) 
group, as well as the direct contact (DIR), indirect contact (IND) and non-contact 
(NON) ACL rupture sub-groups. 
 
 CON 
(n=130) 
ACL 
(n=117) 
DIR 
(n=15) 
IND 
(n=18) 
NON 
(n=50) 
GG genotype (%) 70.0 (91) 68.4 (80) 80.0 (12) 66.7 (12) 72.0 (36) 
GT genotype (%) 25.4 (33) 31.6 (37) 20.0 (3) 33.3 (6) 28.0 (14) 
TT genotype (%) a 4.6 (6) 0 (0) 0 (0) 0 (0) 0 (0) 
G allele (%) 82.7 (215) 84.2 (197) 90.0 (27) 83.3 (30) 86.0 (86) 
T allele (%) 17.3 (45) 15.8 (37) 10.0 (3) 16.7 (6) 14.0 (14) 
 
The values are expressed as a percentage with the number of subjects (n) in parentheses.  
a Due to the absence of participants with a TT genotype in the ACL group and three sub-
groups, the GT and TT participants were combined and compared to the GG participants. 
CON vs. ACL genotypes, p=0.890. CON vs. ACL, TT genotype vs. GG + GT genotypes, 
p=0.031, OR=0.08, 95% CI <0.01 to 1.46. CON vs. NON genotypes, p=0.935. CON vs. ACL 
alleles, p=0.745. CON vs. NON alleles, p=0.548. 
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Figure 3.4: Relative genotype frequencies of the COL1A1 Sp1 binding site polymorphism 
(SNP rs1800012; IVS1+1023G>T) of the asymptomatic control group (CON, clear bars), the 
anterior cruciate ligament rupture group (ACL, black bars), and the non-contact mechanism 
of rupture sub-group (NON, hatched bars).  
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Table 3.4: Genotype effects of the Sp1 binding site polymorphism within the COL1A1 
gene on the characteristics of the combined control (CON) and anterior cruciate 
ligament ruptured (ACL) participants. 
 
 GG GT TT P-value a 
Age (years)b 33.2 ± 11.3 (165) 33.8 ± 11.7 (68) 39.3 ± 10.2 (6) 0.425 
Height (cm)b 176.9 ± 9.9 (158) 177.9 ± 9.1 (66)  172.8 ± 9.4 (6) 0.750 
Weight (kg)b 77.7 ± 15.8 (162) 78.9 ± 13.1 (66) 62.7 ± 8.5 (6) 0.334 
BMI (kg/cm2)b 24.6 ± 3.8 (155) 24.9 ± 2.7 (65) 20.9 ± 1.3 (6) 0.152 
 
 
The values are expressed as a mean ± standard deviation, with the number of subjects (n) 
for each variable is in parentheses. a Except for age, P values are co-varied for gender. b All 
values are self self-reported values at the time of the first ACL rupture for the ACL injured 
participants, and at recruitment for the CON participants.  
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3.4  DISCUSSION 
 
The main finding of this study was that the rare TT genotype of the functional 
COL1A1 Sp1 binding site polymorphism was significantly under-represented 
(OR=12.3; 95% CI 0.7 – 220.4; P=0.031) among participants with ACL ruptures, 
indicating a possible protective role of this genotype for these injuries.  The second 
finding of this study was that participants with an ACL rupture were more than four 
times as likely (OR=4.2; 95% CI = 2.2 – 8.0; P<0.001) of reporting that a blood 
relative had a history of any ligament injury when compared to the control 
participants. The third finding was that the mechanism of the majority of ACL 
ruptures in our population was as a result of a non-contact event, and that the 
genotype distribution in this sub-group was similar to that of the indirect and direct 
injury sub-groups.   
 
The finding of an under-representation of the TT genotype in the ACL participants is 
in agreement with what was previously reported in a Swedish population [9]. 
Furthermore, the genotype distribution of the control participants in this study were 
similar to the Swedish study [9] and other larger cohorts [155;160]. Of specific 
clinical importance is that the TT genotype was absent from all 117 participants with 
ACL ruptures in our study, while only one individual out of 233 participants (0.4%) 
with a cruciate ligament rupture in the Swedish study had the TT genotype [9]. The 
combined results from these two studies provide strong evidence that the TT 
genotype of the Sp1 binding site polymorphism within the COL1A1 gene has a 
protective role in anterior cruciate ligament ruptures, as will be further analysed and 
discussed in Study 5 of this thesis.   
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Previous investigations have proposed that the increased Sp1 transcription factor 
binding, which occurs when a G nucleotide is substituted for a T at the Sp1 binding 
site, leads to increased expression of the α1(I) chain [155]. Although the 
consequence is not yet fully understood, the increased expression of the α1(I) chain 
has been shown to reduce the quality and strength of bone [155]. There is no known 
previous study that has investigated the effect of this polymorphism on other type I 
collagen containing connective tissues such as ligaments.  It is however interesting 
to note that the TT genotype of the Sp1 binding site polymorphism is not always 
associated with increased risk of pathology, and has also been shown to be 
associated with reduced risk of radiographic osteoarthritis of the hip characterised by 
joint space narrowing [160]. No studies, to date, have investigated changes in 
COL1A1 RNA or type I collagen protein levels in ruptured ACL material.  Differential 
expression of the type I collagen genes has however been shown to be associated 
with the degree of healing after ACL rupture [161]. 
 
The second finding from this study, that participants with an ACL rupture were more 
than four times as likely to have a blood relative with a ligament injury, also supports 
a genetic risk for ligament injury.  Despite the fact that it was not possible to control 
for exposure to non-genetic factors in family members of our ACL ruptured 
participants, the results are similar to that reported by Flynn et al. [7], where siblings 
of individuals whom had an ACL tear were at a two times greater risk of also tearing 
their ACL.  
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The third finding of this study was that the majority (57.7%) of ACL ruptures occurred 
during a non-contact event compared to direct contact (19.2%) or indirect contact 
(23.0%) events.  Non-contact ACL ruptures occur from the athletes own movements, 
and not as result of contact with another athlete or objects [13], it may thus be 
hypothesised that intrinsic risk factors, in particular genetic elements, may have a 
greater contributing role in non-contact ACL ruptures.  Even though the direct and 
indirect contact sub-groups did involve the application of an external force, it might 
be of clinical relevance to note that the TT genotypes were also absent in these sub-
groups. 
 
It is important to note that there are strengths and limitations to the study design 
presented in this chapter. A strength of this study was that the injury population 
consisted of a homogenous group of participants with confirmed diagnosis of ACL 
ruptures at surgery.  Furthermore, our injured population and controls included both 
genders and were suitably matched.  One of the limitations of this study was that the 
exposure to extrinsic risk factors could not be well documented in all the control 
participants. However, as previously mentioned, the genotype frequencies of the 
control participants in this study was similar to other much larger cohorts [155;160]. 
Although care was taken to recruit physically active individuals, participation in high 
risk sports such as sports involving cutting, pivoting and landing was not known in all 
the control participants. Additional physically active control participants, with known 
sports participation history, were therefore recruited for the subsequent studies of 
this thesis.  Sample sizes in these sub-groups (according to injury mechanism) were 
small and therefore separate analysis of genotype frequencies need to be 
interpreted with caution.     
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The main findings of this study support the hypothesis that genetic factors are 
associated with the risk of ACL ruptures.  However, it is important to emphasise that 
ACL rupture is a multifactorial disorder and is therefore caused by a complex 
interaction of a number of different intrinsic and extrinsic risk factors [162]. It is 
therefore highly likely that sequence variants within other genes may also be 
associated with ACL rupture. As previously described, the aim of this thesis is to test 
whether genes which encode for the collagen microfibril are associated with ACL 
ruptures. This will be further explored in subsequent chapters of the thesis.   
 
In conclusion, this study found that the rare TT genotype of the functional Sp1 
binding site polymorphism within intron 1 of COL1A1 was significantly under-
represented in participants with ACL ruptures, when compared to gender-matched 
controls, in an independent second population (Figure 3.5). 
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Figure 3.5: A schematic presentation of the primary finding from this study. The COL1A1 
Sp1 binding site polymorphism was associated with risk of ACL ruptures. The COL1A1 gene 
encodes for the α1 chain of type I collagen, the major component of the collagen microfibril 
fibril. Refer to Section 2.5.1 for further detail regarding the structure of the collagen 
microfibril.    
Study 1:
COL1A1 Sp1 binding 
site polymorphism
ACL rupture
MICROFIBRIL
Type I collagen molecule
α1(I) chain
Type I collagen
α2(I) chain
Type V collagen
Type XII collagen
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CHAPTER 4 
STUDY TWO 
 
THE COL5A1 GENE IS ASSOCIATED WITH ANTERIOR CRUCIATE LIGAMENT 
RUPTURES IN FEMALE PARTICIPANTS 
 
The data presented in this chapter was published in the following peer-reviewed 
article:  Posthumus, M. September, AV. O’Cuinneagain, D. van der Merwe, W. Schwellnus, 
MP. Collins, M. The COL5A1 gene is associated with increased risk of anterior cruciate 
ligament ruptures in female participants. American Journal of Sports Medicine, In Press. 
 
 
4.1 INTRODUCTION 
 
The primary objective of this thesis is to identify genetic factors which predispose 
individuals to ACL ruptures. As discussed (Section 2.4.2.4.2), the rare TT genotype 
of the functional Sp1 binding site polymorphism within the first intron of the COL1A1 
gene, which encodes for th  α1 chain of type I collagen, was shown to be under-
represented in Swedish patients with cruciate ligament ruptures and shoulder 
dislocations [9]. Study 1 of this thesis provides further evidence that this genetic 
variant within the COL1A1 gene is also associated with risk of ACL ruptures in a 
second independent South African Caucasian population. Since ACL rupture is a 
complex disorder, it is unlikely that this is the only genetic variant predisposing or 
protecting individuals from ACL ruptures [163]. Therefore, variants within other 
genes that also encode for structural components of the most basic unit of ligaments, 
the collagen microfibril, may also be associated with these injuries. 
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As reviewed (Section 2.5.3.2), the gene encoding for the α1 chain of type V collagen, 
COL5A1, was selected as a candidate gene for ACL ruptures for the following 
reasons: (1) the BstUI RFLP within the gene has been shown to be associated with 
Achilles tendinopathy in two independent populations, and (2) type V collagen was 
shown to be the second largest component in ligaments (Section 2.5.1), and 
regulates the diameter of the collagen microfibril [114;157].  
 
The primary aim of this study was therefore to determine if the two sequence 
variants (BstUI and DpnII RFLPs) within the 3’-UTR of the COL5A1 gene are 
associated with an increased risk of ACL ruptures. Although a relatively larger 
proportion of ACL ruptures occur in males, females have a 4.6 times increased risk 
of ACL ruptures [13]. Specific intrinsic risk factors have been implicated in the 
increased predisposition to ACL ruptures among females, however, the underlying 
etiology of the observed increased risk associated with females is still unknown. A 
secondary aim of this study was therefore to determine if there were any possible 
gender-specific associations between the two COL5A1 sequence variants and 
increased risk of ACL ruptures. 
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4.2 MATERIALS AND METHODS 
 
4.2.1 Participants 
 
As described in Study 1, 129 (38 females and 91 males) Caucasian participants with 
surgically confirmed ACL ruptures were recruited for this study as described in Study 
1 (Section 3.2.1). All 129 ACL participants were successfully genotyped and included 
in this study. In addition, 217 (84 females and 133 males) apparently healthy, 
unrelated, physically active Caucasian participants, without any self-reported history 
of ACL injury, and detailed sports participation information, were recruited as control 
(CON) participants for this study and the next study (Study 3) from sport clubs and a 
wellness centre (SSISA) within the Southern Suburbs region of Cape Town, South 
Africa. During the current study only 216 CON participants (84 females and 132 
males) were successfully genotyped, and therefore included in the study.  
 
Prior to participation in this study, all participants gave informed written consent 
(Appendix 2) and completed the questionnaire (Appendix 3), as detailed in Study 1 
(Section 3.2.1). The CON group for the current study and the next study (Study 3) of 
this thesis is different to the control participants included in Study 1. As discussed 
(Section 3.2.1), not all the control participants in Study 1 completed detailed sports 
participation information in the questionnaire (Appendix 3). This was a limitation of 
study one and therefore 179 additional CON participants were recruited. It is 
however important to mention that 37 of the 130 CON participants which were 
included in Study 1, did complete the detailed sports participation information and 
were thus also included in the current study.   
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Sports participation was categorised into contact sports, non-contact jumping sports, 
non-contact non-jumping sports and skiing sports, as previously defined [7], with 
slight modification. Contact sports included soccer, rugby, touch rugby, Gaelic 
football, muay thai, hurling, Australian football league (AFL) and boxing. Non-contact 
jumping sports included netball, basketball, volleyball, gymnastics, ballet, 
motorcross, skateboarding, paragliding, handball and sky diving. Non-contact non-
jumping sports included field hockey, cricket, tennis, horseback riding, running, 
bicycling, spinning, squash, swimming, aerobics, yachting, athletics (excluding long 
and triple jump), golf, dancing, tennis, canoeing, waterpolo, surfing, windsurfing, 
badminton, gym training, bowls, triathlon, softball and lifesaving. Skiing sports 
included any mode of water or snow skiing.  
 
The exact mechanism of injury could only be identified in 21 female (55.7%) and 67 
male (73.6%) participants. Participants who had ruptured their ACL via a non-contact 
(NON) mechanism, as previously defined [13], were identified and analysed in this 
study as a separate sub-group. Thirty-six (53.7%) male participants and 18 (85.7%) 
female participants ruptured their ACL through a non-contact mechanism. 
 
This study was approved by the Research Ethics Committee of the Faculty of Health 
Sciences within the University of Cape Town, South Africa (reference number 
164/2006; Appendix 4).   
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4.2.2 DNA extraction and COL5A1 genotyping 
 
Approximately 4.5 ml of venous blood was obtained from each participant by 
venipuncture of a forearm vein and collected into an EDTA vacutainer tube.  Blood 
samples were stored at 4°C until total DNA extraction.  DNA was extracted using the 
procedure described by Lahiri and Nurnberg [159], with slight modification, as 
described in Study 1.  
 
A 667 bp fragment containing the DpnII (single nucleotide polymorphism, SNP 
rs13946) and BstUI (SNP rs12722) RFLPs within the 3’-UTR of the COL5A1 gene 
was PCR amplified as described by Greenspan and Pasquinelli [164] and modified 
by Mokone et al. [143] (Figure 4.1). Briefly, the PCR reaction was performed in a 
final volume of 60 µl containing at least 100 ng of DNA, 20 pmol of the forward (5’-
GAA GAC GTT TCT GGA GGA TC-3’) and reverse (5’-GGA GGC ACC TGC AGA 
ATG AC-3’) primers, 20 mM Tris-HCl pH 8.4, 50 mM KCl, 1.5 mM MgCl2, 0.2 mM of 
each dNTP (dATP, dTTP, dCTP and dGTP) and 2.5 units of DNA Taq polymerase 
(New England Biolabs, Ipswich, Massachusetts, USA). The amplification was 
performed with an initial denaturing step at 94°C for 3 minutes, followed by 35 cycles 
of denaturing at 94°C for 1 minute, annealing at 53°C for 1 minute, extension at 72°C 
for 1.5 minutes, and a final extension step at 72°C for 8 minutes (XP Thermal Cycler 
Block; Bioer technology Co; Middlesex, UK).      
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Figure 4.1: A schematic representation of exon (vertical lines) and intron (horizontal lines) 
boundaries of the the COL5A1 gene, as well as a 720 bp genomic sequence at the 5’-end of 
exon 66, which contains the start (stop codon, underlined TAG sequence) of the 3’-UTR. 
The binding position of the forward (F) and reverse (R) primers (solid arrows) designed to 
amplify a 667 bp PCR fragment containing the DpnII (rs 13946) and BstUI (rs 12722) 
restriction fragment length polymorphisms (RFLPs; grey boxes in the genomic sequence). 
The recognition (undelined) sequences of the DpnII (/GATC) and BstUI (CG/CG) restriction 
enzymes are indicated on the genomic sequence. The T to C substitution for the BstUI RFLP 
and the T to C substitution for the DpnII RFLP causes a recognition sequence to be 
destroyed. 
 
 
ACCAAGAAAG GCTACCAGAA GACGGTTCTG GAGATCGACA CCCCCAAAGT GGAGCAGGTG       60
CCCATCGTGG ACATCATGTT CAATGACTTC GGTGAAGCGT CACAGAAATT TGGATTTGAA       120
GTGGGGCCGG CTTGCTTCAT GGGCTAGGAG CCGCCGAGCC CGGGCTCCCG AGAGCAACCT       180
CGTGACCTCA GCATGCCATT GCTTCGTGAG TGTCCCGTGC ACGTCCTGAC TCTGGACAGT       240
GAAGGCTTCT CCCTCCCCTC CCACCTGACT TCATCTACGC CTCGGCACCA CGGGGTGTGG       270
GACCCCAGCC CGGAGAGAAC AGAGGGAAGG AGCCGCGCCC CCACCTGGAG CTGAATCACA 360
TGACCTAGCT GCACCCCAGC GCCTGGGCCC GCCCCACGCT CTGTCCACAC CCACGCGCCC 420
CGGGAGCGGG GCCATGCCTC CAGCCCCCCA GCTCGCCCGA CCCATCCTGT TCGTGAATAG 480
GTCTCAGGGG TTGGGGGAGG GACTGCCAGA TTTGGACACT ATATTTTTTT CTAAATTCAA 540
CTTGAAGATG TGTATTTCCC CTGACCTTCA AAAAATGTTC CAAGGTAAGC CTCGTAAAGG 600
TCATCCCACC ATCACCAAAG CCTCCGTTTT TAACAACCTC CAACACGATC CATTTAGAGG 660
CCAAATGTCA TTCTGCAGGT GCCTTCCCGA TGGATTAAAG GTGCTTATGT TTTTGTGAGT 720
5’ 3’
COL5A1
5’ end of 
exon 66
F
R
T
C
T
C
rs 13946
rs 12722
stop codon
DpnII
DpnII
BstUI
DpnII
BstUI
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The C and T alleles of the two polymorphisms were identified by digesting the PCR 
products with the restriction endonucleases, BstUI or DpnII, as previously described 
[143;145]. Digestion of the 667 bp PCR fragment with DpnII produced 612 bp, 40 bp 
and 15 bp fragments for the C allele and 418 bp, 194 bp, 40 bp and 15 bp fragments 
for the T allele. Digestion of the same 667 bp PCR fragment with BstUI produced 
351 bp and 316 bp fragments for the T allele, and 316 bp, 271 bp and 80 bp 
fragments for the C allele. The resultant fragments were separated, together with a 
100 bp DNA ladder of known size markers (Promega Corporation, Madison, 
Wisconsin, USA) and SYBER® Gold nucleic acid gel stain (Invitrogen Molecular 
ProbesTM, Oregon, USA), on 6% non-denaturing polyacrylamide gels (Figure 4.2). 
The gels were photographed under UV light using a Uvitec photodocumentation 
system (Uvitec Limited, Cambridge, UK) and genotypes were determined based on 
the sizes of the DNA fragments. 
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Figure 4.2: A typical 6% non-denaturing polyacrylamide gel showing the genotypes of the 
COL5A1 DpnII and BstUI restriction fragment length polymorphisms (RFLPs). Digestion of 
the 667 bp PCR product with DpnII produced 612 bp, 40 bp and 15 bp fragments for the C 
allele and 418 bp, 194 bp, 40 bp and 15 bp fragments for the T allele. Digestion of the same 
667 bp fragment with BstUI produced 351 bp and 316 bp fragments for the T allele, and 316 
bp, 271 bp and 80 bp fragments for the C allele.  The 80 bp, 40 bp and 15 bp fragments ran 
off the gel and are therefore not visible on the Figure. The left lane contains the 100 bp 
molecular weight marker (MW) with the appropriate fragment sizes given in base pairs (bp). 
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4.2.3 Statistical analysis 
 
Data were analysed using STATISTICA Version 8.0 (Statsoft Inc., Tulsa, Oklahoma, 
USA) and Graphpad InStat Version 3 (Graphpad Software, San Diego, California, 
USA) statistical programs.  The data were initially analysed for the whole group and 
then separately according to gender.  Because the sample consisted predominately 
of males the whole group results were similar to the male participants.  Only the 
separate male and female results are reported in this chapter, while the combined 
results, where appropriate, are reported in Appendix 1 (additional material).  A one-
way analysis of variance (ANOVA) was used to determine any significant difference 
between the characteristics of the ACL and CON group, as well as the CON group 
and NON sub-group.  The direct (DIR) and indirect (IND) mechanisms of ACL 
ruptures sub-groups were not included in this and subsequent chapters of the thesis 
due to small sample sizes. A chi-squared (χ2) analysis or Fisher’s exact test was 
used to analyse any differences in the genotype and allele frequencies, as well as 
other categorical data between the groups. Significance was accepted when P<0.05. 
Hardy-Weinberg equilibrium was established using the program Genepop web 
version 3.4 (http://genepop.curtin.edu.au/).  
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4.3 RESULTS 
 
4.3.1 Participant characteristics 
 
There were no significant differences in the proportion of female participants within 
the CON (n=84, 38.9%) and ACL (n=38, 29.5%) groups (P=0.260), as well as 
between the CON group (P=0.715) and the NON sub-group (n=18, 33.3%). The 
female and male participants within the CON and ACL groups, as well as the NON 
sub-group, were matched for age, height and country of birth (Table 4.1).  The 
female CON and ACL groups, as well as the NON sub-group were also matched for 
weight and BMI.  The male participants within the ACL group and NON sub-group 
were however significantly heavier and had a significantly higher BMI than the CON 
group.  Within the ACL group, the female participants self-reported age, weight and 
BMI at recruitment were 6.4 ± 9.9 years (n=37), 0.7 ± 4.5 kg (n=34) and 0.4 ± 1.5 
kg/m2 (n=33), greater than at the time of the first ACL rupture. The males self-
reported age, weight and BMI at recruitment were 4.3 ± 7.7 years (n=83), 1.6 ± 4.7 
kg (n=76) and 0.5 ± 1.5 kg/m2 (n=73), greater than at the time of the first ACL 
rupture. The combined analysis of the male and female participant characteristics 
are included in the additional material (Appendix 1, Table A1.4).  
  
The relative frequency of the self-reported history of any other (excluding ACL) 
ligament (P=0.003) and other knee ligament (P=0.029) injuries were significantly 
higher in the female ACL group when compared to the female CON group (Table 
4.2).  The previous other knee ligament injuries included injury to either the posterior 
cruciate ligament (PCL), the lateral collateral ligament (LCL), or the medial collateral 
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ligament (MCL).  Similarly, the female participants within the NON sub-group also 
reported significantly greater history of any other previous ligament (P=0.014) and 
knee ligament (P=0.018) injuries compared to the CON group.  
 
 
4.3.2 Family history  
 
It is interesting to note that the self-reported family history of any ligament injury at 
the time of recruitment, was significantly higher in the female ACL group (P=0.002), 
as well as the NON sub-group (P=0.014), when compared to the female CON group. 
Except for a significant difference in the frequency of other knee ligament injuries 
(P=0.047) between the male ACL and CON groups, there were no significant 
differences between the ACL and CON groups, as well as between the CON group 
and NON sub-group for a history of Achilles tendon injury or any other category of 
personal or family history of ligament injury.   
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Table 4.1: Characteristics of the female and male participants within the 
asymptomatic control (CON) group, the anterior cruciate ligament rupture (ACL) 
group and the ACL sub-group with a non-contact (NON) mechanism of injury. 
 
 CON ACL P-Value b NON P-value c 
Female participants:- n=84 n=38  n=18  
Age a (years) 28.2 ± 10.0 (83) 29.8 ± 12.1 (37) 0.453 28.6 ± 13.1 (18) 0.896 
Height (cm) 166.2 ± 5.8 (210) 166.4 ± 6.8 (34) 0.929 167.8 ± 6.7 (17) 0.325 
Weight a (kg) 61.9 ± 8.3 (82) 62.2 ± 7.5 (34) 0.864 63.2 ± 7.8 (17) 0.570 
BMI a (kg/m2) 22.4 ± 2.7 (79) 22.3 ± 2.1 (33) 0.940 22.1 ± 2.0 (16) 0.727 
Country of birth 
(% South Africa) 82.5 (80) 80.0 (35) 0.955 77.8 (18) 0.737 
Male participants:- n=132 n=91  n=36  
Age a (years) 29.0 ± 12.2 (132) 28.1 ± 10.5 (87) 0.584 27.6 ± 9.7 (36) 0.512 
Height (cm) 180.4 ± 6.3 (131) 181.1 ± 6.6 (79) 0.450 181.8 ± 6.6 (35) 0.436 
Weight a (kg) 82.0 ± 13.9 (130) 87.3 ± 14.3 (80) 0.008 87.5 ± 14.7 (36) 0.040 
BMI a (kg/m2) 25.1 ± 3.8 (129) 26.6 ± 3.7 (76) 0.010 26.7 ± 4.2 (34) 0.037 
Country of birth 
(% South Africa) 89.0 (127) 85.4 (82) 0.577 88.9 (36) 1.000 
 
Gender and country of birth are represented as a frequency (%). The remaining variables 
are expressed as a mean ± standard deviation. The number of subjects (n) for each variable 
is in parentheses.  
a  Age, weight and body mass index (BMI) are self-reported values at the time of the first 
ACL rupture for the ACL group, as well as the NON sub-group, and at recruitment for the 
control group. For the ACL group, age, weight and BMI at recruitment were 6.4 ± 9.9 years 
(n=37), 0.7 ± 4.5 kg (n=34) and 0.4 ± 1.5 kg/m2 (n=33), greater than at the time of the first 
ACL rupture for the female participants, and 4.3 ± 7.7 years (n=83), 1.6 ± 4.7 kg (n=76) and 
0.5 ± 1.5 kg/m2 (n=73), greater than at the time of the first ACL rupture for the male 
participants.   
b  CON vs. ACL. c CON vs. NON.  
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Table 4.2: Self-reported personal and family (blood relative) history of soft tissue 
injuries within the asymptomatic control (CON) group, the anterior cruciate ligament 
rupture (ACL) group and non-contact (NON) mechanism of ACL injury sub-group in 
the female and male participants. 
 
 CON ACL P-value c NON P-value d 
Female Participants:- n=84 n=38  n=18  
Any other ligament injury a  25.9 (81) 54.3 (35) 0.003 55.6 (18) 0.014 
Knee ligament injury b 1.2 (81) 11.4 (35) 0.029 16.7 (18) 0.018 
Achilles tendon injury 4.9 (81) 5.7 (35) 1.000 11.1 (18) 0.299 
Family ligament injury 21.5 (79) 50.0 (34) 0.002 52.9 (17) 0.014 
Male Participants:- n=132 n=91  n=36  
Any other ligament injury a 43.6 (124) 57.5 (80) 0.051 54.3 (35) 0.260 
Knee ligament injury b 4.8 (124) 12.5 (80) 0.047 8.6 (35) 0.414 
Achilles tendon injury 10.5 (124) 11.1 (81) 0.887 20.0 (35) 0.134 
Family ligament injury 27.1 (122) 33.8 (80) 0.308 34.3 (35) 0.404 
 
Values are represented as frequencies (%) with the number of subjects (n) is in 
parentheses.  
a Excluding ACL injuries 
b Includes the posterior cruciate ligament (PCL), the lateral collateral ligament (LCL), and the 
medial collateral ligament (MCL)  
c CON vs. ACL 
d CON vs. NON 
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4.3.3 Sports participation 
 
When compared to all the male participants, significantly more females participated 
in non-contact jumping sports (P<0.001) (Table 4.3).  The female and male 
participants however participated for a similar number of years in non-contact 
jumping sports (P=0.918).   The female and male participants were similarly matched 
for proportion and duration of participation in non-contact non-jumping and skiing 
sports. More males participated in contact sports (P<0.001) for significantly more 
years (P=0.001), when compared to the female participants.   
 
When only the female participants were analysed, similar proportions of participants 
within the CON and ACL groups participated in contact, non-contact non-jumping 
and skiing sports. In contrast, the female ACL group however reported a greater 
participation in non-contact jumping sports (P=0.035). The ACL and CON female 
participants reportedly participated for a similar number of years in contact sports, 
non-contact jumping sports and non-contact non-jumping sports. Similar proportions 
of male participants within the CON and ACL groups participated in non-contact 
jumping, non-contact non-jumping and skiing sports for a similar number of years.  
Significantly more male participants within the ACL group participated in contact 
sports when compared to the CON group (P<0.001).  There were however no 
significant differences in the duration of participation (P=0.374).   
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Table 4.3: Sports participation according to type of sport within the asymptomatic control (CON) groups, the symptomatic 
anterior cruciate ligament rupture (ACL) groups, as well as the symptomatic noncontact (NON) mechanism of injury 
subgroups for all female and male participants. 
 Female Participants  Male Participants  
 CON (n=82) 
ACL 
(n=35) P-Value 
e  CON (n=126) 
ACL 
(n=82) P-Value 
e P-Value f 
Contact sports a         
    Participants (%) 13.4 (11) 5.7 (2) 0.339  65.9 (83) 87.8 (72) <0.001 <0.001 
    Participation (years)  5.7 ± 3.6 1.0 ± 0.0 0.101  12.6 ± 7.6 11.5 ± 7.9 0.374 0.001 
Non-contact jumping sports b         
    Participants (%) 34.1 (28) 57.1 (20) 0.035  5.6 (7) 13.4 (11) 0.086 <0.001 
    Participation (years)  8.2 ± 5.2 9.3 ± 5.8 0.493  10.9 ± 5.2 7.0 ± 5.4 0.152 0.918 
Non-contact non-jumping sports c         
    Participants (%) 93.9 (77) 94.3 (33) 1.000  94.4 (119) 92.7 (76) 0.826 0.923 
    Participation (years)  28.4 ± 20.8 28.2 ± 22.6 0.953  25.4 ± 17.9 24.4 ± 22.2 0.729 0.169 
Skiing sports d         
    Participants (%) 3.7 (3) 14.3 (5) 0.051  5.6 (7) 9.8 (8) 0.384 0.900 
 The legend is on the following page.
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(Legend from the previous page) The number of participants is represented as a frequency 
(%), while the years of participation is represented as a mean ± standard deviation. The 
number of participants (n) is in parentheses. 
a  Soccer, rugby, touch rugby, Gaelic football, muay thai, hurling, Australian football league 
(AFL) and boxing.  
b Netball, basketball, volleyball, gymnastics, ballet, motorcross, skateboarding, paragliding, 
handball and sky diving.  
c Field hockey, cricket, tennis, horseback riding, running, bicycling, spinning, squash, 
swimming, aerobics, yachting, athletics (excluding long and triple jump), golf, dancing, 
tennis, canoeing, waterpolo, surfing, windsurfing, badminton, gym training, bowls, triathlon, 
softball and lifesaving. 
d Any mode of water or snow skiing. 
e CON vs. ACL  
f male (CON + ACL) vs. female (CON + ACL) participants. 
 
 
 
4.3.4 COL5A1 genotype and allele frequencies 
 
4.3.4.1 The BstUI RFLP genotyping 
 
When the female and male participants were analysed together, there were no 
significant differences in genotype or allele frequencies between the CON and ACL 
groups, nor the CON group and NON sub-group for the COL5A1 BstUI RFLP (data 
presented in Appendix 1, Additional material, Table A1.5). However when the female 
and male participants were analysed separately, the BstUI RFLP CC genotype was 
over-represented in the control participants within the female (Figure 4.3A) (OR=6.6; 
95% CI 1.5 - 29.7; P=0.006), but not the male (Figure 4.3B) participants, when the 
ACL group were compared to the CON group. The allele frequencies between the 
CON and ACL groups for the BstUI RFLP was also significantly different within the 
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female participants (OR=2.2; 95% CI 1.2 - 4.0; P=0.010)(Figure 4.4A), but not the 
male participants (Figure 4.4B). The T allele was significantly over-represented 
among the female ACL group. Similarly, the T allele of the BstUI RFLP was also 
significantly over-represented in the female NON sub-group (OR= 2.6; 95% CI; 1.2 - 
5.7; P=0.016) when compared to the CON group (Figure 4.4A). This data should be 
interpreted with caution because of the small sample size, however the genotype 
frequency of the BstUI RFLP was not significantly different when the female CON 
group and NON sub-group were analysed (Figure 3.1A), although a trend existed for 
the CC to be over-represented in the control population (P=0.065). There were no 
further significant BstUI genotype (Figure 4.3B) or allele (Figure 4.4B) frequency 
differences when the male CON group and NON sub-group were analysed.  
 
Similar BstUI RFLP genotype distributions were obtained when a sub-group of 105 
(48.6%) control participants without a self-reported history of any ligament or tendon 
injuries were analysed separately (females 15 TT, 31.2%; 21 TC, 43.8% and 12 CC, 
25.0%; males 17 TT, 29.8%; 32 TC, 56.1% and 8 CC, 14.04%). The genotype 
distribution of all groups was in Hardy-Weinberg equilibrium for the BstUI RFLP 
(Table 4.4). 
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4.3.4.2 The DpnII RFLP genotyping 
 
There were no significant differences in the COL5A1 DpnII RFLP genotype 
distribution when male and female participants were analysed together (data 
presented in Appendix 1, Additional material, Table A1.5), or separately between the 
female (Figure 4.3C and Figure 4.4C) or male (Figure 4.3D and Figure 4.4D) CON 
and ACL groups, as well as the NON sub-groups. 
 
Furthermore, there were also no significant differences in allele frequency 
distributions between the groups (Figure 4.4 C and D). The genotype distribution of 
all groups was in Hardy-Weinberg equilibrium for the DpnII RFLP (Table 4.4). 
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Figure 4.3: The relative genotype frequency of the COL5A1 gene BstUI and DpnII restriction 
fragment length polymorphisms (RFLP) within the asymptomatic control (CON; black bars) 
groups, the anterior cruciate ligament rupture groups (ACL; white bars) and the non-contact 
mechanism of injury sub-group (NON; grey bars) in all female (A and C) and male (B and D) 
participants. The number of participants (n) within each group is shown in parentheses. 
Because of the small sample size of the BstUI RFLP CC genotype in the female ACL and 
NON groups (A), the CC genotype was compared to the combined TC and TT genotypes.  
The TT genotype was also compared to the combined TC and CC genotypes. Similarly, 
because of the small sample size of the rare DpnII RFLP CC genotype (C and D), it was 
combined with the TC genotype and compared to the TT genotype. (A) The BstUI RFLP 
genotype frequency distributions within the female participants. CON vs. ACL, P=0.006 (CC 
vs. TT+TC) and P=0.131 (TT vs. TC+CC); CON vs. NON, P=0.065 (CC vs. TT+TC) and 
P=0.110 (TT vs. TC+CC). (B) The BstUI RFLP genotype frequency distributions within the 
male participants. CON vs. ACL, P=0.987; CON vs. NON, P=0.879. (C) The DpnII RFLP 
genotype frequency distributions within the female participants. CON vs. ACL, P=0.829 (TT 
vs. TC+CC); CON vs. NON, P=0.925 (TT vs. TC+CC). (D) The DpnII RFLP genotype 
frequency distributions within the male participants; CON vs. ACL, P=0.938 (TT vs. TC+CC); 
CON vs. NON, P=0.892 (TT vs. TC + CC).  
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Figure 4.4: The relative allele frequency of the COL5A1 gene BstUI and DpnII restriction 
fragment length polymorphisms (RFLP) within the asymptomatic control (CON; black bars) 
groups, the anterior cruciate ligament rupture groups (ACL; white bars) and the non-contact 
mechanism of injury sub-group (NON; grey bars) in all female (A and C) and male (B and D) 
participants. (A) The BstUI RFLP allele frequency distributions within the female participants. 
CON vs. ACL, P=0.010; CON vs. NON, P=0.016. (B) The BstUI RFLP allele frequency 
distributions within the male participants. CON vs. ACL, P=0.960; CON vs. NON, P=0.789. 
(C) The DpnII RFLP allele frequency distributions within the female participants. CON vs. 
ACL, P=0.860; CON vs. NON, P=0.982. (D) The DpnII RFLP allele frequency distributions 
within the male participants; CON vs. ACL, P=0.860; CON vs. NON, P=0.982.  
 
 
FEMALE PARTICIPANTS
T C
0
10
20
30
40
50
60
70
80 CON (n=84)
ACL (n=38)
NON (n=18)
COL5A1 BstUI RFLP
Fr
eq
ue
nc
y 
(%
)
P=0.010
P=0.016
MALE PARTICIPANTS
T C
0
10
20
30
40
50
60
70
80
CON (n=132)
ACL (n=91)
NON (n=36)
COL5A1 BstUI RFLP
Fr
eq
ue
nc
y 
(%
)
T C
0
10
20
30
40
50
60
70
80
COL5A1 DpnII RFLP
Fr
eq
ue
nc
y 
(%
)
T C
0
10
20
30
40
50
60
70
80
COL5A1 DpnII RFLP
Fr
eq
ue
nc
y 
(%
)
A)
D)C)
B)
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
COL5A1 AND ACL RUPTURES 
115 
 
Table 4.4: Hardy-Weinberg Equilibrium (HWE) P-values of all separately analysed 
groups for the DpnII and AluI restriction fragment length polymorphisms (RFLP).  
 
 
 
 
4.3.4.3 BstUI RFLP Genotype effect of family history of ligament injury 
 
Lastly, it is interesting to note that there was a significant difference in the BstUI 
RFLP genotype distribution when all (ACL and CON) participants in the study were 
divided into those with and without a family history of ligament injuries (P=0.022). 
This association was also significant when only the female participants (Figure 
4.5A)(TT vs. TC + CC, P=0.005), but not the male participants (Figure 
4.5B)(P=0.396) were analysed. In the female participants the TT genotype was 
significantly over-represented in those with a family history of ligament injury (n=34; 
TT, 52.9%) when compared to those without a previous family history of ligament 
injury (n=79; TT, 24.1%) (OR=3.6; 95% CI 1.5 - 8.3; P=0.005). The CC genotype 
was however not significantly under-represented in those with a family history of 
ligament injury (n=34; CC, 11.8%) when compared to those without a previous family 
history of ligament injury (n=79; CC, 24.1%) (P=0.203). 
 DpnII RFLP BstUI RFLP 
 HWE P-Value HWE P-value 
Female ACL group 0.439 0.132 
Male ACL group 0.391 0.785 
Male + Female ACL groups 0.273 0.336 
Female CON group 0.385 0.429 
Male CON group 0.283 0.480 
Male + Female CON groups 0.784 0.742 
All participants 0.382 0.405 
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Figure 4.5: The relative genotype frequency of the COL5A1 gene BstUI and DpnII restriction 
fragment length polymorphisms (RFLP) when (A) female (B) and male participants in the 
study were divided into those with and without a family history of ligament injuries. (A) The 
BstUI RFLP genotype distributions within the female participants; TT vs. TC + CC, P=0.005; 
CC vs. TC + TT, P=0.203. (B) The BstUI RFLP genotype distributions within the male 
participants; P=0.396. 
 
 
FEMALE PARTICIPANTS
TT TC CC
0
10
20
30
40
50
60 No family history (n=79)
Family history (n=34)
COL5A1 BstUI RFLP
Fr
eq
ue
nc
y 
(%
)
P=0.005
MALE PARTICIPANTS
TT TC CC
0
10
20
30
40
50
60 No family history (n=142)
Family History (n=59)
COL5A1 BstUI RFLP
Fr
eq
ue
nc
y 
(%
)
A)                                                                      B)
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
COL5A1 AND ACL RUPTURES 
117 
 
4.4    DISCUSSION 
 
The main finding of this study was that the CC genotype of the one variant (the BstUI 
RFLP) within the 3’-untranslated region of the COL5A1 gene was associated with a 
6.6 times decreased risk (OR 6.6; 95% CI 1.5 - 29.7; P=0.006) of ACL ruptures in 
female, but not in male, participants. The second variant (the DpnII RFLP) was not 
associated with ACL ruptures in either the female or the male participants. An 
additional finding of this study was that the female, but not male, participants within 
the ACL group reported a significantly higher family history of ligament injuries 
(OR=3.6; 95% CI 1.5 - 8.3; P=0.005). The BstUI RFLP was also associated with a 
family history of ligament injuries among the female participants. 
 
The novel finding, that females with a CC genotype of the COL5A1 BstUI RFLP had 
a decreased risk of ACL ruptures, has not been previously reported. The COL5A1 
gene encodes for the α1 chain in type V collagen which is an important structural 
constituent of both ligaments and tendons [165]. It is therefore of interest to note that 
a previous study from this research unit has found the same CC genotype to be 
associated with a decreased risk of chronic Achilles tendinopathy in males and 
females [143;145]. The observation that the DpnII RFLP within the COL5A1 gene 
was not associated with ACL ruptures in this study is in agreement with the 
previously published study investigating chronic Achilles tendinopathy [143;145]. It is 
important to mention that the findings of this study did not change when participants 
who reported a past history of Achilles tendon injury, were excluded from the 
analysis (Data in Appendix 1, Additional material, Table A1.6).  
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The additional finding of this study, that the ACL group reported a significantly higher 
family history of ligament injuries when compared to the CON group, is in agreement 
with the results from Study 1 of this thesis, even though two different control groups 
were used. However, when the male and female participants were analysed 
separately, this finding was only present among the female, and not the male 
participants. The reason for this gender-specific association is unknown. The 
previous studies which found a familial predisposition to ACL ruptures did not 
analyse male and female participants separately [7;10]. Although it is possible that 
the family members of the ACL participants, especially the females, in the current 
study were exposed to a greater amount of contact sports, or other extrinsic risk 
factors for ligament injuries, this observation is however consistent with a familial 
predisposition to an increased risk of ligament injuries. In support of this genetic 
predisposition, our study found that the BstUI RFLP within COL5A1 was also 
associated with a self-reported family history of ligament injuries in the female, but 
not male, participants when both symptomatic and asymptomatic groups were 
combined. However, it is not apparently obvious why this association was only 
present in females.  
 
Although various intrinsic risk factors have been proposed to be associated with 
female ACL ruptures [4;12], the exact mechanism by which these factors contribute 
to an increased risk of ACL ruptures in females remain unknown. Certain intrinsic 
risk factors broadly classified as, anatomical, hormonal or neuromuscular, might be 
specific or exaggerated in females [12]. One hypothesis may be that gene-hormone 
interactions exist which makes this genetic association specific to females.  Sex 
hormones are known to exert their biological effects on the ACL through regulating 
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gene expression, especially many of the matrix metalloproteinases (MMPs) [147]. 
Although no previous research has investigated the effect of the female sex 
hormones on the regulation of COL5A1 gene expression, previous research has 
however shown that relative to COL1A1 gene expression, MMP3 and MMP1 gene 
expression is higher in the ACL of females when compared to males [166]. It is 
therefore interesting to note that Raleigh et al. [147] recently reported an interaction 
between a sequence variant within the MMP3 gene and the COL5A1 BstUI RFLP 
that modifies the risk of Achilles tendinopathy. Further studies are required to 
determine whether variants within the MMP3 gene are associated with ACL ruptures, 
particularly within females. 
 
Since ACL ruptures are complex disorders, some non-genetic factors, which are 
potential confounding variables in injury risk, need to be discussed. In this study, the 
female participants within the CON and ACL groups were matched for age, height, 
body weight, BMI and country of birth. It has previously been shown that body weight 
and BMI are risk factors for ACL ruptures in females, but not males [55]. Female 
participants were also matched for participation in contact sports, non-contact non-
jumping sports and skiing sports. Significantly more females within the ACL group 
did however participate in non-contact jumping sports when compared to the control 
group. Since participation in non-contact jumping sports does increase the risk of 
ACL ruptures, this is a potential limitation of this study.  There was however no 
genotype effects with sports participation in this study (data not shown). It is 
important to note that significantly more non-contact ACL ruptures were observed in 
the female group (85.7%) when compared to the male group (53.7%). This may be 
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expected, as it is widely reported that females are at a greater risk than males to 
develop non-contact ACL ruptures [4;12]. 
 
Among the male participants in the current study, the ACL group and NON sub-
group were significantly heavier, and had a significantly higher BMI than the CON 
group. Although the possibility cannot be excluded, the level of certainty that BMI is a 
risk factor is weak (Section 2.4.2.1.7). The ACL group had however reported playing 
a significantly greater amount of contact sports. The fact that the male controls were 
not matched for participation in contact sports is a limitation of this study. It must 
however be noted that weight, BMI or exposure to contact sports had no effects on 
genotype distributions. Furthermore, no genotype associations were observed when 
a sub-group of the male participants were matched according to weight and 
exposure to contact sports (data not shown).  
 
Another limitation of this study was the relatively small sample size of the female 
participants.  The primary aim of our study was not designed to investigate gender 
specific genetic risk factors and therefore further research is required to confirm this 
finding in larger female cohorts.   
 
In conclusion, the study presented in this chapter found that the CC genotype of the 
BstUI RFLP within the 3’-UTR of the COL5A1 gene is associated with reduced risk of 
ACL rupture in female participants (Figure 4.6).  
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Figure 4.6: A schematic presentation of the primary finding from this study. The COL5A1 
BstUI RFLP was associated with risk of ACL ruptures in female participants. The COL5A1 
gene encodes for the α1 chain of type V collagen, a member of the family of minor fibrillar 
collagens. Refer to Section 2.5.1 for further detail regarding the structure of the collagen 
microfibril. 
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CHAPTER 5 
STUDY THREE 
 
THE ASSOCIATION BETWEEN THE COL12A1 GENE AND ANTERIOR 
CRUCIATE LIGAMENT RUPTURES 
 
The data presented in this chapter was published in the following peer-reviewed 
article:  Posthumus, M. September, AV. O’Cuinneagain, D. van der Merwe, W. Schwellnus, 
MP. Collins, M. The COL12A1 gene and risk of anterior cruciate ligament ruptures. British 
Journal of Sports Medicine, In Press. 
 
5.1 INTRODUCTION 
 
In the previous study (Study 2) of this thesis, the gene encoding the α1 chain of type 
V collagen, COL5A1, was associated with risk of ACL ruptures in female 
participants. This finding provides further evidence that it is likely that multiple 
genetic sequence variants alter the risk of developing ACL ruptures. This result also 
provides additional reasoning for the selection of the gene encoding for type XII 
collagen, COL12A1, as a candidate gene for ACL ruptures. As discussed in Section 
2.5, the COL12A1 gene was selected as a candidate gene for the following reasons; 
(1) The COL12A1 and COL5A1 genes encode for quantitatively minor components 
of the collagen microfibril which are involved in a similar biological process 
(fibrillogenesis), and (2) both the GG and CC genotypes of the AluI and BsrI 
restriction fragment length polymorphisms (RFLPs) respectively, within this gene, 
were not present in participants with another acute soft tissue injury (Achilles tendon 
rupture) [148].  
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The primary objective of this study was to determine if two selected non-synonymous 
exonic single nucleotide polymorphisms (SNPs), namely the AluI (rs240736) and 
BsrI (rs970547) RFLPs, within the COL12A1 gene are associated with ACL ruptures. 
A secondary objective of this study is to investigate if a similar gender-specific 
association, as shown in Study 2, is also present between the two COL12A1 
sequence variants and increased risk of ACL ruptures. 
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5.2 MATERIALS AND METHODS 
 
5.2.1 Participants 
 
One hundred and twenty nine (38 Females and 91 Males) Caucasian participants 
with surgically diagnosed ACL ruptures and 217 (84 females and 133 males) 
asymptomatic control (CON) participants were recruited as previously described in 
Study 2 (Section 4.2.1). Of the 217 CON participants only 216 (83 females and 133 
males) were successfully genotyped for the selected SNPs within this study. Except 
for this minor difference in the CON groups (one additional male CON participant 
and one less female CON participant), the CON and ACL groups are identical to 
what was described in Study 2 of this thesis. Prior to participation in this study, all 
participants gave informed written consent (Appendix 2) and completed the 
questionnaire (Appendix 3), as detailed in Study 2. As previously described (Study 
2), sports participation was categorised into contact sports, non-contact jumping 
sports, non-contact non-jumping sports and skiing sports [7]. Participants who had 
ruptured their ACL via a non-contact (NON) mechanism [13] were identified and 
analysed in this study as a separate sub-group. Thirty-six (53.7%) male participants 
and 18 (85.7%) female participants ruptured their ACL through a non-contact 
mechanism. 
 
This study was approved by the Research Ethics Committee of the Faculty of Health 
Sciences within the University of Cape Town, South Africa (reference number 
164/2006; Appendix 4).   
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5.2.2 COL12A1 genotyping 
 
From databases hosted by the National Centre for Biotechnology Information (NCBI) 
and the Ensembl Genome Data Centre, two single nucleotide polymorphisms 
(SNPs) were selected for the COL12A1 gene [148]. SNPs with the highest 
heterozygous frequencies were selected and preference was given to non-
synonymous coding variants (SNPs which change the amino acid sequence in the 
gene product). From the NCBI database, only two non-synonymous exonic SNPs, 
(1) a C/T transition at position 116 of exon 29 (5326 C/T; T1738I; rs240736) and (2) 
a A/G transition at position 162 of exon 65 (9285 A/G; S3058G; rs970547), were 
identified in COL12A1. These two SNPs, 50 Kb apart, are located within the region 
of the COL12A1 gene which encodes for the short XIIB-1 isoform predominantly 
expressed in tendons and ligaments [130], and were therefore selected for this study 
(Figure 5.1). 
 
Genomic DNA was extracted from blood samples donated from each participant as 
previously described in the Study 1 of this thesis. Primer pairs were designed to 
amplify the DNA fragments containing each of the two selected SNPs. Polymerase 
chain reaction (PCR) amplification of these fragments was performed in 60 μl 
volumes containing 200 ng genomic DNA; 20 pmol of each primer; 2.0mM MgCl2; 
50mM KCl; 10mM Tris-HCl (pH 8.3); 200 μMdATP, dCTP, dGTP, and dTTP and 0.5 
U Taq DNA polymerase (New England Biolabs, Ipswich, Massachusetts, USA). 
Amplifications were conducted by denaturing for 1 cycle at 94ºC for 3 minutes, 
followed by 30 cycles at 94ºC for 30 seconds, 55ºC for 30 seconds, and 72ºC for 1 
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minute, followed by a final extension of 1 cycle at 72ºC for 5 minutes on a thermal 
cycler (Hybaid; PCR Express, Middlesex, UK). 
 
The 673 bp fragment (containing SNP rs240736) generated from primer pairs 
COL12-2F 5’-GAG CTC ATG ACA TGC ATC AG-3’ and COL12-2R 5’-GTC TTG 
GAC TTC TCA GCC TC-3’ was digested with restriction endonuclease BsrI to 
produce 57 bp, 616 bp sized fragments for the T allele and 57 bp, 366 bp, 250 bp 
sized fragments for the C allele (Figure 5.2). The 615 bp fragment (containing SNP 
rs970547) generated from primer pairs COL12-1F 5’-GAG AAT CCA GAA CAG CTC 
CAC CAG-3’ and COL12-1R 5’-CAT GGC TAG TAT GGG ACA G-3’ was digested 
with restriction endonuclease AluI to produce 16 bp, 599 bp sized fragments for the 
G allele and 16 bp, 139 bp, 460 bp sized fragments for the A allele. The COL12-1F 
primer was designed to contain a mutated nucleotide (underlined in the primer 
sequence) which introduces and additional restriction site (AG/CT) for the AluI 
restriction endonuclease. The resultant fragments were separated, together with a 
100 bp DNA ladder of known size markers (Promega Corporation, Madison, 
Wisconsin, USA) and SYBER® Gold nucleic acid gel stain (Invitrogen Molecular 
ProbesTM, Oregon, USA), on 6% non-denaturing polyacrylamide gels. The gels were 
photographed under UV light using a Uvitec photodocumentation system (Uvitec 
Limited, Cambridge, UK) and genotypes were determined based on the sizes of the 
DNA fragments. 
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Figure 5.1: Legend on the following page 
TGTTGTCAAT AAGCATTTAT TGACATTTGA GCTCATGACA TGCATCAGAG CAGGAGGAAC 60       
ATCTGGCTAA ATAATGTGAA TAAACTGCCA TTGAGTGTGT ATGATGTAAG TGGAGACTTA 120 
CTTTTGCGTG GGTATGTTTT TGTCCTCTTT CTCCAAGACC ATCTTAAATG GAGATGAAAA 180 
CACTTTGGTG TTCGAAAACC TGAACCCCAA CACCATCTAT GAAGTTTCCA TTACTGCCAT 240 
CTATCCTGAT GAGTCAGAAA GTGATGACCT GATTGGCAGT GAGCGCACAC GTAGGTGTTT 300 
AGCTTTCAAA TAGGACATTG ATATTTTAAA GTTAATTTTT AAAAAATAGG GCTACAGCTA 360 
TATTAGTAAT GTGTTCCCAA ATTCTGTTTT CTTTTAGTGC CTATCTTAAC AACACAAGGT 420 
AAGAATTTAA TTTGATGAAT TGTTTGAATG AACAAATAAT GAATGAATGT ATAAATGAAA 480 
AGTACCATAA GATACATAAT AAATAGGTCA TCTGCTTTTA AATCCTAAGA TGTTCATTGA 540 
GAACTCTTTT ACATAGGCTT TTCTTGAAAA ACTTTGCTTT GCTACTACTT GTTTTGGAGT 600 
GTATTGATCA GCTTGGGGTG CCATAACAAA AGATTAGACT GGATGGCATA AATAACAGAA 660 
ATTTATATTC TCACAATTCT GGAGGCTGAG AAGTCCAAGA CCAAGGTGCT ATTCAATTCG 720
5’ 3’
COL12A1
F
R
rs 240736BsrI
BsrI
A)
Exon 29 and adjacent 
genomic sequence 
TTGTTTTAAC TCCACACTAG GTCCACAAGG AGAATCCAGA ACAGGTCCAC CAGGGTCCAC 60
AGGTTCAAGA GGTCCCCCTG GCCCCCCTGG CCGTCCTGGA AACTCAGGTA TCCGAGGACC 120
CCCAGGTCCT CCTGGATACT GTGATTCTTC TCAGTGTGCC AGCATCCCAT ACAACGGGCA 180
AGGCTATCCA GGTACGTTGT TGCCATTGTA GGAACCCCAA CTCACCTGAA GTAAAGAACT 240
TTACGGAAAT GAAGTTCCTT AGGATTGAAG GAAGGCTGAT TTGAAGATGT CTTGAAGATA 300
ACAACTCTTT CAGTTCTGAT TATATAATAA TAGTGTTTGC TATCATAGCA CACAACATTA 360
TTTCACTGTT AGGATTGAAT TATTTTCTTT TTTCCCCATG TTTCTGCATT TACCAAATCA 420
CATCATAAAC CTCCCCTTAC TTCTCTTGGG ACTTCAAAGC ATGCTAGTAA TTGACTTTTT 480
TTTTTTCTTT TCCCCAAGAT TGGGAACAGG GATTTGTTAA ATACAACTGT AAAATGCCAA 540
GAATATGTAT TTAAAAATTG TTTTGGGAAT CTAATTTATG GGTAAACTAT GTAATAATAT 600
GGTGTAGACA ACTGAACATA GTTAACTGTC CCATACTAGC CATGGAATTA ATATTTATAA 660
F
R
A
G rs 970547AluI
Exon 65 and adjacent 
genomic sequence 
T
C
B)
AluI
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(Legend from the previous page) A schematic representation of exon (vertical lines) and 
intron (horizontal lines) boundaries of the short variant of COL12A1, as well as the genomic 
sequence surrounding A) the BsrI restriction fragment length polymorphism (RFLP) within 
exon 29, and B)  the AluI RFLP within exon 65 of the short variant of COL12A1. The exact 
binding position of the forward (F) and reverse (R) primers are shown with solid arrows. The 
selected SNPs are boxed within the genomic sequence. The T>C transition (rs240736) 
within intron 29 changes the recognition sequence (ACTGGN/) of the restriction 
endonuclease BsrI, and therefore only digests the 673 bp DNA fragment when the C allele is 
present. Similarly, the A>G transition (rs970547) within exon 65 changes the recognition 
sequence (AG/CT) of the restriction endonuclease AluI, and therefore only digests the 615 
bp DNA fragment when the A allele is present. The BsrI RFLP sequence included an 
additional recognition sequence which is underlined in Figure. The forward primer of the AluI 
RFLP was designed to contain a mutated nucleotide which introduces and additional 
restriction site (underlined in the genomic sequence) for the AluI restriction endonuclease. 
 
 
5.2.3 Statistical analysis 
 
Data were analysed using STATISTICA Version 8.0 (Statsoft Inc., Tulsa, Oklahoma, 
USA) and Graphpad InStat Version 3 (Graphpad Software, San Diego, California, 
USA) statistical programs.  The data were initially analysed for the whole group and 
then separately according to gender.  The sample consisted predominately of males 
and therefore the whole group results were similar to the male participants. Only the 
separate male and female results are reported in this chapter, while the combined 
results, where appropriate, are reported in Appendix 1 (additional material).  A one-
way analysis of variance (ANOVA) was used to determine any significant differences 
between the characteristics of the ACL and CON group, as well as the CON group 
and NON sub-group.  A chi-squared (χ2) analysis or Fisher’s exact test was used to 
analyse any differences in the genotype and allele frequencies, as well as other 
categorical data between the groups. Significance was accepted when P<0.05. 
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Hardy-Weinberg equilibrium was established using the program Genepop web 
version 3.4 (http://genepop.curtin.edu.au/). In addition, gene-gene interactions 
between the COL12A1 AluI RFLP and the COL5A1 BstUI RFLP were assesed. 
Allele combinations consisting of the markers on the two different genes were 
constructed and their association with case-control status was tested. For the gene-
gene interactions, significance was accepted when P<0.025. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Typical 6% non-denaturing polyacrylamide gels showing the genotypes of the 
COL12A1 BsrI (Left panel) and AluI (right panel) restriction fragment length polymorphisms 
(RFLPs). Left Panel: Digestion of the 673 bp PCR product with BsrI produce 616 bp and 57 
bp fragments for the T allele and 366 bp, 250 bp and 15 bp fragments for the C allele. The 
57 bp and 15 bp fragments ran off the gel and are therefore not visible on the Figure. Right 
Panel: Digestion of the 615 bp PCR product with AluI produce 599 bp and 16 bp fragments 
for the G allele and 460 bp, 139 bp and 16 bp fragments for the A allele. The 16 bp 
fragments ran off the gel and is therefore not visible on the Figure. The left lane of the gel on 
the left shows the 100bp molecular weight (MW) marker with the appropriate fragment sizes 
given in base pairs (bp). 
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5.3 RESULTS 
 
5.3.1 Participant characteristics 
 
Although there were slight differences in the number of CON participants included in 
this study, when compared to Study 2, there were still no significant differences in 
the proportion of female participants within the CON (n=83, 38.4%) and ACL (n=38, 
29.5%) groups (P=0.116), as well as between the CON group and NON sub-group 
(n=18, 33.3%)(P=0.593). The female and male participants within the CON and ACL 
groups, as well as the NON sub-group, were also still matched for age, height and 
country of birth (Table 5.1).  The female CON and ACL groups, as well as the NON 
sub-group were also still matched for weight and BMI.  In addition, the male 
participants within the ACL group were significantly heavier, with a significantly 
higher BMI when compared to the CON group. Contrary to what was reported in the 
previous chapter, the male NON group was not significantly heavier (P=0.123). 
However, the BMI in this group was still significantly higher when compared to the 
CON participants. Within the ACL group, the mean ± standard deviation of the 
difference between the self reported age, weight and BMI at the time of first ACL 
rupture and that at recruitment, has been reported in the previous study (Chapter 4) 
of the thesis. 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 5  
132 
 
Table 5.1: Characteristics of the female and male participants within the 
asymptomatic control (CON) group, the anterior cruciate ligament ruptures (ACL) 
group and the ACL sub-group with a non-contact (NON) mechanism of injury. 
 
 CON ACL P-Value b NON P-value c 
Female participants:- n=83 n=38  n=18  
Age a (years) 28.2 ± 10.0 (82) 29.8 ± 12.1 (37) 0.480 28.6 ± 13.1 (18) 0.921 
Height (cm) 166.4 ± 5.8 (78) 166.4 ± 6.8 (34) 0.931 167.8 ± 6.7 (17) 0.329 
Weight a (kg) 62.0 ± 8.4 (81) 62.2 ± 7.5 (34) 0.880 63.2 ± 7.8 (17) 0.583 
BMI a (kg/m2) 22.4 ± 2.7 (78) 22.3 ± 2.1 (33) 0.923 22.1 ± 2.0 (16) 0.716 
Country of birth 
(% South Africa) 82.3 (79) 80.0 (35) 0.955 77.8 (18) 0.915 
Male participants:- n=133 n=91  n=36  
Age a (years) 29.0 ± 12.1 (133) 28.1 ± 10.5 (87) 0.596 27.6 ± 9.7 (36) 0.519 
Height (cm) 180.5 ± 6.3 (132) 181.1 ± 6.6 (79) 0.472 181.4 ± 6.6 (35) 0.452 
Weight a (kg) 82.8 ± 16.5 (131) 87.3 ± 14.3 (80) 0.045 87.5 ± 14.7 (36) 0.123 
BMI a (kg/m2) 25.2 ± 3.8 (130) 26.6 ± 3.7 (76) 0.012 26.7 ± 4.2 (34) 0.043 
Country of birth 
(% South Africa) 89.1 (128) 85.4 (82) 0.577 88.9 (36) 1.000 
 
Gender and country of birth are represented as a frequency (%). The remaining variables 
are expressed as a mean ± standard deviation. The number of subjects (n) for each variable 
is in parentheses.  
a  Age, weight and body mass index (BMI) are self-reported values at the time of the first 
ACL rupture for the ACL group, as well as the NON sub-group, and at recruitment for the 
control group. For the ACL group, age, weight and BMI at recruitment were 6.4 ± 9.9 years 
(n=37), 0.7 ± 4.5 kg (n=34) and 0.4 ± 1.5 kg/m2 (n=33), greater than at the time of the first 
ACL rupture for the female participants, and 4.3 ± 7.7 years (n=83), 1.6 ± 4.7 kg (n=76) and 
0.5 ± 1.5 kg/m2 (n=73), greater than at the time of the first ACL rupture for the male 
participants.   
b  CON vs. ACL. c CON vs. NON. 
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Although the relative frequencies of the male and female CON participants are 
slightly different to what was reported in the previous study (chapter 4) of the thesis, 
it did not change the previously reported findings (Table 5.2). Briefly, amongst the 
female participants the relative frequency of the self-reported history of any other 
(excluding ACL) ligament (CON vs. ACL, P=0.004; CON vs. NON, P=0.016) and 
other knee ligament (CON vs. ACL, P=0.029; CON vs. NON, P=0.019) injuries were 
also still significantly higher in the female ACL group and NON sub-group, when 
compared to the female CON group. A history of previous other knee ligament 
injuries included injury to either the posterior cruciate ligament (PCL), the lateral 
collateral ligament (LCL), or the medial collateral ligament (MCL). In addition, the 
frequency (%) of a self-reported family history of any ligament injury at the time of 
recruitment was still significantly higher in the female ACL group (P=0.003), as well 
as the NON sub-group (P=0.021), when compared to the female CON group. 
Amongst the male participants, the frequency of other knee ligament injuries 
(P=0.045) between the male ACL and CON groups was still the only significantly 
different reported frequency. 
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Table 5.2: Self-reported personal and family (blood relative) history of soft tissue 
injuries within the asymptomatic control (CON) group, the anterior cruciate ligament 
ruptures (ACL) group and non-contact (NON) mechanism of ACL injury sub-group in 
the female and male participants. 
 
 CON ACL P-value c NON P-value d 
Female Participants:- n=83 n=38  n=18  
Any other ligament injury a  26.3 (80) 54.3 (35) 0.004 55.6 (18) 0.016 
Knee ligament injury b 1.3 (80) 11.4 (35) 0.029 16.7 (18) 0.019 
Achilles tendon injury 5.0 (80) 5.7 (35) 1.000 11.1 (18) 0.303 
Family ligament injury 21.8 (78) 50.0 (34) 0.003 52.9 (17) 0.021 
Male Participants:- n=133 n=91  n=36  
Any other ligament injury a 44.4 (126) 57.5 (80) 0.067 54.3 (35) 0.302 
Knee ligament injury b 4.8 (125) 12.5 (80) 0.045 8.6 (35) 0.412 
Achilles tendon injury 10.4 (125) 11.1 (81) 0.871 20.0 (35) 0.129 
Family ligament injury 27.6 (123) 33.8 (80) 0.353 34.3 (35) 0.445 
 
Values are represented as frequencies (%) and the number of participantss (n) are in 
parentheses.  
a Excluding ACL injuries 
b Includes the posterior cruciate ligament (PCL), the lateral collateral ligament (LCL), and the 
medial collateral ligament (MCL)  
c CON vs. ACL 
d CON vs. NON 
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5.3.2 Sports participation 
 
The small change in relative frequency of the CON groups in this study did not 
change the results found for sports participation (Table 5.3) between the groups in 
the previous study, Study 2, of the thesis. Briefly, significantly more female ACL and 
male ACL participants had participated in non-contact jumping (P=0.035) and 
contact sports (P=0.001) respectively. In addition, significantly more males had 
participated in contact sports for a significantly greater number of years (P<0.001). A 
significantly greater relative number of females had also participated in non-contact 
jumping sports (P<0.001) in this study. 
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Table 5.3: Sports participation according to type of sport within the asymptomatic control (CON) groups, the symptomatic anterior 
cruciate ligament ruptures (ACL) groups, as well as the symptomatic noncontact (NON) mechanism of injury subgroups for all female 
and male participants. 
 
 Female Participants  Male Participants  
 CON (n=81) 
ACL 
(n=35) P-Value 
e  CON (n=127) 
ACL 
(n=82) 
P-Value 
e P-Value f 
Contact sports a         
    Participants (%) 13.6 (11) 5.7 (2) 0.339  65.9 (84) 87.8 (72) 0.001 <0.001 
    Participation (years)  5.7 ± 3.6 1.0 ± 0.0 0.101  12.7 ± 7.6 11.5 ± 7.9 0.340 0.001 
Non-contact jumping sports b         
    Participants (%) 34.6 (28) 57.1 (20) 0.035  5.6 (7) 13.4 (11) 0.083 <0.001 
    Participation (years)  8.2 ± 5.2 9.3 ± 5.8 0.493  10.9 ± 5.2 7.0 ± 5.4 0.152 0.918 
Non-contact non-jumping sports c         
    Participants (%) 95.1 (77) 94.3 (33) 1.000  94.4 (120) 92.7 (76) 0.815 0.890 
    Participation (years)  28.4 ± 20.8 28.2 ± 22.6 0.953  25.3 ± 17.9 24.4 ± 22.2 0.762 0.169 
Skiing sports d         
    Participants (%) 3.7 (3) 14.3 (5) 0.051  5.6 (7) 9.8 (8) 0.375 0.925 
Legend on next page 
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(Legend from the previous page) The number of participants is represented as a frequency 
(%), while the years of participation is represented as a mean ± standard deviation. The 
number of participants (n) is in parentheses. 
a  Soccer, rugby, touch rugby, Gaelic football, muay thai, hurling, Australian football league 
(AFL) and boxing.  
b Netball, basketball, volleyball, gymnastics, ballet, motorcross, skateboarding, paragliding, 
handball and sky diving.  
c Field hockey, cricket, tennis, horseback riding, running, bicycling, spinning, squash, 
swimming, aerobics, yachting, athletics (excluding long and triple jump), golf, dancing, 
tennis, canoeing, waterpolo, surfing, windsurfing, badminton, gym training, bowls, triathlon, 
softball and lifesaving. 
d Any mode of water or snow skiing. 
e CON vs. ACL  
f male (CON + ACL) vs. female (CON + ACL) participants. 
 
 
5.3.3 COL12A1 genotype and allele frequencies 
 
5.3.3.1 The AluI RFLP 
 
When the female and mal  participants were analysed together, there were no 
significant differences in genotype or allele frequencies between the CON and ACL 
groups (genotype, P=0.067; allele, P=0.122, nor the CON group and NON sub-group 
(genotype, P=0.208; allele, P=0.433) for the AluI RFLP (Appendix 1, Additional 
material, Table A1.7).  
 
However, when the female participants were analysed separately, the AluI RFLP AA 
genotype was significantly over-represented (AA vs. GT + GG; OR=2.4; 95% CI 1.0 - 
5.5; P=0.048) in the ACL group when compared to the CON group (Figure 5.3A). 
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There were however no AluI RFLP genotype association (AA vs. GT + GG; P=0.359) 
when the male ACL group was compared to the male CON group (Figure 5.3B).  
 
Furthermore, the genotype frequencies between the CON groups and NON sub-
groups for the AluI RFLP was not significantly different within the female participants 
or the male participants (Figure 5.3A and B). However, it must be noted that the 
sample size of the female NON group was too small (n=18). 
 
The allele frequencies between the CON and ACL groups for the AluI RFLP was not 
significantly different within the female participants, or the male participants (Figure 
5.4A and B). As reported in Table 5.4, all the groups were in Hardy-Weinberg 
equilibrium. 
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Figure 5.3: The relative genotype frequency of the COL12A1 gene AluI and BsrI restriction 
fragment length polymorphisms (RFLP) within the asymptomatic control (CON; black bars) 
groups, the anterior cruciate ligament rupture groups (ACL; white bars) and the non-contact 
mechanism of injury sub-group (NON; grey bars) in all female (A and C) and male (B and D) 
participants. The number of participants (n) within each group is shown in parentheses. 
Because of the small sample size of the AluI RFLP GG genotype (A and B), the AA 
genotype was compared to the combined GA and GG genotypes. Similarly, because of the 
small sample size of the BsrI RFLP CC genotype in the female and male NON groups (C 
and D), the CON vs. NON genotype data was analysed by comparing the TT genotype to 
the combined TC and CC genotypes. (A) The AluI RFLP genotype distributions within the 
female participants. CON vs. ACL, P=0.044 (AA vs. GA + GG); CON vs. NON, P=0.180 (AA 
vs. GA + GG) (B) The AluI RFLP genotype distributions within the male participants. CON 
vs. ACL, P=0.359 (AA vs. GA + GG); CON vs. NON, P=0.471 (AA vs. GA + GG). (C) The 
BsrI RFLP genotype distributions within the female participants. CON vs. ACL, P=0.433; 
CON vs. NON, P=0.643 (TT vs. TC+CC). (D) The BsrI RFLP genotype distributions within 
the male participants; CON vs. ACL, P=0.746; CON vs. NON, P=0.533 (TT vs. TC + CC). 
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Figure 5.4: The relative allele frequency of the COL12A1 gene AluI and BsrI restriction 
fragment length polymorphisms (RFLP) within the asymptomatic control (CON; black bars) 
groups, the anterior cruciate ligament rupture groups (ACL; white bars) and the non-contact 
mechanism of injury sub-group (NON; grey bars) in all female (A and C) and male (B and D) 
participants. (A) The AluI RFL1P allele distributions within the female participants. CON vs. 
ACL, P=0.090; CON vs. NON, P=0.385. (B) The AluI RFLP allele distributions within the 
male participants. CON vs. ACL, P=0.634; CON vs. NON, P=0.870. (C) The BsrI RFLP allele 
distributions within the female participants. CON vs. ACL, P=0.230; CON vs. NON, P=0.227. 
(D) The BsrI RFLP allele distributions within the male participants; CON vs. ACL, P=0.749; 
CON vs. NON, P=0.645. 
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Table 5.4: Hardy-Weinberg P-values of all separately analysed groups for the AluI and 
BsrI restriction fragment length polymorphisms (RFLP).  
 
 AluI RFLP BsrI RFLP 
 P-value P-Value 
Female ACL group ≥0.572 ≥0.489 
Male ACL group 1.000 1.000 
Male + Female ACL groups 1.000 ≥ 0.534 
Female CON group 0.372 ≥ 0.783 
Male CON group 0.217 ≥ 0.405 
Male + Female CON groups 0.088 ≥ 0.737 
All participants 0.195 1.000 
 
 
5.3.3.2 The BsrI RFLP 
 
When the female and male participants were analysed together, there were no 
significant differences in genotype or allele frequencies between the CON and ACL 
groups (genotype, P=0.665; allele, P=0.730), nor the CON group and NON sub-
group (genotype, P=0.679; allele, P=0.556) for the BsrI RFLP. (Appendix 1, 
Additional material, Table A1.7).  
 
There were also no significant differences in the COL12A1 BsrI RFLP genotype 
(Figure 5.3 C and D) or allele (Figure 5.4 C and D) frequency distributions between 
the female or male CON and ACL groups. Similarly, there were also no significant 
genotype (Figure 5.3 C and D) or allele (Figure 5.4 C and D) frequency distibutions 
between the CON groups and NON sub-groups. As reported in Table 5.4 all the 
groups were in Hardy-Weinberg equilibrium. 
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5.3.3.3 AluI RFLP genotype effects on family history of ligament injury 
 
Although there were no genotype differences between the female and male 
participants with and without a previous history of ligament injury, there is a trend for 
the AA genotype to be over-represented (AA vs. GA + GG; P=0.082) in female 
participants with a family history of ligament injury (Figure 5.5). This finding is similar 
to the association noted between with the COL5A1 BstUI RFLP and family history in 
Study 2. 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: The relative genotype frequency of the COL12A1 gene AluI restriction fragment 
length polymorphism (RFLP) when all female (A) and male (B) participants in the study were 
divided into those with and without a family history of ligament injuries. (A) The AluI RFLP 
genotype distribution within the female participants; AA vs. GA + CC, P=0.082; (B) The AluI 
RFLP genotype distribution within the male participants; P=0.854. 
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5.3.3.4 Combined analysis of the COL12A1 AluI and COL5A1 BstUI RFLPs. 
 
It was shown in the previous study of the thesis that the CC genotype of the COL5A1 
BstUI RFLP is over-represented in the female CON group when compared to a 
female CON group. The combined analysis of the AluI RFLP and the BstUI RFLP 
within the male and female participants are therefore reported in Table 5.5. Although 
this data should not be over interpreted, the best estimates of risk of the combined 
genotype for ACL ruptures resulted from comparing the female CON and ACL 
groups with a TT genotype for the BstUI RFLP and a AA genotype for the AluI RFLP 
(OR = 2.43; 95% CI 0.95 – 6.19; P=0.079), as well as the female CON and ACL 
participants with a TC genotype for the BstUI RFLP and a AA genotype for the AluI 
RFLP (OR = 1.83; 95% CI 0.81 – 4.15; P=0.199)(Table 5.4). Of interest, when the 
above mentioned genotype combinations of highest risk were combined, a T allele 
(TT or TC genotype) for the BstUI RFLP and a AA genotype for the AluI RFLP was 
significantly over-represented (OR=3.62; 95% CI 1.57 – 8.34; P=0.003) in the ACL 
group (70.3%), when compared to the CON group (39.5%). 
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Table 5.5: The genotype pairs of the COL12A1 AluI and COL5A1 BstUI RFLPs, 
together with their frequencies within the anterior cruciate ligament rupture (ACL) and 
control (CON) groups, as well as their estimated risk (OR). 
 
  Female Participants  Male Participants 
COL12A1 COL5A1  CON (N=81) 
ACL 
(N=37) 
OR  CON 
(N=133) 
ACL 
(N=88) 
OR 
AA TT 14.8 (12) 29.7 (11) 2.43  16.7 (22) 20.5 (18) 1.30 
AA TC 27.2 (22) 40.5 (15) 1.83  34.9 (46) 33.0 (29) 0.93 
AA CC 12.4 (10) 2.7 (1) n.d.  6.8 (9) 10.2 (9) 1.57 
         
AG TT 12.4 (10) 13.5 (5) 1.11  12.1 (16) 5.7 (5) 0.44 
AG TC 14.8 (12) 10.8 (4) 0.70  18.1 (24) 21.6 (19) 1.25 
AG CC 14.8 (12) 0 (0) n.d.  8.3 (11) 5.7 (5) 0.67 
         
GG TT 0 (0) 0 (0) n.d.  0.8 (1) 2.3 (2) n.d. 
GG TC 3.7 (3) 0 (0) n.d.  1.5 (2) 0 (0) n.d. 
GG CC 0 (0) 2.7 (1) n.d.  0.8 (1) 1.1 (1) n.d. 
 
The CON and ACL values are represented as a frequency (%) with the number of subjects 
(N) in parenthesis. 
n.d. = not determined due to small sample sizes. 
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5.4 DISCUSSION 
 
The main finding of this study was that the AA genotype of the AluI RFLP within the 
terminal exon 65 of the COL12A1 gene was associated with a 2.4 times increased 
risk (OR=2.4; 95% CI 1.0 - 5.5; P=0.048) of ACL ruptures in female, but not male 
participants. The upstream BsrI RFLP, within exon 29, was however not associated 
with ACL ruptures in neither the females nor the male participants. The finding of an 
increased frequency of family history of ligament injury amongst participants in the 
ACL group was reported and discussed in the previous Study 2. An interesting 
finding of this study was that there was a trend (not statistically significant) for the AA 
genotype of the AluI RFLP to be over-represented in female participants with a 
family history of ligament injury. An additional finding of this study was that female 
participants with an AA genotype for the COL12A1 AluI RFLP and a T allele (TC or 
TT genotype) for the COL5A1 BstUI RFLP were at 3.6 times greater risk (OR=3.6; 
95% CI 1.6 – 8.3; P=0.003) of ACL ruptures, when the results from this study were 
combined with the results from the study reported in Study 2 of this thesis.  
 
The novel finding, that females with an AA genotype for the AluI RFLP had a 
increased risk of ACL ruptures, has not been previously reported. The COL12A1 
gene, which has been mapped to 6q12-q13, and encodes both the various long 
(XIIA) and short (XIIB) isoforms of type XII collagen, is a homotrimer consisting of 3 
α1(XII) chains [130]. The short XIIB-1 isoform is predominantly expressed in both 
tendons and ligaments in response to mechanical loading [130]. The AluI RFLP 
within exon 65, is a non-synonymous coding variant, which changes the amino acid 
at position 3058 from a serine to a glycine. It is interesting to note that the wild type 
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amino acid, serine, is a neutral polar amino acid with a larger side chain than the 
non-polar neutral glycine amino acid; this change in amino acid sequence has no 
known function. The findings from this study do however suggest that the A>G 
substitution of this variant results in an altered type XII collagen protein, and, 
although speculative, this may alter the biomechanical properties of the collagen 
fibril. Further research is therefore required.  
 
The BsrI RFLP of type XII collagen, which changes the amino acid at position 1738 
from isoleucine to threonine, was however not associated with ACL ruptures in male 
or females participants. Although the genotype frequencies of the AluI and BsrI 
RFLPs in the current study are similar to what has previously been reported [148], it 
is interesting to note that the AluI RFLP GG genotype and the BsrI RFLP CC 
genotypes were not indentified in patients with Achilles tendon ruptures. The 
significance of this finding is however not currently known [148]. Furthermore, the 
AluI and BsrI RFLPs were previously shown not to be in linkage disequilibrium [148]. 
 
The additional finding of this study, that female participants with an AA genotype for 
the AluI RFLP and either a TC or TT genotype for the BstUI RFLP within the 
COL5A1 were at 3.6 times greater risk of ACL ruptures. These results should 
however be interpreted with caution due to the small sample size. This finding 
provides useful information to direct future research, and in particular, to the design 
of appropriate multifactorial models that may be developed to reduce the incidence 
of ACL ruptures in genetically predisposed individuals. Interestingly, previous data 
have also demonstrated that a significant interaction exists between the BstUI RFLP 
within COL5A1 and the MMP-3 gene and the risk of Achilles tendinopathy [147]. 
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.  
The main finding of this study is remarkably similar to the main finding of Study 2 of 
this thesis. In this previous study the BstUI RFLP within COL5A1 was also only 
associated with ACL rupture in female participants. As discussed in Study 2, the 
reasons for these gender-specific associations are unknown. Specific to the gender-
association of the AluI RFLP within COL12A1 and ACL ruptures, there are no known 
previous reports of the effects of the female sex hormones on the regulation of 
COL12A1 or any gene-gene interactions which could possibly provide a possible 
explanation. Both genes however encode for quantitatively minor structural 
components of the collagen fibril, the major building block of the ligament [14;112].  
 
It has been widely reported that females are at increased risk of ACL rupture when 
compared to males (refer to Section 2.3.1.3). A number of intrinsic anatomical risk 
factors classified as either anatomical, hormonal, or neuromuscular, have been 
linked to this phenomenon [4;12]. The gender-specific association found in this study 
(as well as the results reported in Study 2), may indicate that genetic variants alter 
structure and/or biomechanical function of the ACL which may compromise this 
ligament. Therefore it remains possible that even though the biomechanical 
properties of the ACL were influenced by the AluI RFLP in male and females 
participants, it did not alter the risk of ACL rupture in the male participants 
significantly enough to demonstrate an association in this study. For this reason, a 
larger group of homogenous male participants with non-contact ACL ruptures and 
exposure matched controls are required for further investigation.  
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 5  
148 
 
The previous discussion of the non-genetic factors which may be possible 
confounding variables in determining injury risk, as described in Study 2 is also valid 
for the current study. Briefly, the fact that females were not matched for participation 
in non-contact jumping sports, and males were not matched for contact sports, is a 
limitation of this study. Furthermore, the BMI of the male ACL group and NON sub-
group were both significantly higher than the CON group, and is thus another 
limitation of the study. A third limitation of this study, as previously discussed (Study 
2), was the relatively small sample size of the female participants. The primary aim 
of the thesis was not designed to investigate gender specific genetic risk factors and 
therefore further research is required to confirm this finding in larger female cohorts.   
 
In conclusion, the AA genotype of the AluI RFLP within exon 65 of the COL12A1 
gene is associated with an increased risk of ACL rupture in female participants 
(Figure 5.6).  
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Figure 5.6: A schematic presentation of the primary finding from this study. The COL12A1 
AluI RFLP was associated with risk of ACL ruptures in female participants. The COL12A1 
gene encodes for type XII collagen, a member of the FACIT collagens commonly found 
within the microfibril. Refer to Section 2.5.1 for further detail regarding the structure of the 
collagen microfibril. 
Study 2:
COL5A1 BstUI RFLP
(females only)
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COL1A1 Sp1 binding 
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CHAPTER 6 
STUDY FOUR 
 
THE COL1A1 SP1 BINDING SITE POLYMORPHISM: RISK FOR OTHER ACUTE 
AND CHRONIC SOFT TISSUE INJURIES 
 
The data presented in this chapter was published in the following peer-reviewed 
article:  Posthumus, M., September, A.V., Schwellnus, M., Collins, M. Investigation of the 
Sp1 binding site polymorphism within the COL1A1 gene in participants with Achilles tendon 
injuries and controls. Journal of Science and Medicine in Sport, 2009. 12(1); 184-189 
 
 
6.1 INTRODUCTION 
 
The first three experimental chapters (Studies 1 to 3) of this thesis investigated the 
association of variants within three candidate genes (COL1A1, COL5A1 and 
COL12A1) and the risk of ACL ruptures. Previous research studies from this 
laboratory have also investigated whether the same variants within the COL5A1 
[143;145] and COL12A1 [148] genes are associated with another common chronic 
(Achilles tendinopathy) and acute (Achilles tendon rupture) soft tissue injury. 
Although some interesting similarities were found between the genetic risk factors for 
ACL ruptures, chronic Achilles tendinopathy and/or spontaneous Achilles tendon 
ruptures, there were also some notable differences. These findings do however 
provide initial evidence that there are, in part, some potential common underlying 
genetic predispositions to these acute and chronic soft tissue injuries. 
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Among the three candidate genes investigated in the first three studies of this thesis, 
only the COL1A1 variant has not been investigated as a candidate gene for other 
chronic and acute musculoskeletal soft tissue injuries.  
 
The aim of this study was therefore to determine whether the functional Sp1 binding 
site polymorphism within intron 1 of the COL1A1 gene is also associated with acute 
(spontaneous Achilles tendon ruptures) and chronic (Achilles tendinopathy) injuries 
of another soft tissue, namely the Achilles tendon. 
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6.2 MATERIALS AND METHODS 
 
6.2.1 Participants 
 
Eighty five Caucasian participants diagnosed with chronic Achilles tendinopathy 
(TEN), and 41 Caucasian participants diagnosed with partial (n=3) or complete 
(n=38) Achilles tendon ruptures (RUP) were previously recruited from the medical 
practice at the Sports Science Institute of South Africa and other clinical practices 
within the greater Cape Town area of South Africa (as previously described 
[143;144]). In addition, 126 apparently healthy, unrelated, Caucasian participants 
without any history of symptomatic Achilles tendon injuries (CON) were also included 
in this study. The TEN, RUP and CON participants compared in this study were the 
same cohort that was previously used to identify candidate genes for Achilles tendon 
injuries [143-145;147;148].     
 
An experienced clinician made the diagnosis of chronic Achilles tendinopathy using 
clinical criteria.  The diagnostic criteria for every subject were reviewed by an 
experienced Sports Physician (MS). The clinical diagnostic criteria for chronic 
Achilles tendinopathy were gradual progressive pain over the posterior lower limb in 
the Achilles tendon area for greater than 6 months, together with at least one out of 
the following six criteria: (1) early morning pain over the Achilles tendon area, (2) 
early morning stiffness over the Achilles tendon area, (3) a history of swelling over 
the Achilles tendon area, (4) tenderness to palpation over the Achilles tendon, (5) 
palpable nodular thickening over the affected Achilles, or (6) movement of the painful 
area in the Achilles tendon with plantar-dorsi-flexion (positive “shift” test) [167;168]. 
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[168;168;168] In addition to these clinical diagnostic criteria, soft tissue ultrasound 
examination was performed in a sub-group (n=36) of participants to confirm the 
diagnosis of the affected Achilles tendon.   
 
The diagnosis of Achilles tendon rupture was made clinically using standard 
validated criteria [167] [142;169;169]and confirmed in all cases by examination at the 
time of surgery (33 of 41, 80.5%s) or by ultrasound imaging (5 of 41, 12.2%), MRI 
imaging (2 of 41, 4.9%) or computer tomography (CT) scan (1 of 41, n=2.4%).  
Participants who had a history of current or past fluoroquinolone antibiotic use or 
previous local corticosteroids injection in the Achilles tendon or the area surrounding 
the Achilles tendon were excluded from the study. This was necessary because of 
the known association between fluoroquinolone antibiotic [170] or possibly 
corticosteroids use, and an increased risk of Achilles tendon rupture [171].  
Furthermore, participants who had been diagnosed with any connective tissue 
disorders or any other systemic diseases believed to be associated with Achilles 
tendon pathology, such as, but not limited to, Ehlers-Danlos syndrome, benign 
hypermobility joint syndrome, rheumatoid arthritis, systemic lupus erythematosus, 
hyperparathyroidism, renal insufficiency, diabetes mellitus and familial 
hypercholesterolaemia were also excluded from the study [171].   
 
Multiple (greater than one) injuries to the same Achilles tendon were documented in 
17 (20.0%) and 14 (34.1%) of the TEN and RUP subjects respectively.  Forty four 
percent of the TEN (37 of 85) and 34% (14 of 41) the RUP subjects reported either a 
bilateral and/or multiple Achilles tendon injuries. 
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Prior to participation in this study, all the participants gave informed written consent.  
In addition, each subject completed medical history questionnaire forms (Appendix 
5). This study was approved by the Research Ethics Committee of the Faculty of 
Health Sciences within the University of Cape Town, South Africa (reference number 
170/2005, Appendix 6).   
 
6.2.2 DNA extraction and COL1A1 genotyping 
 
Approximately 4.5 ml of venous blood was collected from each subject into EDTA 
vacutainer tubes by venipuncture of a forearm vein and stored at 4°C until DNA 
extraction. DNA was extracted using the procedure described in Study 1 and 
modified by Mokone et al. [143]. DNA samples were genotyped for the functional 
Sp1 binding site polymorphism (SNP rs1800012; IVS1+1023G>T) within intron 1 of 
the COL1A1 gene using a nested polymerase chain reaction (PCR) as previously 
described in the first study of the thesis (Section  3.2.3). 
 
The resultant fragments together with 100 bp molecular weight marker (Promega 
Corporation, Madison, Wisconsin, USA), were separated on 6% non-denaturing 
polyacrylamide gels and visualised by ethidium bromide staining. The gels were 
photographed under UV light using a Uvitec photodocumentation system (Uvitec 
Limited, Cambridge, UK) and the sizes of the DNA fragments determined. The G 
allele produces a 260 bp fragment while the T allele produces 242 bp and 18 bp 
fragments (Figure 3.3, chapter 3). 
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6.2.3 Statistical analysis 
 
Data was analysed using STATISTICA Version 7 (Statsoft Inc., Tulsa, Oklahoma, 
USA) and Graphpad InStat Version 3 (Graphpad Software, San Diego, California, 
USA) statistical programs.  A one-way analysis of variance (ANOVA) was used to 
determine any significant differences between the characteristics of the TEN, RUP 
and CON groups.  A least squares difference (LSD) post-hoc test was used to 
identify specific differences when the overall F value was found to be significant.  A 
chi-squared (χ2) analysis was used to analyse any differences in the genotype 
frequencies and allele frequencies between the three groups.  Significance was 
accepted when P<0.05. Hardy-Weinberg equilibrium was established using the 
program Genepop web version 3.4 (http://genepop.curtin.edu.au/).  
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6.3 RESULTS 
 
6.3.1 Participant Characteristics 
 
The TEN, RUP and CON groups were similarly matched for age, height, gender and 
country of birth (Table 6.1).  The age of the TEN and RUP groups are the age of 
initial onset of the Achilles tendon injury, which were on average 7.9 ± 9.3 and 7.6 ± 
8.7 years after their initial symptoms respectively.  The TEN and RUP groups were 
on average significantly heavier (P<0.001) with corresponding higher body mass 
indexes (P<0.001) than the CON group. There were however no COL1A1 genotype 
effects on weight and BMI (Table 6.2).  
 
6.3.2 COL1A1 genotype and allele frequencies. 
 
There were no significant differences in the distribution of the genotype (P=0.602) or 
allele (P=0.578) frequencies of the COL1A1 Sp1 binding site polymorphism between 
the CON, TEN and RUP groups (Figure 6.1). The rare TT genotype was however not 
present in the RUP group. Due to the small sample size this finding was not 
statistically significant (TT vs. GG + GT; P=0.338).  
 
The COL1A1 genotype distribution of the CON (P=0.198), TEN (P=1.000) and RUP 
(P=1.000) groups were in Hardy-Weinberg equilibrium.  
  
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 6  
158 
 
 
 
Table 6.1:  Characteristics of the control (CON), Achilles tendinopathy (TEN) and 
Achilles rupture (RUP) participants. 
 
 CON (n) TEN (n) RUP (n) P valueb 
Age (years)a 37.1 ± 10.6 (119) 39.4 ± 14.7 (79) 40.2 ± 11.3 (40) 0.241 
Height (cm) 174.8 ± 9.3 (121) 176.2 ± 9.3 (78) 175.5 ± 8.4 (41) 0.554 
Weight (kg) 71.3 ± 12.0 (124)c,d 78.0 ± 14.0 (80)c,e 86.4 ± 14.3 (41)d,e <0.001 
BMI (kg/cm2) 23.3 ± 2.6 (121)c,d 24.9 ± 3.4 (78)c,f 28.0 ± 3.7 (41)d,f <0.001 
Gender (% 
males) 64.0 (125) 71.8 (85) 75.61 (43) 
0.279 
Country of 
birth (% South 
Africa) 
72.6 (124) 71.6 (81) 80.49 (43) 0.504 
 
Gender and country of birth are represented as a frequency (%), while the remaining 
variables are expressed as mean ± standard deviation.  
BMI – body mass index.  
aThe age of the TEN and RUP groups are the age of the onset of the initial symptoms of 
Achilles tendon pathology, which were on average 7.9 ± 9.3 and 7.6 ± 8.7 years after their 
initial symptoms respectively . 
b P value = CON vs. TEN vs. RUP; c CON vs. TEN (P<0.001); d CON vs. RUP (P<0.001); e 
TEN vs. RUP (P=0.002); f TEN vs. RUP (P<0.001) 
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Table 6.2:  Genotype effects of the Sp1-binding site polymorphism (SNP rs1800012; 
IVS1+1023G>T) within the COL1A1 gene on the characteristics of the combined 
control (CON), Achilles tendinopathy (TEN) and Achilles rupture (RUP) participants. 
 
 GG genotype (n) GT genotype (n) TT Genotype (n) p valueb 
Age (years)a 38.2 ± 11.8 (169) 38.0 ± 13.7 (61) 45.4 ± 8.58 (8) 0.262 
Height (cm) 174.7 ± 9.5 (172) 177.6 ± 7.5 (60) 174.2 ± 10.7 (8) 0.096 
Weight (kg) 75.4 ± 14.8 (175)
 78.4 ± 11.9 (61) 71.3 ± 15.3 (8) 0.232 
BMI (kg/cm2) 24.6 ± 3.7 (172)
 24.7 ± 3.0 (60) 23.2 ± 2.4 (8) 0.540 
Gender (% males) 65.9 (179) 76.6 (64) 62.5 (8) 0.342 
Country of birth 
(% South Africa) 
71.59 (176) 80.65 (62) 62.5 (8) 0.296 
 
Gender and country of birth are represented as a frequency (%), while the remaining 
variables are expressed as mean ± standard deviation.  
BMI – body mass index. 
a The age of the TEN and RUP groups are the age of the onset of the initial symptoms of 
Achilles tendon pathology, which were on average 7.9 ± 9.3 and 7.6 ± 8.7 years after their 
initial symptoms respectively . 
b P value = CON vs. TEN vs. RUP. 
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Figure 6.1: Relative genotype (A) and allele (B) frequencies of the COL1A1 Sp1 binding site 
polymorphism (SNP rs1800012; IVS1+1023G>T) of the asymptomatic control (CON, solid 
bars), the chronic Achilles tendinopathy (TEN, clear bars) and Achilles tendon rupture (RUP, 
grey bars) participants. There were no significant differences in the distribution of the 
genotype (P=0.602) or allele (P=0.578) frequencies of the COL1A1 Sp1 binding site 
polymorphism between the three groups. 
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6.4 DISCUSSION 
 
The purpose of this study was to investigate whether the functional Sp1 binding site 
polymorphism within intron 1 of the gene encoding for the α1 chain of type I collagen 
(COL1A1) was associated with other soft tissue injuries, namely spontaneous 
Achilles tendon rupture and/or chronic Achilles tendinopathy. The main finding of this 
study was that there was no association between this functional COL1A1 
polymorphism and any of the studied Achilles tendon injuries. The rare TT genotype 
was however not present in the small group of participants with Achilles tendon 
rupture. This observation was similar to the findings presented in Study 1, which 
found no TT genotypes in participants with ACL ruptures, and the findings of the 
previous Swedish study [9], which found the TT genotype to be under-represented in 
participants with acute ligament injuries. When combined, the observation that the 
TT genotype is rare, suggests that the Sp1 binding site polymorphism is a common 
genetic risk factor for several different acute soft tissue injuries. This observation will 
be further explored in the next chapter of this thesis. 
   
The genotype frequencies of the CON group in this study were notably similar to the 
genotype distribution of the independent control group used in Study 1 of this thesis, 
the Swedish study [9] reporting an association with acute ligament injuries, and other 
very large cohorts [154;155] (Table 6.3).  
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 6  
162 
 
Table 6.3:  The genotype frequencies of the Sp1 binding site polymorphism, 
and the sample size (N) of the control groups of the current study (Study 4), 
the first study of the thesis (Study 1), the study by Khoschnau [9], and other 
very large cohort studies[155;160]. 
 
 Posthumus (PhD thesis 2009 
- Study 4) 
Posthumus (PhD 
thesis 2009 – 
Study  1) 
Khoschnau 
[9] 
Mann 
[155]* 
Lian 
[160] 
N 126 130 325 4733 4175 
GG (%) 70.6 70.0 70.8 66.1 65.3 
GT (%) 24.6 25.5 25.5 29.5 30.9 
TT (%) 4.8 4.6 3.7 4.4 3.8 
 
 
Although it has been reported that the T allele of the functional Sp1 binding site 
polymorphism alters the α1(I) collagen to α2(I) collagen protein ratio [155], no 
statistically significant association with Achilles tendinopathy was observed. It is 
however interesting to note that only 2 participants (2 of 85; 2.4%) within the Achilles 
tendinopathy group had a TT genotype. Further research with a larger sample size 
will be required to determine if there is any minor affect of this polymorphism on 
Achilles tendinopathy.  
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CHAPTER 7 
STUDY FIVE 
 
THE COL1A1 GENE AND ACUTE SOFT TISSUE RUPTURES 
 
The data presented in this chapter was published in the following peer-reviewed 
article: Collins, M. Posthumus, M. Schwellnus, M. The COL1A1 gene and acute soft tissue 
ruptures. British Journal of Sports Medicine. In Press.  
 
 
7.1 INTRODUCTION 
 
Acute soft tissue injuries, such as Achilles tendon ruptures and anterior cruciate 
ligament ruptures, are not only common, but also amongst the most severe injuries 
sustained in recreational and competitive athletes [3;35]. A critical step in an injury 
prevention model, as discussed in the first chapter of this thesis, is understanding 
the aetiology and mechanisms of injury [11]. The aetiology and mechanisms may be 
described by a complex interaction between intrinsic risk factors, extrinsic risk 
factors, and a specific inciting event [39]. As reviewed (Section 2.4.2), intrinsic risk 
factors, which include a genetic component, may influence the risk of sustaining a 
soft tissue rupture, predisposing an individual to injury. Furthermore, the addition of 
extrinsic risk factors may render the individual susceptible to injury. It is important to 
note that the mere presence of these risk factors is not sufficient to result in injuries, 
they merely “prepare” the athlete for an injury to occur in a given situation, termed 
the “inciting event”. However, understanding these risk factors is important for the 
development of injury prevention models. 
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The functional Sp1 binding site polymorphism within the first intron of the COL1A1 
(as discussed in Section 2.5.3.1), has recently been associated with cruciate 
ligament ruptures [9] and shoulder dislocations [9]. In addition this polymorphism 
was shown in Study 1 of this thesis to be associated with ACL ruptures in a South 
African Caucasian population. In this study the rare TT genotype for this 
polymorphism was not present in participants with ACL ruptures. Similarly, the 
previous study (Study 4) of this thesis also found no TT genotypes in a small group 
of participants with Achilles tendon ruptures.    
 
As shown in Table 6.3 of the previous chapter, the genotype distribution of this 
polymorphism was similar within the asymptomatic 256 South African Caucasian 
(4.7% TT genotype) (Study 1 and Study 4) and 325 Swedish (3.7% TT genotype) [9] 
control populations. It is important to mention that the Swedish control population 
consisted of only female participants [9], while only 36% (Study 4) and 25% (Study 
1) of the South African studies consisted of female subjects.  Similarly, the genotype 
distribution within the South African and Swedish control populations were similar to 
the distributions reported in larger control cohorts consisting of 4175 and 4733 
asymptomatic subjects, which reported a TT genotype frequency of 3.8% and 4.4%, 
respectively (refer to Table 6.3) [155;160]. 
 
By combining the similar results that were observed in the independent South 
African (Studies 1 and 4) and Swedish [9] studies, the association between acute 
soft tissue ruptures and a specific genotype could perhaps be strengthened. 
Stronger evidence that the COL1A1 TT genotype potentially protects an athlete from 
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an acute musculoskeletal soft tissue rupture would have significant clinical relevance 
in any injury risk model. 
 
Therefore, the aim of this chapter is to report the combined effect, from the published 
Swedish study [9], and the results presented in this thesis, of the rare TT genotype of 
the COL1A1 Sp1 binding site polymorphism on the risk of acute soft tissue ruptures. 
A Fisher’s exact test was used to analyse any differences in the genotype 
frequencies (TT vs. GT and GG) of the 581 combined control (CON) and injured 
groups in the three combined studies. The injured groups were analysed as (1) 350 
cruciate ligament ruptures (CL), (2) 476 cruciate ligament ruptures and shoulder 
dislocations (CLSD), and (3) all 517 soft tissue ruptures (ALL; cruciate ligament, 
shoulder dislocations and Achilles tendon).  
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7.2 RESULTS 
 
The rare TT genotype was significantly under-represented in the CL group (0.3% TT 
genotype, n=1) when compared to the CON group (4.1% TT genotype, n=24) of all 
three published studies (OR=15.1; 95% CI 2.0 - 111.7; P=0.0002).  Similar results 
were obtained when the CLSD group (0.4% TT genotype, n=2; OR=10.2; 95% CI 2.4 
- 43.4, P<0.0001) or the ALL group (0.4% TT genotype, n=2; OR=11.1; 95% CI 2.6 - 
47.2; P<0.0001) were compared to the CON group (Figure 7.1). 
 
 
Figure 7.1: The relative genotype frequencies of the functional Sp1 binding site 
polymorphism within intron 1 of the COL1A1 gene of the combined Swedish [9] and South 
African (Study 1 and 4) for the (1) asymptomatic control (CON), (2) cruciate ligament 
ruptures (CL), (3) cruciate ligament ruptures and shoulder dislocations (CLSD), and the, (4) 
soft tissue ruptures (cruciate ligament, shoulder dislocations Achilles tendon) (ALL).  The 
data from both the South African Caucasian control populations were from unrelated 
individuals. 
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7.3 DISCUSSION 
 
In summary, the combined results from the recently published Swedish study [9], 
and the data that was presented in this thesis (Study 1 and 4), show that the TT 
genotype of the COL1A1 Sp1 binding site polymorphism is associated with an 11.1 
times reduced risk (OR=11.1; 95% CI 2.6 – 47.2; P<0.001) of acute musculoskeletal 
soft tissue ruptures. Furthermore, when only the risk of cruciate ligaments were 
analysed, the TT genotype was associated with a 15.1 times reduced risk (OR=15.1; 
95% CI 2.0 – 111.7; P<0.001) of cruciate ligament rupture.   
 
The biological mechanism/s to explain this finding is not known. Furthermore, these 
data should be interpreted with some caution due to the low frequency of the rare TT 
genotype. 
 
In conclusion, this COL1A1 gene pol morphism is the first variant to be associated 
with risk of acute soft tissue rupture when data from three independent studies were 
combined.  The clinical relevance of this finding is that the COL1A1 TT genotype 
protects an athlete from acute soft tissue ruptures and should be included in future 
risk models for acute soft tissue ruptures.  
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CHAPTER 8 
STUDY SIX 
 
THE BstUI RFLP WITHIN THE COL5A1 GENE: FURTHER UNDERSTANDING 
 
 
8.1 INTRODUCTION 
 
The previous study (Study 5) of this thesis reported the combined results of three 
independent studies on the COL1A1 Sp1 binding site polymorphism as a risk factor 
for acute musculoskeletal soft tissue ruptures. This combined analysis further 
strengthened the evidence that the COL1A1 TT genotype appear to protect 
individuals from acute musculoskeletal soft tissue ruptures. Similarly to the COL1A1 
Sp1 binding site polymorphism, the BstUI RFLP within the COL5A1, which was 
shown to be associated with ACL ruptures in female participants in Study 2 of this 
thesis, has also been associated with other musculoskeletal soft tissue injuries 
[143;145]. For this reason, performing a comparative analysis of the results 
presented in Study 2, and the results from the two previously published studies 
[143;145], may further strengthen our understanding of the association between the 
BstUI RFLP and the risk of musculoskeletal soft tissue injuries.         
 
Initial studies performed by this laboratory demonstrated that the BstUI RFLP within 
the 3’-UTR of the COL5A1 gene was associated with chronic Achilles tendinopathy 
in a South African (SA) Caucasian population [143;145]. The main finding from this 
initial investigation was that the CC genotype of this polymorphism was significantly 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 8  
170 
 
over-represented in an age-matched asymptomatic control group (28%) when 
compared to the group with Achilles tendinopathy (13%) (Figure 8.1).  In a repeat of 
the initial study in an Australian (AUS) Caucasian population, the CC genotype of the 
COL5A1 BstUI RFLP was also significantly over-represented in an age-matched 
asymptomatic control group (24%), when compared to the Achilles tendinopathy 
group (12%) [145]. The frequency of the CC genotype within the asymptomatic 
control and symptomatic Achilles tendinopathy groups were similar in both the SA 
and AUS studies (Figure 8.1). 
 
Based on the findings of these two independent Achilles tendinopathy studies, the 
association of the COL5A1 BstUI RFLP with ACL ruptures was investigated, and this 
was reported in Study 2 of this thesis. Due to the reported increased risk of ACL 
ruptures in females (Section 2.4.2), the male and females participants were analysed 
separately. In this, the third study investigating the BstUI RFLP as a risk factor for 
musculoskeletal soft tissue injuries, it was reported that the CC genotype of this 
polymorphism was significantly over-represented in the female age-matched 
asymptomatic control participants (27%), when compared to the female participants 
with ACL ruptures (5%). The female control group had a similar CC genotype 
frequency to the combined male and female control participants of the previous two 
SA and AUS Achilles tendinopathy studies (Figure 8.1). It is however interesting to 
note that this association was not present when the male participants in the SA ACL 
study were analysed. The frequency of the CC genotype of the age-matched 
asymptomatic male control participants (16%) where distinctly different (Figure 8.1) 
to the frequency of the previously reported combined male and female asymptomatic 
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control participants in the Achilles tendon studies, as well as the females participants 
in the ACL study (24-27%). 
 
 
 
 
 
 
 
 
 
 
Figure 8.1: The CC genotype frequency within the South African chronic Achilles 
tendinopathy study (SA TEN) [143], the Australian chronic Achilles tendinopathy study (AUS 
TEN) [145], and the South African ACL study, presented in study two of this thesis, with 
females (Female ACL) and males (Male ACL) analysed separately. The soft tissue injury 
and control groups are shown as hatched and solid bars respectively. The SA TEN and AUS 
TEN studies consisted of both male and females participants. 
 
 
Considered together, the results of these three studies highlight two important 
aspects which need further investigation. Firstly, based on the gender-specific 
association of the COL5A1 BstUI RFLP in the ACL study, it may retrospectively be 
seen as a limitation that the male and female participants were not analysed 
separately in the SA and AUS Achilles tendinopathy studies. Secondly, although the 
asymptomatic control participants in these case-control studies were all matched for 
age of their respective symptomatic groups, the age of the male and female 
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participants within the ACL study was about 10 years younger than the combined 
male and female control participants in the two Achilles tendon studies (Figure 8.2).  
 
Therefore, the first objective of this study was to determine whether there are any 
gender-specific COL5A1 BstUI RFLP genotype effects on chronic Achilles 
tendinopathy. The younger male control group within the ACL study had a lower CC 
genotype frequency, and therefore the second objective was to investigate whether 
the distribution of this COL5A1 polymorphism within the combined asymptomatic 
control participants is age-dependent, particularly among the males.  
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Figure 8.2: The mean (black dots) and standard deviation (horizontal error bars) of the age 
of the (A) male and (B) female CON (asymptomatic control participants), ACL (participants 
with ACL rupture) and TEN (participants with Achilles tendinopathy) groups within the South 
African ACL study (SA ACL), the South African Achilles tendinopathy study (SA TEN), and 
the Australian Achilles tendinopathy study (AUS TEN). The number of participants (n) in 
each group is shown in parentheses.    
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8.2 RESULTS 
 
8.2.1 GENDER-SPECIFIC COL5A1 BSTUI RFLP GENOTYPE EFFECTS IN 
CHRONIC ACHILLES TENDINOPATHY. 
 
When re-analysed, there was no observed evidence that the COL5A1 CC genotype 
was only associated with Achilles tendinopathy in females (Figure 8.3 B,C,E and F).  
Although the relative distribution of the BstUI RFLP CC genotypes within the SA 
CON participants (CC vs. TT + TC, P=0.085)(Figure 8.3 B), as well as the AUS male 
CON participants (CC vs. TT + TC, P=0.055)(Figure 8.3 C) were not significantly 
over-represented when compared to the TEN groups, the genotype distributions of 
the male participants were similar to the genotype distributions of the female 
participants (Figure 8.3 E and F). Furthermore, the CC genotype was only 
significantly over-represented within the female CON participants of the SA TEN 
study (CC vs. TT + TC, P=0.013), and not within the female CON participants of the 
AUS TEN study (CC vs. TT + TC, P=0.291). 
 
It is interesting to note that certain groups (refer to Figure 8.3) were not in Hardy-
Weinberg equilibrium (HWE), and the relevance of this finding will be addressed in 
the following discussion. 
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Figure 8.3: Legend on the following page. 
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(Legend from the previous page) The genotype frequencies of the BstUI RFLP within the 3’-
UTR of the COL5A1 gene among, (A) South African (SA) male participants with ACL 
ruptures (ACL) and controls (CON) (B) South African (SA) male participants with Achilles 
tendinopathy (TEN) and controls (CON) (C) Australian (AUS) male participants with Achilles 
tendinopathy (TEN) and controls (CON) (D) South African (SA) female participants with ACL 
ruptures (ACL) and controls (CON) (E) South African (SA) female participants with Achilles 
tendinopathy (TEN) and controls (CON) (F) Australian (AUS) female participants with 
Achilles tendinopathy (TEN) and controls (CON). The number of participants (n) within each 
groups is shown in parentheses. The Hardy-Weinberg Equilibrium (HWE) P-values for each 
group is also shown.  
 
 
8.2.2 AGE-DEPENDANT DISTRIBUTION OF THE COL5A1 BSTUI RFLP 
GENOTYPE WITHIN ASYMPTOMATIC CONTROL PARTICIPANTS 
 
To investigate whether the genotype distribution of the COL5A1 BstUI RFLP within 
the  asymptomatic control participants is age-dependent, all 550 (299 male, age 
range 18-77 years and 251 female, age range 18-72 years) participants from the 
three studies (SA ACL, 131 male and 83 female;  SA TEN, 84 male and 46 female; 
and AUS TEN, 84 male and 123 female) were combined and divided into three male 
and three female age groups; namely (1) <25 years old (male 21.8 ± 1.4 years and 
female 22.1 ± 1.5 years), (2) 25 to 41 years old (male 31.5 ± 4.9 years and female 
31.6 ± 4.7 years), and (3) >41 years old (male 51.7 ± 8.3 years and female 52.0 ± 
6.8 years).  The average age of onset of injury in the SA ACL study (29.8 ± 12.1 
years, as reported in Study 2 and Study 3 of this thesis), the SA TEN study (39.4 ± 
14.7 years) [143], and the AUS TEN study (40.8 ± 14.2 years) [145], as well as the 
final number of samples in each group was used to determine the age ranges of the 
three groups. 
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As shown in Figure 8.4A there was a similar CC genotype content in all three female 
age groups (23 to 26%).  There was however a significant linear trend (P=0.047) for 
the CC genotype frequency amongst the male age groups, where the youngest 
group had the lowest CC frequency (17%), and the oldest group the highest CC 
frequency (29%) (Figure 8.4 B). It is interesting to note that the genotype distribution 
within certain age categories were not in Hardy-Weinberg equilibrium (HWE) (Figure 
8.4 A and 8.4 B).       
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Figure 8.4: The genotype frequency of the COL5A1 BstUI restriction fragment length 
polymorphism (RFLP) within all (A) female and (B) male asymptomatic control participants 
divided according to age, into participants less than 25 years old (black bars), between 25 
and 41 years old (thatched bars), and greater than 41 years old (clear bars). A significant 
linear trend (P=0.047) for the CC genotype content amongst the male age groups was 
found. The number of participants (n) within each category, as well as the Hardy-Weinberg 
Equilibrium (HWE) P-values are shown in parentheses. 
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8.3 DISCUSSION 
 
The main finding of this study was that there is no observed evidence that the 
associations of the COL5A1 BstUI RFLP with Achilles tendinopathy in the two 
previously published studies were gender-specific. An additional finding was that 
there is an age-dependant distribution of the COL5A1 BstUI RFLP CC genotype 
within the pooled asymptomatic male control participants of the three studies which 
investigated this polymorphism as a possible risk factor for soft tissue injury. These 
two findings provide additional information which may assist in understanding the 
observations presented in Study 2 of this thesis, and the two previously published 
studies [143;145]. 
 
A possible explanation for the age-dependant increase in the frequency of the CC 
genotype of the COL5A1 BstUI RFLP within the pooled asymptomatic male control 
participants is illustrated in Figure 8.5. The youngest group of control participants will 
most likely consists of a mixture of individuals who are at a low and high risk for ACL 
ruptures and/or Achilles tendinopathy, due to the fact that they haven’t been exposed 
to a sufficient number of extrinsic risk factors and/or an inciting event (as described 
in Section 2.4 of the literature review). However, with increasing chronological age, 
and thus an increased likelihood of sufficient exposure to extrinsic factors and an 
inciting event, more individuals with an inherent genetic predisposition in this 
asymptomatic group will become injured, and less subjects will remain 
asymptomatic. This could explain the observed increased frequency of participants 
at low risk of ACL and Achilles tendinopathy within the older groups. It is evident 
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from this explanation that a well selected asymptomatic control group is also highly 
selective, especially with increasing age, similar to the symptomatic injury group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.5: A proposed explanation for the significant linear trend in CC genotype frequency 
among the asymptomatic male participants when divided into the 3 age groups (<25 year, 25 
– 41 year, and >41 years). It is proposed that asymptomatic participants in the age category, 
<25 years, will most likely include participants at high risk of ACL rupture (grey individuals), 
those at high risk of Achilles tendinopathy (black individuals), and those with low risk of ACL 
ruptures and/or Achilles tendinopathy (light individuals). Increasing chronological age is 
graphically represented in the top grey box. The age-specific incidence (age at which 
individuals are most likely to incur an injury) of ACL ruptures and Achilles tendinopathy [28] 
are graphically represented within the bottom grey box, and the mean age of onset (mean 
age of all injuries) of ACL and TEN injuries are shown with a white start. The age-specific 
incidence and the mean age of onset are indications of the age at which individuals are 
exposed to sufficient extrinsic factors and/or an inciting event to develop the injury. 
Individuals are more accurately selected for either the asymptomatic cohort or symptomatic 
cohort once they have been exposed to sufficient extrinsic factors. 
 
>41 year25-41 years<25 years
Asymptomatic
Cohort
(Controls)
Symptomatic
Cohort
Chronological Age:
ACL
TEN
TENACL
Chronic Achilles 
tendinopathy
Incidence:
ACL ruptures
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
  COL5A1 COMBINED ANALYSIS  
181 
 
 
The selection which occurs when recruiting symptomatic injury and asymptomatic 
control participants may be observed as a departure from Hardy-Weinberg 
equilibrium (HWE), which, amongst other possible explanations, can also be an 
indication of a natural selection for a particular genotype [158]. Due to the selective 
nature of the symptomatic and asymptomatic injury groups, especially the older 
asymptomatic control groups, not all groups from the previous studies were in Hardy 
Weinberg equilibrium (HWE) (refer to Figure 8.3). However, when all the 
asymptomatic and symptomatic participants were combined and analysed, the 
genotype distributions of all participants in the study were in HWE (SA ACL study 
p=0.911, SA TEN study p=0.276, and AUS TEN study p=0.724) [145;172].   
 
Furthermore, it is interesting to note that the frequency of the CC genotype in the 
young female asymptomatic control participants with ACL ruptures, were similar to 
the older AUS TEN and SA TEN studies. This could be explained by the fact that it 
has been widely reported, as previously discussed (Section 2.4.2), that females are 
at greater risk of ACL rupture compared to their male counterparts. Therefore it 
remains possible that, among already predisposed female participants, the 
asymptomatic participants will become more selected at an earlier age, when 
compared to male asymptomatic participants.  
 
 A limitation of this study was that it was not possible to analyse the SA and AUS 
data separately due to small sample sizes and uneven genotype distribution.  Forty-
three percent (n=39 of 90) of the oldest male age group for example were from the 
AUS study, while 87% (n=74 of 85) of the youngest male age group were from the 
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SA studies.  Another limitation of this study was that although all the control 
participants were asymptomatic for ACL and/or Achilles tendon injuries, as 
discussed in chapter 4, and in the previously published original articles [143;145], not 
all of the participants were free of self-reported tendon and ligament injuries. 
 
In conclusion, although the CC genotype of the COL5A1 BstUI RFLP was 
significantly under-represented in females, but not males with ACL ruptures (refer to 
Study 2), there appears to be no gender-specific under-representation of this 
genotype within chronic tendinopathy. Consequently, there is an age-dependant 
increase in the CC genotype of this sequence variant within a pooled group of 
asymptomatic controls. 
 
The practical implication of this study is that the selection of control groups is of 
critical importance when future studies of this nature are designed. Future research 
investigating this genetic variant as a risk factor for soft tissue injuries should 
consider the findings of this study when selecting a control group.   
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CHAPTER 9 
 
SUMMARY AND CONCLUSIONS 
 
 
The exact aetiology of and risk factors for ruptures of the anterior cruciate ligament 
(ACL) in the knee are not yet fully understood. This is despite a large volume of 
published research in this area. However, in reviewing the existing literature 
(Chapter 2), it is clear that ACL rupture is a multifactorial condition, for which various 
extrinsic and intrinsic risk factors have been identified [6]. Recently, among the 
intrinsic risk factors, certain genetic elements have been suggested to predispose 
individuals to ACL ruptures. To date, only two studies have investigated a possible 
familial predisposition for ACL ruptures [7;10], while only a single study has 
investigated the association of a specific sequence variant, namely the functional 
COL1A1 Sp1 binding site polymorphism with acute ligament injuries [9]. Of further 
interest, genetic sequence variants within the COL5A1 [143;145], TNC [144] and 
MMP-3 [147] genes have on the other hand been shown to be associated with 
another soft tissue injury, Achilles tendinopathy. Previous research from this 
laboratory has also suggested that variants within the COL12A1 gene might 
specifically be associated with Achilles tendon ruptures [148]. These observations 
suggest that soft tissue injuries such as Achilles tendon injuries and ACL ruptures 
might be polygenic in nature. Therefore, an approach to 1) identify possible 
candidate genes that are associated with these soft tissue injuries, and 2) conduct 
studies to determine a possible association between the candidate genes and these 
injuries, is logical. Data from these studies will increase the understanding of 
possible intrinsic risk factors for these injuries and may ultimately influence 
prevention, treatment and rehabilitation strategies for these injuries.  
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The COL1A1, COL5A1 and COL12A1 genes encode for structural collagenous 
components of the microfibril, the basic building block of ligaments. Since variants 
within these three genes have been shown or suggested to be associated with other 
soft tissue injuries, they were selected as candidate genes for the genetic 
association studies that were presented in this thesis. In this concluding chapter of 
the thesis, the aims will be-restated, and then a summary of the results from the 
studies that were conducted to address the aims will be presented. 
    
1. Primary aim: To identify whether the selected candidate genes (COL1A1, 
COL5A1 and COL12A1) predispose individuals to ACL ruptures.  
 
As previously mentioned, the rare TT genotype of the functional COL1A1 Sp1 
binding site polymorphism was previously reported to be under-represented in 
Swedish participants with acute ligament injuries (cruciate ligament ruptures and 
shoulder dislocations) [9]. In support of this finding, this polymorphism was shown, in 
this thesis, to be significantly under-represented (OR=12.3; CI 0.7 - 220.4; P=0.031) 
in participants with ACL ruptures, when compared to controls with no history of 
ligament or tendon injuries, in a South African Caucasian population. In addition, 
there was no evidence of a gender-specific effect of this variant on ACL ruptures. 
 
The novel findings of this thesis were that the COL5A1 BstUI RFLP and the 
COL12A1 AluI RFLP were significantly associated with ACL ruptures in female, but 
not male participants. The CC genotype of the COL5A1 BstUI RFLP (OR=6.6, 95% 
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CI 1.5 – 29.7; P=0.006) and the AA genotype of the COL12A1 AluI RFLP (OR=2.4, 
95% CI 1.0 – 5.5; P=0.048) were significantly under- and over-represented, 
respectively, in the female ACL group, when compared to the female CON group. No 
significant genotype distributions between the CON and ACL groups were however 
observed for the COL5A1 DpnII and COL12A1 BsrI RFLPs.  
 
These findings only provide initial evidence that sequence variants within genes 
which encode for structural collagenous components of the ligament microfibril are 
significant risk factors for ACL ruptures, especially among females. The possible 
reasons for the gender-specific associations of the COL5A1 BstUI and COL12A1 
AluI RFLPs are not known. It is however not a unique observation that certain 
intrinsic risk factors for ACL ruptures are only associated with females. It has been 
documented that other intrinsic risk factors, such as BMI [55] and anterior knee laxity 
[55] are also risk factors which have only been found to be associated with ACL 
ruptures among female, but not the male participants. In addition, certain proposed 
anatomical risk factors such a ACL geometry, generalised joint laxity and lower 
extremity alignment have been shown to be significantly different between males and 
females. More specifically, females have a smaller ACL when normalised for 
bodyweight [71], increased generalised joint laxity [87] and an increased Q angle 
[59;60].  
 
Besides the specific intrinsic risk factors which predispose females to ACL ruptures, 
the type of playing surface, an extrinsic risk factor, has also been shown to be 
associated with female, but not male participants [54]. It was proposed that greater 
traction may interact with the more prevalent intrinsic risk factors in women, when 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER 9  
186 
 
compared to men, and thereby only increase the risk of ACL ruptures in females 
[54]. Similarly to this proposed mechanism, the gender-specific genetic associations 
in this thesis may also be a result of the interaction between the COL5A1 BstUI and 
COL12A1 AluI RFLPs and the additional intrinsic risk factors within females. Based 
on the gender-specific associations found in this thesis, it is proposed that separate 
models are developed to understand the causation of ACL ruptures in males and 
females (Figure 9.1).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1: A schematic diagram, adapted from the original model proposed my Meeuwisse 
[39], illustrating the complex relationship between intrinsic risk factors, extrinsic risk factors 
and a specific inciting event in the causation of ACL ruptures. Several intrinsic risk factors, 
broadly classified as either anatomical, hormonal, neuromuscular or genetic elements, have 
been identified. The findings from this thesis are incorporated into the model. Different 
genetic sequence variants (the COL1A1 Sp1 binding site polymorphism, the COL5A1 BstUI 
RFLP and the COL12A1 AluI RFLP) have been identified for males and females, and it is 
therefore proposed that separate injury causation models are produced.  
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2.  Secondary aim: To further investigate the similarities and differences 
between the genetic risk factors for ACL ruptures and other soft tissue 
injuries. 
 
Due to the similar structure of tendons and ligaments, it has been proposed that 
injuries to these tissues might share common genetic risk factors [163]. On the other 
hand, tendons and ligaments are functionally different, which implies that there might 
also be specific genetic sequence variants only associated with a specific injury 
[173]. The primary findings that the COL5A1 BstUI and COL12A1 AluI RFLPs are 
associated with ACL ruptures in females provide initial evidence that there are, in 
part, some potential common underlying genetic predispositions to ACL ruptures and 
Achilles tendinopathy and/or Achilles tendon ruptures. Furthermore, among the 
candidate genes investigated in this thesis, only the COL1A1 variant has not been 
investigated as a candidate gene for other chronic and acute musculoskeletal soft 
tissue injuries (Achilles tendinopathy and/or Achilles tendon ruptures).   
 
COL1A1 Sp1 binding site polymorphism 
Although not statistically significant the rare TT genotype of the COL1A1 Sp1 binding 
site polymorphism was absent in participants with another acute soft tissue injury 
(spontaneous Achilles tendon ruptures). The TT genotype was however present in 
participants with chronic Achilles tendinopathy. When the data for the COL1A1 Sp1 
binding site polymorphism from this thesis, and previously published data, were 
combined and analysed, the TT genotype was shown to be associated with an 11.1 
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times reduced risk of acute musculoskeletal soft tissue ruptures (cruciate ligament 
ruptures, shoulder dislocations, and Achilles tendon ruptures). Furthermore, when 
only the risk of cruciate ligaments were analysed, the TT genotype was associated 
with a 15.1 times reduced risk of cruciate ligament ruptures.   
 
The T allele of the functional Sp1 binding site polymorphism has been shown to be 
associated with an increased binding affinity for the transcription factor Sp1, which 
was accompanied by an increase in COL1A1 mRNA, and an altered production of 
the α1(I) chain relative to the α2(I) chain [155]. The relative increase in the α1(I) 
chain production is believed to result in a homotrimeric type I collagen molecule, 
consisting of 3 α1(I) chains, which has been proposed as a possible explanation for 
reduced bone quality and strength, that is seen in osteoporosis [155]. From the 
findings presented in this thesis, and the previous Swedish study [9], the COL1A1 
Sp1 binding site polymorphism does however seem to have the opposite effect 
within soft tissues. The previously proposed increased COL1A1 mRNA which results 
from a TT genotype [155], may increase the tensile strength of ligaments, thereby 
reducing the risk of ACL rupture. 
 
COL5A1 BstUI RFLP 
Furthermore, there was no evidence that the previously reported association of the 
COL5A1 BstUI RFLP with Achilles tendinopathy was gender-specific. There was 
however a significant age dependant increase in the CC genotype distribution 
(P=0.047) among the pooled male asymptomatic CON participants studied in this 
thesis, and previously published papers [143;145]. A similar trend among the female 
participants was not observed. It was proposed that the younger male control 
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participants will most likely consist of a mixture of individuals who are at low and high 
risk of ACL ruptures and/or Achilles tendinopathy, due to the fact that they have not 
been exposed to a sufficient number of extrinsic risk factors and/or an inciting event. 
However, with increasing chronological age, and thus an increased likelihood of 
sufficient exposure to extrinsic factors and an inciting event, more individuals will 
become injured, and less individuals will remain asymptomatic. This comparative 
analysis highlights the importance of control groups recruitment and selection. 
 
As proposed in this thesis, it is important to mention that unlike the functional 
COL1A1 Sp1 binding site polymorphism, the exact functions of the COL5A1 BstUI 
and COL12A1 AluI RFLPs are unknown. Although a priori hypothesis was used in 
selection of the candidate genes, the function of the variants used within these 
genes were not necessarily known. The nature of genetic association studies do not 
exclude the fact that the associated sequence variant is in linkage disequilibrium with 
the functional polymorphism within the same gene or a neighbouring gene. This 
possibility can however not be excluded. The BstUI RFLP within the 3’-UTR of the 
COL5A1 gene and the AluI RFLP within exon 65 of the COL12A1 do however have 
interesting features which warrant further discussion.  
 
The 3’-UTR of a gene has been described as a zone rich in translational control 
mechanisms [174]. Regions within the 3’-UTR have been proposed to regulate (1) 
mRNA stability, (2) subcellular localisation of transcripts, (3) termination of 
transcription, and (4) the stabilisation of specific transcripts [174]. Moreover, miRNA 
recognition sequences [145], expressed sequence tags (ESTs) [145] and different 
polyadenylation signals (N, Laguette, personal communication) have been identified 
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within the 3’-UTR of the COL5A1 gene. Further studies, using molecular and cell 
biological techniques are required to establish whether any of these features 
contribute to altered transcription and/or translation of the COL5A1 gene.  
 
COL12A1 AluI RFLP 
The COL12A1 AluI RFLP was not investigated as an additional combined analysis, it 
is however important to note that the findings of this thesis were consistent to the 
previous observations in Achilles tendon ruptures [148]. Although the GG genotype 
of the COL12A1 AluI RFLP which was absent in participants with Achilles tendon 
ruptures, was present in ACL participants, the opposite AA genotype was over-
represented in participants with ACL ruptures. Furthermore, the AluI RFLP is a non-
synonomous polymorphism, which changes the amino acid at position 3058 from a 
serine to a glycine. Although it is interesting to note that glycine is a smaller amino 
acid than serine, the exact function of this change in amino acid sequence is not 
known. Further research is therefore required to establish the function of this 
polymorphism, and more specifically, the function of this amino acid substitution on 
the protein. 
 
* 
In the process of answering the primary and secondary aims of this thesis, other 
noteworthy observations were made.  In agreement with the previous findings of a 
familial predisposition to ACL ruptures [7;10], the participants in the ACL group had a 
significantly higher family history of ligament injury (13.5% vs. 39.6%, P<0.001), 
when compared to the CON participants in Study 1. When the CON group of Study 1 
was separated by gender, both the male and female participants of the ACL group 
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had a significantly greater family history of ligament injuries. Similar findings were 
observed when the female ACL group was compared to the female CON group 
included in Studies 2 and 3 (21.5% vs. 50.0%, P=0.002). It is interesting to note that 
no significant difference was found when the male ACL group was compared to the 
male CON group included in Studies 2 and 3. The reasons for these differences are 
not apparently obvious. It is however important to note that there were differences 
between the CON groups of Study 1, 2 and 3. The CON group in Study 1 had no 
previous history of any ligament and/or tendon history, whereas the CON 
participants in Studies 2 and 3 had no previous history of only ACL ruptures. 
 
These data further suggest that the genetic risk of ACL ruptures may be pronounced 
in females. As mentioned, only two studies have previously reported a familial 
predisposition to ACL ruptures, and therefore the data presented in this thesis 
contribute to the body of evidence suggesting a genetic predisposition as a risk 
factor for ACL ruptures (Table 9.1). As discussed in section 2.4.2.4.1, the level of 
certainty from the two previous studies, that familial predisposition is risk factor for 
ACL ruptures is moderate. However, the previous studies which investigated a 
familial predisposition did not analyse the male and female participants separately. 
When data from previous studies, and the data from the current thesis were 
combined, the level of certainty that familial predisposition is a risk factor for ACL 
ruptures is moderate among females, and low among males, due to the conflicting 
results (Table 9.1).  
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Table 9.1: Summary of research studies, from previous research and the results of 
this thesis, investigating genetic risk factors for ACL ruptures, including the level of 
evidence of each individual study and the level of certainty that the risk factor is 
associated with risk of ACL ruptures.  
 
The findings from this thesis are underlined. a The level of evidence according to evidence-
based medicine criteria [42]. b The level of certainty, as described in section 2.4. c All bilateral 
ACL ruptures. d All cruciate ligament injuries, ACL and PCL. 
Risk Factor 
Study Details and 
References 
Number 
of ACL 
ruptures 
Level of 
evidence 
(I-IV)a 
Level of 
Certaintyb 
Familial 
predisposition 
Positive Associations 
Case-control studies: 
ACL patients [10] 
ACL patients [104] 
ACL patients  
- Study 1 of this 
thesis 
- Study 2&3 of this 
thesis – females 
only 
No Associations 
Case-control studies: 
      ACL patients 
           -    Study 2&3 of this 
                thesis - males only 
 
 
31c 
171 
 
117 
 
38 
 
 
 
 
 
 
91 
 
 
III 
III 
 
III 
 
III 
 
 
 
 
 
 
III 
Moderate 
(in females) 
Low (in 
males) 
COL1A1 Sp1 
binding site 
polymorphism 
Positive Associations 
Case-control studies: 
ACL patients [9] 
ACL patients  
- Study 1 of this 
thesis 
 
 
233d 
 
117 
 
 
III 
 
III 
Moderate 
 
COL5A1 BstUI 
RFLP 
Positive Associations 
Case-control studies: 
ACL patients  
- Study 2 of this 
thesis – only 
females 
 
 
 
129 
 
 
 
III 
Low 
COL12A1 AluI 
RFLP 
Positive Associations 
Case-control studies: 
ACL patients  
- Study 3 of this 
thesis – only 
females 
 
 
 
129 
 
 
 
III 
Low 
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Additionally, it was observed that when all the ACL and CON participants were 
combined and analysed, the genotype distribution of the COL5A1 BstUI RFLP was 
significantly different between participants with a family history of ligament injury, and 
participants without a family history of ligament injury (P=0.022). This finding 
remained significant when only female participants were analysed (P=0.005), but not 
when male participants were analysed (P=0.369).  A similar finding was also 
observed for the COL12A1 AluI RFLP and family history of ligament injuries, where 
there was a trend (P=0.082) for the AA genotype of the COL12A1 AluI RFLP to be 
over-represented in female participants with a family history of ligament injury, when 
compared to female participants without a family history of ligament injury. These 
findings provide further support that the BstUI and the COL12A1 AluI RFLPs are 
associated with an increased risk of ACL ruptures in females. 
 
It is important to note that there are strengths and limitations to the study design 
presented in this thesis. A strength of this thesis is that the primary studies 
investigated a single well defined injury, namely ACL ruptures. All ACL ruptures were 
confirmed at the time of surgery. Moreover, all Achilles tendon injuries (Achilles 
tendinopathy and/or Achilles tendon ruptures) were either clinically diagnosed or 
diagnosed at the time of surgery. Furthermore, attempts were made to match the 
ACL, TEN and RUP groups to their respective CON groups, however, it might be 
seen as a limitation that there were certain differences. In particular, there were 
some differences in sports participation between the ACL groups and their 
respective CON groups. Another limitation of this thesis was the relatively small 
sample size of the female participants with ACL ruptures and the small sample size 
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of participants with Achilles tendon ruptures. The primary aim of the thesis was not to 
investigate gender-specific genetic risk factors and therefore future studies should 
recruit a larger group of either males and/or females and determine sample sizes for 
each group separately. Furthermore, there are also differences between chronic 
Achilles tendinopathy and acute Achilles tendon ruptures, future studies should also 
investigate these injuries separately.     
 
It is important to emphasise that the findings of this thesis, particularly for the novel 
associations of the COL5A1 BstUI and COL12A1 AluI RFLPs, be confirmed in future 
studies within independent populations. The field would be advanced if international 
consortia collaborated to use high throughput genome wide association or 
sequencing technologies on large cohorts. Proposed molecular mechanisms from 
these association studies should be tested using various cell and molecular biology 
techniques.  These experiments would assist to eventually determine a cause and 
effect relationships between polymorphisms and specific soft tissue 
injuries. Eventually, prospective cohort studies should be designed to confirm the 
clinical significance and relevance of these associations. Nevertheless, this thesis 
does provide very useful initial evidence that genetic elements within genes which 
encode for structural components of the ligament microfibril are significant risk 
factors for ACL ruptures, in particular among females. As reviewed (Section 2.4.2.4), 
prior to this thesis only a few studies have investigated genetic factors as risk factors 
for ACL ruptures (Refer to Table 2.5). The additional contribution this thesis makes 
to the body of research investigating genetic risk factors to ACL ruptures is 
significant (Table 9.1). In addition, this thesis has implicated specific genes which 
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require further investigation to assist our understanding of the aetiology of ACL 
ruptures. 
 
Furthermore, the data presented in this thesis has potential significant clinical 
implications. Identifying individuals at an increased risk of ACL rupture may have 
significant application in the reduction of these severe injuries. It is recommended 
that the findings of this thesis be incorporated into multifactorial models developed to 
reduce the incidence of ACL ruptures among predisposed individuals.  
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APPENDIX 1 
 
ADDITIONAL INFORMATION 
 
 
 
Table A1.1: The frequencies of the most common self reported form of sports 
participation in the female and male anterior cruciate ligament rupture (ACL) group.  
Female participants (n=35)  Male participants (n=82) 
Sportsa Frequency (%)  Sportsb Frequency (%) 
Field hockey 60.0  Rugby 75.6 
Tennis 42.5  Cricket 36.6 
Netball 42.9  Squash 29.3 
Squash 25.7  Soccer 24.4 
Swimming 22.9  Tennis 22.0 
Athletics 17.1  Field hockey 15.9 
Road running 14.3  Athletics 14.6 
   Road running 12.2 
   Swimming 12.2 
   Golf 11.0 
 
a Only sports which had been reportedly played by greater than 10% of all female 
participants were included in the table. Other minor sports not listed included aerobics, 
badmington, ballet, cross country, dancing, equestrian, golf, gymnastics, hiking, modern 
dancing, motorcross, paragliding, rugby, snow skiing, surfing, touch rugby, waterpolo and 
waterskiing.  
b Only sports which had been reportedly played by greater than 10% of all male participants 
were included in the table. Other minor sports not listed include action cricket, badminton, 
baseball, basketball, BMX, canoeing, cross country, cycling, equestrian, Gaelic football, 
hurling, kite boarding, martial arts, mountain biking, motocross, paragliding, rowing, sailing, 
skateboarding, snow skiing, surfing, touch rugby, triathlon, volleyball, wakeboarding, 
waterpolo, water skiing and yachting. 
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Table A1.2: General characteristics of the South African born participants in the respective control (CON) and anterior cruciate 
ligament rupture (ACL) groups, as well as the direct contact (DIR), indirect contact (IND) and non-contact (NON) ACL rupture sub-
groups. 
 
Gender and country of birth are represented as a frequency (%). The remaining variables are expressed as mean ± standard deviation. The 
number of subjects (n) for each variable is in parentheses.  
a Age, weight and BMI are self-reported values at the time of the first ACL rupture for the ACL group, as well as the DIR, IND and NON sub-
groups, and at recruitment for the CON group. For the ACL group the age, weight and BMI at recruitment were 5.0 ± 8.7 years (n=90), 1.1 ± 4.5 
kg (n=88) and 0.4 ± 1.5 kg/cm2 (n=85) greater than at the time of the first ACL rupture.   
b  CON vs ACL; c CON vs DIR vs IND vs NON 
Pairwise, post hoc significant differences: d CON vs DIR (p<0.001); e CON vs NON (p<0.001); f DIR vs IND (p=0.032) 
n.d. = not determined due to small sample sizes 
 CON ACL P-value b DIR IND NON P-value c 
Age (years) a 36.1 ± 9.2 (86) d,e 29.2 ± 11.7 (90) <0.001 25.1 ± 12.2 (13) d,f 32.7 ± 12.8 (15) f 27.8 ± 11.4 (42) e <0.001 
Height (cm) 177.6 ± 10.4 (90) 176.7 ± 9.8 (88) 0.580 175.4 ± 8.2 (13) 179.4 ±9.0 (14) 1178.0 ± 9.2 (41) 0.781 
Weight (kg) a 76.8 ± 14.2 (91) 79.5 ± 16.2 (88) 0.244  80.5 ± 12.5 (13) 87.7 ± 15.7 (14)  80.6 ± 16.4 (41) 0.080 
BMI (kg/cm2) a 24.2 ± 3.5 (90) 25.1 ± 3.2 (85) 0.078  26.1 ± 2.7 (13) 25.5 ± 2.7 (13) 25.2 ± 3.5 (40) 0.203 
Gender (% males) 72.5 (91) 71.4 (91) 0.869 92.3 (13) 86.7 (15) 72.5 (42) n.d. 
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Table A1.3: Relative genotype and allele frequencies of the COL1A1 Sp1 binding site 
polymorphism within the South African born control (CON) and anterior cruciate 
ligament rupture (ACL) groups, as well as the direct contact (DIR), indirect contact 
(IND) and non-contact (NON) ACL rupture sub-groups . 
 
 CON 
(n=91) 
ACL 
(n=91) 
DIRb 
(n=13) 
INDb 
(n=15) 
NON 
(n=42) 
GG genotype (%) 71.4 (65) 65.9 (60) 76.9 (10) 73.3 (11) 69.1 (29) 
GT genotype (%) 24.2 (22) 34.1 (31) 23.1 (3) 26.7 (4) 31.0 (13) 
TT genotype (%) a 4.4 (4) 0 (0) 0 (0) 0 (0) 0 (0) 
G allele (%) 83.5 (152) 83.0 (151) 88.5 (23) 86.7 (26) 84.5 (71) 
T allele (%) 16.5 (30) 17.0 (31) 11.5 (3) 13.3 (4) 15.5 (13) 
 
The values are expressed as a percentage with the number of subjects (n) in parentheses.  
a Due to the absence of participants with a TT genotype in the ACL group and three sub-
groups, the GT and TT participants were combined nd compared to the GG participants. 
CON vs ACL genotypes, p=0.523. CON vs NON genotypes, p=0.839. CON vs ACL alleles, 
p=1.000. CON vs NON alleles, p=1.000 
b due the small sample size, the DIR and IND groups were not further analysed. 
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Table A1.4: Characteristics of all participants (combined male and female) within the 
asymptomatic control (CON) group, the anterior cruciate ligament rupture (ACL) 
group and the ACL sub-group with a non-contact (NON) mechanism of injury. 
 
 CON ACL P-Value b NON P-value c 
Age a (years) 28.7 ± 11.4 (215) 28.6 ± 11.0 (124) 0.958 27.9 ± 10.8 (54) 0.641 
Height (cm) 175.1 ± 9.2 (210) 176.7 ± 9.5 (113) 0.145 177.0 ± 9.2 (52) 0.195 
Weight a (kg) 74.2 ± 15.5 (212)d 79.8 ± 17.1 (114) 0.003 79.7 ± 17.2 (53) 0.026 
BMI a (kg/m2) 24.1 ± 3.7 (208) 25.3 ± 3.8 (109) 0.007 25.2 ± 4.3 (50) 0.054 
Gender (% male) 61.1 (216) 70.5 (129) 0.076 66.7 (54) 0.451 
Country of birth (% 
South Africa) 86.5 (207) 86.3 (117) 0.970 85.2 (54) 0.826 
 
Gender and country of birth are represented as a frequency (%). The remaining variables 
are expressed as a mean ± standard deviation. The number of subjects (n) for each variable 
is in parentheses.  
a  Age, weight and body mass index (BMI) are self-reported values at the time of the first 
ACL rupture for the ACL group, as well as the NON sub-group, and at recruitment for the 
control group. For the ACL group, age, weight and BMI at recruitment were 5.0 ± 8.5 years 
(n=120), 1.3 ± 4.6 kg (n=110) and 0.5 ± 1.5 kg/m2 (n=106), greater than at the time of the 
first ACL rupture.   
b  CON vs ACL. c CON vs NON.  
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Table A1.5: Relative genotype and allele frequencies of the BstUI and DpnII restriction 
fragment length polymorphisms (RFLPs) within the 3’-UTR of the COL5A1 gene in all 
(males and females combined) control group, anterior cruciate ligament rupture (ACL) 
group and the non-contact mechanism of ACL rupture sub-group. 
 
 
 CON 
(n=215) 
ACL 
(n=129) P-Value
a NON 
(n=54) P-Value
b 
BstUI RFLP      
     TT genotype (%) 28.8 (62) 33.1 (42) 
0.280 
35.2 (19) 
0.549 
     TC genotype (%) 51.2 (110) 53.5 (68) 50.0 (27) 
     CC genotype (%)  20.0 (43) 13.4 (17) 14.8 (8) 
     T allele (%)  (234)  (152) 
0.199 
 (65) 
0.332      C allele (%)  (196)  (102)  (43) 
DpnII RFLP      
     TT genotype (%) 52.8 (113) 51.2 (66) 
0.921 
55.6 (30) 
0.717c 
     TC genotype (%) 42.1 (90) 44.2 (57) 40.7 (22) 
     CC genotype (%)  5.1 (11) 4.7 (6) 3.7 (2) 
     T allele (%)  (316)  (189) 
0.939 
 (82) 
0.748      C allele (%)  (112)  (69)  (26) 
 
The values are expressed as a percentage with the number of subjects (n) in parentheses. 
a P values for CON vs ACL genotype and allele frequencies. 
b P values for CON vs NON genotype and allele frequencies. 
c Due to the small sample size of the DpnII RFLP CC genotype, the CC and TC participants 
were combined and compared to the TT participants for the CON vs NON analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
APPENDIX 1 
222 
 
Table A1.6: Relative genotype and allele frequencies of the BstUI restriction fragment 
length polymorphisms (RFLPs) within the 3’-UTR of the COL5A1 gene in the male and 
female participants of the control (CON) group, anterior cruciate ligament rupture 
(ACL) group and the non-contact mechanism of ACL rupture sub-group after all 
participants with a history of Achilles tendon injuries were excluded. 
 
 
 CON 
(n=215) 
ACL 
(n=129) P-Value
a NON 
(n=54) P-Value
b 
Male participants      
     TT genotype (%) 27.0 (30) 29.6 (21) 
0.884 
28.6 (8) 
0.822 
     TC genotype (%) 55.9 (62) 52.1 (37) 50.0 (14) 
     CC genotype (%)  17.1 (19) 18.3 (13) 21.4 (6) 
     T allele (%)   55.0 (122)  55.6 (79) 
0.914 
53.6 (30) 
0.881      C allele (%)  45.0 (100)  44.4 (63) 46.4 (26) 
Female participants      
     TT genotype (%) 29.0 (22) 45.5 (15) 
0.021c 
50.0 (22) 
0.098d 
     TC genotype (%) 46.1 (35) 48.5 (16) 43.8 (7) 
     CC genotype (%)  25.0 (19) 6.1 (2) 6.3 (1) 
     T allele (%) 51.2 (79) 69.7 (46) 
0.017 
85.2 (51) 
<0.001      C allele (%)   48.8 (73) 30.3 (20) 14.8 (9) 
 
The values are expressed as a percentage with the number of subjects (n) in parentheses. 
a P values for CON vs ACL genotype and allele frequencies. 
b P values for CON vs NON genotype and allele frequencies. 
c The CC genotype is significantly under-represented in the female ACL group (CC genotype 
vs GG + GT genotypes). 
d CC genotype vs GG +GT. 
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Table A1.7: Relative genotype and allele frequencies of the AluI and BsrI restriction 
fragment length polymorphisms (RFLPs) within the COL12A1 gene in all (males and 
females combined) control group, anterior cruciate ligament rupture (ACL) group and 
the non-contact mechanism of ACL rupture sub-group. 
 
 
 CON 
(n=215) 
ACL 
(n=129) P-Value
a NON 
(n=54) P-Value
b 
AluI RFLP      
     AA genotype (%) 56.5 (121) 66.9 (85) 
0.067c 
67.3 (35) 
0.208c 
     GA genotype (%) 40.2 (86) 29.9 (38) 26.9 (14) 
     GG genotype (%)  3.3 (7) 3.15 (4) 5.8 (3) 
     A allele (%)  76.6 (328)  81.9 (208) 
0.122 
 80.8 (84) 
0.433      G allele (%)  23.4 (100) 18.1 (46)  19.2 (20) 
BsrI RFLP      
     TT genotype (%) 50.2 (108) 50.4 (65) 
0.665 
48.2 (26) 
0.679 
     TC genotype (%) 42.3 (91) 39.5 (51) 40.7 (22) 
     CC genotype (%)  7.4 (16) 10.1 (13) 11.1 (6) 
     T allele (%) 71.4 (307)  70.2 (181) 
0.730 
 68.5 (74) 
0.556      C allele (%)  28.6 (123)  29.8 (77)  31.5 (34) 
 
The values are expressed as a percentage with the number of subjects (n) in parentheses. 
a P values for CON vs ACL genotype and allele frequencies. 
b P values for CON vs NON genotype and allele frequencies. 
c Due to the small sample size of the AluI RFLP GG genotype, the GG and GA participants 
were combined and compared to the TT participants.  
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